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  Abstract 
 
Women remain disproportionately infected by HIV, accounting for more than half of the global 
infected population. Biologically women are more susceptible to HIV infection than men, however, 
their vulnerability is aggravated by various socio-cultural, structural and economic factors. 
Women in Sub-Saharan Africa carry a significant burden of the epidemic, making up 56% of all 
adult infections in the region, and up to 70% of all global infections. Young women aged 15-24 
(AGYW) are hardest-hit by HIV, reportedly making up 25% of all new infections in the region, 
despite constituting only 17% of the adult population.  
 
Despite the alarming infection rates, prevention options for women remain limited. Available 
methods such as the male and female condom have proven to be impractical for women, 
disregarding gender power dynamics that deny women the power to initiate or negotiate safe sex 
practices. Given the limitation of these prevention methods, the field of HIV has shifted focus to 
developing prevention methods that allow women autonomy over their protection against sexually 
acquired HIV. Microbicides are female-initiated biomedical prevention technologies designed to 
reduce women’s reliance on male partner’s cooperation or consent for use. Currently, there is no 
licensed microbicide product for public use, however, a couple of microbicide agents (the 
tenofovir gel and dapivirine ring) have demonstrated efficacy in clinical trials. Various microbicide 
agents are still undergoing clinical trials, coupled with a large volume of complimentary qualitative 
studies that examine possible barriers and facilitators for acceptance and utilisation in real life 
settings. 
 
This study investigates the perceptions of microbicides amongst men and women across urban 
and rural settings in Durban and Nelspruit, South Africa. The study aims to identify the factors 
that may impede or facilitate microbicide use amongst women. The study also builds on a paucity 
of literature on studies assessing the impact of male involvement, and its impact on acceptance 
and uptake of microbicides amongst women. This study aims to contribute to the body of 
knowledge on the various contextual factors to consider when introducing microbicides across 
diverse populations. 
 
The study employed a qualitative research approach, using focus group discussions as a data 
collection method. The data was collected from purposively selected men and women aged 18-
55 from eight urban and rural settings in KwaZulu-Natal and Mpumalanga; provinces with the 
highest HIV prevalence in South Africa. The data was transcribed and analysed through thematic 
analysis, which was used to develop themes that emerged. Drawing from the Social Ecological 
Model of Communication and Health Behaviour (SEMCHB), identifying the community as an 
interrelated entity that has great influence in shaping an individual’s health behaviour. The study 
applied the Culture-Centred Approach (CCA), which proposes that health intervention 
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programmes should be designed in a way that is consistent with a community’s cultural 
framework. 
 
The study found that even with initiatives to empower women, societal structures and masculinity 
still hold great influence on women’s decisions to adopt new prevention methods as they find it 
necessary to consult with men regarding decisions about their sexual health. Male involvement 
is questionable, demonstrating potential for acceptance and male partner support, while also 
posing a threat on women’s autonomy for protection against sexually acquired HIV. 
The study argues that while male involvement can promote acceptance and adherence to 
microbicides in some contexts, this may be detrimental in other contexts, affecting sustainable 
adherence and subjecting women to social harms such as intimate partner violence.  
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CHAPTER ONE: INTRODUCTION 
  
Introduction  
The Human Immunodeficiency Virus (HIV) remains the greatest health problem globally (WHO, 
2016). Despite current preventive and educational interventions, the epidemic continues to grow 
rapidly; becoming widespread in many parts of the world. Approximately ninety percent of the 
world’s infections occur in developing countries due to underdeveloped socio-economic and 
political structures that drive risky sexual behaviour and shape vulnerability to HIV infection (Avert, 
2015). Sub-Saharan Africa (SSA) is the epicentre of the global pandemic in Africa (Avert, 2015), 
reported to be home to 70% of the global HIV infected population (UNAIDS, 2016; Kaiser Family 
Foundation, 2016). Southern and Eastern Africa have the highest HIV profiles in SSA, accounting 
for about 46% of all new HIV cases and over 52% of all people living with HIV globally (KFF, 
2016). South Africa in particular has one of the highest HIV prevalence in the world (Avert, 2015); 
with an estimated 6.19 million people living with HIV (PLHIV) in 2015 (Statistics South Africa, 
2015); the largest HIV population number by country in the world (WHO, 2015). The overall HIV 
prevalence was approximately 11.2% of the total South African population, while there was an 
estimated 16.6% prevalence for adults aged 15–49 years only (Statistics South Africa, 2015).  
 
While the HIV prevalence is generalized within South Africa, infections vary across provinces and 
population groups), as some are more critically affected than others (South African National AIDS 





Figure 1.1: HIV prevalence by province, South Africa, 2013. Source National Department of 
Health (2013) 
 
The statistics above show that there is provincial variation amongst the prevalence, ranging from 
40.1 % in KwaZulu- Natal (KZN), to 17.5% in the Northern Cape (NDOH, 2013). KZN was the 
highest HIV infected province, followed by Mpumalanga (MP) at 37.5% prevalence rates in 2013. 
Furthermore, the districts with the highest prevalence within KZN 2013 were, namely; iLembe- 
45.9%, UMkhanyakude- 44.1%, eThekwini -41.1%, Umgungundlovu- 42.5%, Ugu at 41.1% and 
UThukela 40.0%, and in MP, Gert Sibande at 40.8% (NDOH, 2013). 
 
In terms of population groups, females of reproductive age (15- 49) bear the greatest burden of 
infections (Statistics South Africa, 2015), with prevalence peeking amongst adolescent girls and 
young women (AGYW) aged 15- 24 years (SANAC, 2014). Antenatal reports from NDOH (2013) 
have shown KZN and MP women to have carried a disproportionate burden of infections between 
2009 to 2013. In 2009, KZN women accounted for 39.5% followed by MP women at 34.7 %, and 
40.01 and 37.5 of the national female prevalence in 2013. Both provinces have maintained HIV 
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prevalence increase of between 1.8% to 2.7% during the 5year provincial prevalence trend 
(NDOH, 2013).  
 
This disproportion in infections amongst women is a result of various biological, cultural, socio-
economic and structural factors that increase women’s vulnerability to infection (Ramjee and 
Daniels, 2013; Nxumalo et al, 2014; Mwaura, 2008). These factors are premised on gender 
inequities that perpetuate male dominance in most spheres of women’s lives, including sexual 
issues; while encouraging submissiveness and passivity amongst women (WHO, 2007; Parker, 
2012). Such gender roles and norms, structural and economic imbalances deny women the power 
to negotiate safe-sex practices, thus leaving them vulnerable to infections. Prevention methods 
such as condoms and management strategies that encourage individual behaviour change such 
as the “Abstinence, Be faithful and Condomise” (ABC) approach therefore have been insufficient 
in preventing HIV acquisition amongst women; as they often have limited control over the decision 
to abstain from intercourse, be in monogamous relationships or abstain from intercourse (Alliance 
for microbicide development, 2006; Kline and Oken, 1992). 
 
Given these limitations, biomedical options that offer women control over their protection against 
HIV infection have been proposed. These include the production of Pre Exposure Prophylaxis 
(PrEP) which are antiretroviral-based products such as pills or injectables that are prescribed to 
be used before exposure or possible exposure to HIV by both men and women (SANAC, 2014). 
PrEP includes microbicides which are topical products such as gels, and intravaginal rings that 
can be applied to the vagina or rectum to reduce HIV and STI acquisition (Abdool Karim et al, 
2010; Shattock and Rosenberg, 2012; Vanpouille et al, 2012). Microbicides are presented as the 
first female-initiated HIV prevention methods that have the potential to allow women control over 
their sexual health. Women can gain this control through the possibility of discreet use thus 
reducing reliance on male partner’s consent for protection against HIV (Stein 1990; Kelly et al, 
2015; Ryan et al, 2015). The possibility of new HIV prevention options will broaden women’s 
choices while also making prevention possible for diverse female populations globally (Shattock 
and Rosenberg, 2012; Stein, 1990). Currently, the daily oral truvada is the only PrEP product that 
is licensed for use (UNAIDS, 2016). While there remains no female-initiated PrEP product 
(microbicide) that is licensed for use (AVAC, 2016), some microbicide products (tenofovir gel and 
dapivirine ring) have demonstrated potential in efficacy in preventing HIV amongst women. A 




Moreover, microbicides are regarded as both biomedical and social science products therefore 
they require health and social motivation across all levels of society (Montgomery and Pool, 2001; 
van der Straten et al, 2014). The decision to accept and utilise microbicides occurs within the 
larger structures of family, intimate partners, social networks, community and society (Storey and 
Figueroa, 2012). Therefore, it is crucial that extensive research to understand perceptions 
towards these prevention methods are conducted before they become available. Men are 
influential in acceptance or use of female-centred programmes (Lanham et al, 2014). This 
underpins the importance of acquiring both a male a female’s perspective to women’s use of 
microbicides. Furthermore, understanding men and women’s perspectives will assist in identifying 
which microbicide products may be suitable for different users in their respective contexts. 
Communication therefore has an important role in examining how the various factors meet to 
influence acceptance and uptake of microbicides (Airhihenbuwa, 2005). Socio-behavioural 
research must also be at the centre of all developmental stages of new prevention technologies. 
 
This study explores the perceptions of men and women across urban and rural settings in KZN 
and MP in order to identify possible barriers to acceptance and utilisation of PrEP products 
amongst women. The study further explores the impact of male involvement in microbicides as 
female-initiated prevention methods (FIPM) for HIV.  
 
Background of the study 
Despite the growing prevalence, HIV prevention options for women remain very limited (Tallis, 
2002; Amazu, 2005; Ayanga, 2008). Available prevention methods such as the male and female 
condom have proven insufficient in preventing HIV amongst women, due to disregarding the 
underlying factors that influence women’s ability to adopt and/or adhere to behavioural prevention 
measures (Ogunlela, 2014). This highlights the urgency of prevention methods that enable 
women to have agency over their sexual health (Ryan et al, 2015). 
 
While microbicide products  have the potential to empower women to have increased control of 
their protection against HIV, their effectiveness may not be achieved if the socio-economic, 
structural and gender related factors that influence women’s susceptibility to infection are not 
addressed (Schuler et al, 2013). Clinical and socio-behavioural research reveals challenges with 
acceptability (Lanham et al, 2014), adherence (Avert, 2016), belief in product due to partial 
efficacy (Shattock and Rosenberg, 2012; Orner et al, 2006), partner dynamics (Mantell et al, 2009; 
Woodsong, 2004; Montgomery et al, 2015), and stigma against ARV-based products (Blashil et 
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al, 2015; Van der Straten et al, 2014). These are trends that are likely to occur with microbicide 
use in real-life settings.  
 
Men are generally more educated, they have greater wealth, greater political influence, with fewer 
restrictions on behaviour as compared to women (WHO, 2007). Such structural advantages 
allows men dominance and power to make decisions on women’s behalf, including their sexual 
health (Parker, 2012). Therefore men may prevent women from adopting positive health 
behaviours such as the use of microbicides (MTN, 2016). 
 
Research suggests that addressing the health aspect while disregarding the underlying contextual 
factors that foster unsafe behaviour is an ineffective approach, likely to hinder the success of new 
intervention programmes (Taylor, 1993; Airhihenbuwa and Obregon, 2001; Durden and 
Govender, 2012; UNAIDS, 2016). There remains a need for extensive socio-behavioural research 
and communication strategies to compliment biomedical interventions, in order to understand and 
address the factors that may stand as barriers to women’s acceptance and up-take of 
microbicides. There also remains a gap in research regarding the impact of male involvement in 
microbicides as female-initiated prevention methods.  
 
Purpose of the study 
The purpose of this study is to uncover men and women’s perceptions of microbicides in order to 
identify the underlying factors that can prevent women from accepting or utilising microbicides as 
an HIV prevention method. Part of this study is to investigate the impact of male involvement in 
the acceptance and utilisation of microbicides. The rationale for male involvement in the study is 
based on the observation that while women express lack of power in negotiating safe sex 
practices with their male partners, there is only limited research exploring a male’s perspective 
on this matter. A number of studies reveal that the limitations of current prevention methods such 
as condoms are due to disregarding the underlying influential factors that shape sexual 
behaviours. According to Montgomery and Pool (2011), it is imperative that extensive socio-
behavioural studies on male involvement are conducted while microbicides are still in the 
development stages. Understanding a male’s perspective alongside those of women will provide 
in-depth insight on the factors that influence women’s sexual behaviour, as well as identifying 




This study builds on a number of perception studies conducted in KZN, assessing perceptions of 
microbicides across the province, while also touching on MP as a new research province in the 
field. The study also seeks to build on a paucity of literature on studies assessing the impact of 
male involvement in microbicide acceptance and use. The findings of this research will therefore 
contribute to the body of knowledge on the various contextual factors to consider when introducing 
microbicides across diverse populations.  
 
Research Objectives and Questions 
The main objective of this study is to: 
a) To investigate men and women’s perceptions regarding microbicides as a female-
initiated HIV prevention method. 
b) Identify the underlying socio-cultural, economic and structural factors that may impede 
acceptance and utilisation of microbicides as an HIV prevention method. 
c) Explore the impact of male involvement in acceptance and use of microbicides. 
 
As such, the following research questions drive this study: 
a) What are the perceptions of men and women regarding microbicide as a female-initiated 
HIV prevention method for women? 
b) What are the underlying factors that can influence the acceptance and utilization of 
microbicides by women? 
c) What is the influence of male involvement, and can involving men increase women’s 
acceptance and utilisation of microbicides as an HIV prevention method? 
  
Structure of dissertation 
The dissertation consists of six different yet coherent chapters that address the questions listed 
above. The chapters are as follows: 
 
Chapter One provides a landscape of the current HIV statistics globally (36.7 million infections), 
and more particularly in South Africa (6.9 million infections). The chapter also provides a brief 
background of the study, the purpose of the study, as well as the goals and objectives the study 




Chapter Two presents a detailed account of the global HIV prevalence amongst women, delving 
particularly into the prevalence and incident rates amongst South African women. It also provides 
a detailed background of the underlying factors that perpetuate women’s susceptibility to HIV 
infection, while presenting the history of prevention approaches and methods for women to date. 
This chapter also introduces microbicides as a possible future HIV prevention method for women, 
discussing the development of the field to date, looking at their purpose, use and barriers. The 
chapter also discusses the issue of male involvement in a female-initiated prevention method 
(FIPM), exploring similar studies in light of providing motivation for involving men in a study based 
on products that are designed for women. 
 
Chapter Three presents the Socio-Ecological Model of Communication and Health Behaviour 
(SEMCHB) and the Culture-Centred Approach (CCA) as the conceptual and theoretical 
frameworks that inform this study. The SEMCHB is employed as a holistic approach, suitable for 
studying the interrelated socio-cultural, economic, and structural factors that influence individual 
health behaviour change, while CCA is employed to examine the cultural views (values, beliefs) 
of men and women in order to identify the barriers and facilitators of microbicides as a new female-
initiated prevention method (FIPM) in the various study settings.  
 
Chapter Four presents the research methodology employed in this study. This includes a 
discussion of the research paradigm, the research approach, the study design, data collection 
method, study sample, sampling technique, study context and setting, data analysis method, as 
well as the challenges and limitations of the study. 
 
Chapter Five provides a presentation and analysis of the qualitative data obtained through focus 
group discussions (FGD) conducted between men and women across urban and rural settings in 
Mpumalanga (MP) and KwaZulu-Natal (KZN). The data is presented, analysed and discussed 
under four thematic categories that relate to the subject matter of the study. The chapter 
concludes by presenting a summary of the findings obtained from the analysis. 
  
Chapter Six provides a discussion of the findings under each of the study’s objectives and 
explained through the literature and theory in the previous chapters 
 




CHAPTER TWO: LITERATURE REVIEW 
 
Introduction 
A large volume of literature has been written on the HIV AND AIDS epidemic and substantially on 
the subject of microbicides. This chapter reviews literature on (1) HIV prevalence amongst 
women, (2) women’s vulnerability to HIV infection, (3) The underlying factors that increase 
women’s vulnerability to infection, (4) The limitations of currently available strategies and methods 
for HIV prevention, (5) the introduction of new biomedical HIV prevention technologies (Past, 
current and future advancements in the development of microbicides and (6) Male involvement in 
microbicide use.  
 
HIV amongst women 
HIV remains the greatest health problem for women, reported as the leading cause of death 
amongst women of child-bearing age globally (UNAIDS, 2016). Women have remained the fastest 
growing HIV infected population group since the epidemic’s inception in the early 1980’s (Kaiser 
Family Foundation, 2016). In 1990, statistics showed a 25% disproportion of female to male HIV 
infections globally (Taylor, 1993). These disparate statistics have dramatically increased over the 
years, with over half of the adult population living with HIV being accounted for by women in 2015 
(KFF, 2016; UNAIDS, 2015). Women have a generally high incidence and prevalence rate than 
men (UNFPASA, 2014; SANAC, 2014). In Africa alone, women make up more than 70 percent of 
the population living with HIV (WHO, 2010). As Sub-Saharan Africa (SSA) is the hardest-hit region 
(UNAIDS Fact Sheet, 2014), it is no surprise that women in this region have carried the greatest 
burden of HIV for over two decades now (KFF, 2016). Adolescents girls and young women 
(AGYW) aged 15-24 in particular make up 25% of all new HIV infections among adults in SSA, 
but represent only 17% of the adult population (KFF, 2016). About 450 000 (380 000–530 000) 
new infections were documented in SSA amongst AGYW in 2015, this translating into 
approximately 8600 new weekly infections (UNAIDS, 2016).  
 
Most alarming is the high prevalence rate amongst South African women. In 2010, population-
based zero-surveys and sentinel surveillance of pregnant women reported an increase of HIV 
infection amongst women aged 30- 34, with a prevalence of 42.6% nationally (UNAIDS, 2012). In 
2013, the national prevalence amongst antenatal women was 29.7% (NDOH, 2013). The survey 
further found no indication of statistical difference in the national HIV prevalence estimates 
amongst antenatal care attendees between 2004 to 2013 (NDOH, 2013). In 2012, The Humanities 
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and Social Sciences Research (HSRC) estimated that incidence rates had increased amongst 
females of reproductive age (aged 15- 49) in 2012 (SANAC, 2014), while recent reports from 
Statistics South Africa (2015) revealed that one-fifth of South African women in their reproductive 
ages were HIV positive.  
 
While South African women are generally highly infected, women in some age groups maintain 
high prevalence and incidence rates than others (Kharsany et al, 2012). In 2012, the HSRC 
reported a particular peak amongst adolescent girls and young women (AGYW) aged 15–24 
(SANAC, 2014). The new National Strategic Plan (NSP) (2012-2016) has identified adolescent 
girls and young women (AGYW) to be amongst the most vulnerable population groups to HIV 
infection in the country (UNAIDS, 2016). HIV incidence is said to be highest for women in these 
age groups, who are likely to get infected five to seven years earlier than their male peers, despite 
boy’s early sexual debut as compared to girls (Abdool-Karim and Humphries, 2008; Dellar et al, 
2015a). There has been a 6% decline in new infections amongst AGYW between 2010 and 2015 
however, infection rates are still significantly high (UNAIDS, 2016). Approximately 7500 new HIV 
infections occur in AGYW each week, a rate two and a half times that of their male counterparts 
UNAIDS (2016). Additionally, one third of AGYW are likely to have been infected with HIV by the 
age of twenty (Dellar et al, 2015a). This highlights an urgent need for effective intervention 
programmes, particularly for key populations such as AGYW. According to Abdool Karim (2014), 
reducing the HIV burden amongst AGYW would move us a step closer to achieving an AIDS free 
generation. UNAIDS asserts that achieving the goal of reducing HIV infections amongst AGYW 
to below 100 000 by 2020 requires comprehensive approaches tailored to fit local contexts 
(UNAIDS, 2016). This includes combination of biological, structural and behavioural interventions 
(Dellar et al, 2015a; UNAIDS, 2016).  
  
Women’s vulnerability to HIV infection 
Biologically women are more susceptible to HIV infection than men. Their vulnerability however 
is heightened by various socio-cultural, structural and economic factors that perpetuate women’s 
susceptibility while also denying them power to protect themselves against infection (Ramjee and 
Daniels, 2013; Nxumalo et al, 2014; Mwaura, 2008). Figure 2.1 illustrates the various factors that 




Figure 2.1: Network of factors that amplify risk of infection for South African Women, (Dellar et 
al, 2015b) 
Women’s biological vulnerability to HIV infection 
Women’s increased susceptibility to HIV infection is attributed primarily to their physiology/ biology 
(Quinn and Overbaugh, 2005; James, 2008). Their increased susceptibility can be explained by 
a number of factors, explained comprehensively by UNAIDS;  
 
the larger surface area of the vagina compared to the penis, increased mucosal HIV exposure 
time, the potential for micro-abrasions and tears of the vagina or cervix, the higher concentration 
of HIV in semen than vaginal fluids, the increased expression of HIV co-receptors in cervical 
cells (compared to foreskin cells), and high levels of activation of the immune cells in the female 
genital tract (UNAIDS, 2016). 
 
Women’s biology plays a major role in women’s increased vulnerability to infection. The area 
where the penis enters a woman’s body has many CD4 cells which HIV holds on to (AIDS.Gov, 
2014). This is more severe in young girls whose genital tracts are immature, having fewer layers 
of mucous membrane therefore posing an increased possibility of the HIV-virus entering their 
bloodstream (James, 2008). Furthermore, male semen carries a higher viral load than vaginal 
discharge (James, 2008). The vagina retains seminal fluids therefore it is prone to fungal 
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infections and sexually transmitted infections (STIs), thus increasing women’s chances of 
infection (Okemwa, 2008; AIDS.Gov, 2014). Physiological differences therefore makes 
transmission of the virus through heterosexual sex more efficient from men to women than vice 
versa (Okemwa, 2008; Higgins et al, 2010). Furthermore, the potential for viral infection in the 
female body is said to be heightened between 5 to seven days after ovulation, a time considered 
to be a window period in which the woman has an even higher susceptibility to HIV infection 
(Ramjee and Daniels, 2013). 
 
Bacterial Vaginosis and STIs increase HIV vulnerability 
Bacterial vaginosis (BV) has long been identified as one of the factors that heighten the risk of 
HIV vulnerability amongst women. (Taha et al, 1998; Hillier, 1993; Myer et al, 2005; Passmore et 
al, 2016). BV occurs when there is a disturbance in normal vaginal flora called lactobacilli, and an 
increase in vaginal pH, which incapacitates the vagina from constraining potentially harmful 
bacteria while also facilitating the growth of STIs (Macdonald et al, 2007). Although BV is not 
classified as an STI, it is associated with sexual activity as it often occurs after intercourse with a 
new sexual partner or a frequent change of sexual partners (Mitchell, 2004). Other causes of BV 
include the use of spermicides, lubricants, vaginal douching (Scholes et al, 1993; Mitchell, 2004), 
and particularly in the African context this includes various vaginal practices (Low et al 2011; 
Beksinska et al, 1999). A study in the late 1990’s found that approximately 50% of African women 
were prone to BV, which made them more susceptible to HIV infection (Taha et al, 1998). In a 
recent cohort study (Passmore et al, 2016), African women were found to have a high 
inflammatory profile that contributes to the high risk of HIV acquisition.  
Recent findings reveal that persistent genital inflammation (GI) increases women’s risk of 
acquiring HIV (Masson et al, 2015; Passmore et al, 2016). Although the major cause of GI hasn’t 
been elucidated, a fraction of it can be attributed to BV (Taha et al, 1998; Hillier, 1993; Myer et al, 
2005) and asymptomatic STIs; which are likely to remain untreated thereby leaving women at risk 
of infection (Masson et al, 2015; Passmore et al, 2016). In this study, GI was associated with 
lower genital tract inflammation caused by BV and asymptomatic STIs, as they activate HIV target 
cells and disrupt the vaginas defensive bacteria (Passmore et al, 2016). The study also found that 
inflammation of the genital tract creates an environment that allows for reproduction and 
establishment of permanent infection (Passmore et al, 2016). Latest findings from CAPRISA 
revealed that South African women with an overgrowth of Prevotella bivia had an increased risk 
of HIV infection that is almost 13 times higher than those with low levels or absence of this vaginal 
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bacteria (Williams et al, Forthcoming). This causes GI, therefore it resembles BV in increasing 
women’s vulnerability to HIV infection (Williams et al, Forthcoming). Another study found that in 
the absence of lactobacilli, Gardnerella vaginalis (GV) becomes dominant in the vagina, therefore 
raising the vaginal pH balance (Burgener, Forthcoming). 
Thus far, the treatment of BV and STIs has been inadequately managed in Africa, hence the high 
HIV prevalence amongst women (Passmore et al, 2016). According to the Centre for the AIDS 
Programme of Research in South Africa (CAPRISA) (2016), these findings (Williams et al, 
Forthcoming; Burgener, Forthcoming) are key to realizing a significant impact on the spread of 
HIV in women in South Africa. Determining which women need treatment for BV will be made 
easier as both PB and GV raise vaginal pH, making them easy to detect (CAPRISA, 2016). These 
possible interventions however need to be complimented by effective treatment of asymptomatic 
STIs and BV as well as efficient educational programmes on vaginal health and hygiene for 
women at high risk of HIV infection (Passmore et al, 2016).  
The next part of this section will discuss other factors which increase women’s biological 
susceptibility to HIV acquisition. 
Hormonal contraceptives influence HIV acquisition  
A large volume of research (Quinn and Overbaugh, 2005; Ramjee and Wand, 2012; Haddad et 
al, 2014; Polis and Curtis, 2013) revealed that the use of progestogen-only hormonal 
contraceptives, such as depot medroxyprogesterone Acetate (DMPA) and norethisterone 
enanthate (NET-EN) may heighten the risk of HIV infection amongst women. DMPA is an 
aqueous suspension of 17-acetoxy 6-methyl progestin administered at a dosage of 150mg/ml by 
intramuscular depot injection every three months, while NET-EN is administered at a dosage of 
200mg/ml norethisterone every two months (Draper et al, 2006; Mishell, 1996). Findings from 
epidemiological research however has been inconsistent as other studies have found either little 
or no association (Ralph et al, 2016; Polis et al, 2014). Given insufficient evidence in support of 
this claim, the WHO strongly advised that progestogen-only hormonal contraceptives should be 
used in conjunction with condoms (WHO, 2015; UNAIDS, 2012; USAID, 2013).  
A recent meta-analysis of 24 studies found that Depo-Provera, a widely used DMPA-based 
contraceptive in SSA, increases women’s risk of acquiring HIV by up to 49% (Brind et al, 2015). 
DMPA is the active ingredient used for an estimated 70% of contraceptives procured by non-
governmental agencies such as UNFPA and USAID (Abbamonte, 2016). High contraceptive 
acceptance is often associated with non-condom use (Abbamonte, 2016). This is especially true 
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in SSA where hormonal contraception efficacy is high (Population Research Institute, 2016) while 
the primary mode of transmission is through sexual intercourse due to a decline in condom use 
(Ramjee & Daniels, 2013).The study also found consistent evidence that DMPA-based 
contraceptive users acquired HIV at a significantly higher rate than non-contraceptive users 
(Brind, Condly, Mosher, & Morse, 2015), confirming data from two recent meta-analysis (Ralph 
et al, 2015; Morrison et al, 2015), that DMPA increases the risk of infection by 40 to 50% (PRI, 
2016).  
A possible biological explanation is that DMPA and progesterone weakens the immune system, 
while thinning the natural epithelial layer, increasing concentration of susceptible cells thus 
allowing the HIV virus to manifest (Abbamonte, 2016; Goode et al, 2014; Brind, 2015). Research 
also suggests that progesterone treatment reduces the concentration of lactobacilli (Mitchelle et 
al, 2014). As highlighted earlier, a decrease in lactobacilli entails a disturbance in vaginal flora, 
which causes BV and genital inflammation, which in turn increases the risk of HIV acquisition 
(Macdonald et al, 2007; Hillier, 1993). In light of this evidence, the PRI (2016) suggests revisiting 
WHO’s current recommendation that DMPA be provided without restriction for all women 
including those at substantial risk of HIV infection. The article further asserts that women are to 
be informed about the possible risk of infection posed by this hormonal contraceptive. The 
suggestion for DMPA to be used in conjunction with the condom is perceived as an irresponsible 
recommendation (Abbamonte, 2016), taking into consideration the high rates of non-condom use, 
particularly in high incident areas such as SSA.  
Whilst there is significant evidence of women’s biological susceptibility to HIV infection, their 
vulnerability is also increased substantially by various cultural, gender, social, structural, and 
economic factors (Nxumalo et al, 2014; Mwaura, 2008). 
Culture and women’s vulnerability to HIV 
Culture is identified as one of the key factors that influence high infection rates amongst women. 
UNESCO (2000) defines culture as a set of distinctive spiritual, material, intellectual and 
emotional features of a society or a social group. In addition, it encompasses aspects such as art, 
literature, lifestyles, ways of living together, value systems, traditions and beliefs. Culture is also 
defined as a socially constructed phenomena Culture is also described as a socially constructed 
phenomena that creates knowledge, beliefs and customs which form individual or group identity 
within a given society (Wadesango et al, 2011). This phenomena is deeply entrenched in all 
aspects of a society, including local perceptions of illness and health seeking behaviors (Nandoya, 
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2014; Peterson, 2009). In this research, culture is examined as one of the key determinants 
towards the HIV crisis amongst women. 
Cultural gender roles and the spread of HIV amongst women 
One defining characteristic of culture is the notion of gender, defined as “a culturally defined set 
of economic, social, and political roles, responsibilities, rights, entitlements, and obligations based 
solely on the physical differences between males and females” (Lanham et al, 2014:6). What can 
be drawn from this definition is that gender is a socio-cultural construct that defines how men and 
women should interact with each other (Burger, 2005).  
Amongst the widely apparent discourses of the gender system is enforcement of a culture of 
submissiveness, passivity and silence amongst women, while men are often encouraged to be 
strong and dominant in all spheres of life, including sexual matters (Lanham et al, 2014). Such 
gender norms often make negotiation about sexuality impossible for women (van Damme et al, 
2008), as good women are said to be passive and uninformed about sexual matters (Weiss et al, 
2010; Lanham et al, 2014; Abdool Karim, 2005). This subordinate positioning of women and the 
social pressure to maintain innocence is detrimental to their health, restricting women’s access to 
information on sexual health (Buvé, 2002). As a result, women are often reluctant to seek 
information regarding their sexuality, or openly discuss sexual matters with their partners, or 
request the use of protective barriers due to fear of appearing promiscuous (Varga, 1997).  For 
young women, this includes fear of suspicion of being sexually active, therefore they are unable 
to make informed choices about their sexual health (Ramjee et al, 2001; Weiss et al, 2010; ICAD, 
2006). The notion of gender therefore is used negatively, to serve the needs of men while 
exploiting and oppressing women (Ackerman, 2008; Ayanga, 2008). 
The UNAIDS draws a strong association between the notion of gender and women’s increased 
susceptibility to HIV infection (UNAIDS, 2014). The WHO (2007) also postulates that cultural 
gender inequities damage the health of girls and women across the globe, acting as “an indirect 
yet powerful factor in the sexual spread of HIV” (Murphy et al, 2006: 1443). This observation is 
evident in many African countries that remain patriarchal, enforcing gender roles and norms that 
deny women control over their own sexuality, or that of their partners (James, 2008; Ramjee 
and Daniels, 2013; Buvé, 2002; Peterson, 2009). Cultural values and beliefs of gender are 
deeply entrenched in discriminatory views on the role and position of women in society. These 
are often carried out through harmful customs and traditional practices such as polygamy, child 
marriage, female genital mutilation (FGM) (Wadesango et al, 2016). Not only do these 
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phenomena violate women’s rights, they leave them vulnerable to diseases such as HIV 
(Nyathikazi, 2013; Jewkes et al, 2010; Kun, 1997; Taha et al, 1998). 
The practice of polygamy and Child marriage 
Culturally, men’s sexual power and pleasure is privileged over their female partners (Kelly et al, 
2015), regularly depicted as irrepressible therefore justifying their risky sexual behaviours (Stern 
and Bukeima, 2013). The practice of polygamy is a great example of such a cultural practice, 
where men can have more than one spouse at the same time (Nyathikazi, 2013). This is a cultural 
practice that is prevalent almost universally across Africa (Njoh, 2016) and it is sanctioned by both 
cultural and legal systems (Nyathikazi, 2013). Polygamy is considered a major factor in the spread 
of HIV and AIDS in Africa (Oppong, 1998). Research indicates that polygamy perpetuates HIV, 
consequences of which are suffered by women and children (Nyathikazi, 2013).  
In South Africa, various public figures including the current state president Mr. Jacob Zuma and 
various traditional leaders practice polygamy (Nyathikazi, 2013). In Swaziland the strong 
traditional ideologies of polygamy overpower prevention and management interventions against 
the high infection rates (Mbirimtengerenji, 2007). A study in the North Coast of KZN found that 
this practice does not necessarily discourage engagement in illicit relationships therefore it may 
be a risk factor exacerbating the spread of HIV amongst polygamists (Nyathikazi, 2013).  
In the 21st century, polygamy has since trickled into social norms where it is practiced in informal 
sexual relationships. In a study conducted in rural KZN, Harrison et al (2006) found that male 
participants were of the opinion that men should not be limited to a single sexual partner. In the 
same setting, women were expected to have heightened control of their sexual desires. Failure 
to do so results in being labelled as promiscuous or not meeting the social standards of a ‘good 
woman’ (Harrison et al, 2006). In another study in the Western Cape, participants strongly 
believed in the ‘male sex drive’ discourse, where men’s sexual desires are believed to be 
irrepressible therefore their risky sexual behaviour is permissible (Strebel et al, 2012). Women’s 
sexual restriction therefore is naturalised into social and cultural systems, and is sometimes 
supported by larger structures such as the legal system (WHO, 2007).  
Young women are forced into early marriages in Africa. This is a cultural practice believed to 
preserve family honour and a state of a country’s civil registration system therefore it is socially 
approved, and further condoned by larger structures of customary or religious laws (UNICEF, 
2016). The latest update from UNICEF (2016) shows that one in four girls in SSA are married 
before the age of 18, and about 1 in 8 gets married or is living in union before the age of 15. Not 
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only does this practice violate young girls human rights but, it also puts them at health risk of 
contracting STIs including HIV resulting from early sexual debut, the risk of being coerced into 
harmful sexual practices and compromising situations such as sexual exploitation, intimate 
partner violence (IPM) and abuse (UNFPA, 2016; Hotchkiss et al, 2016). In such instances, 
women do not have the power to negotiate safe sex practices, or to leave the partner placing 
them at risk of HIV infection due to various socio-economic factors that restrict their independence 
in most spheres of their lives (Murphy et al, 2006; Dunkle et al, 2004; Jewkes et al, 2010; Prince 
et al, 2005). Women’s disadvantaged gender and social positions therefore leave them vulnerable 
to infection, and it is often not through their own behaviour but as a result of their partner’s risky 
behaviour (Higgins et al, 2010). 
Vaginal practices  
In a context where men’s sexuality is deemed irrepressible (Kelly et al, 2015), women resort to 
various vaginal practices in efforts to “enhance men’s sexual pleasure, ensure men’s fidelity and 
exercise agency and control in their relationships” (Scorgie et al, 2009: 267). A number of studies 
(Beksinska et al, 1999; Scorgie et al, 2011; Ramjee et al, 2001) reveal South African men’s 
preference for ‘dry sex’, which includes drying, tightening or warming of the vagina for sexual 
intercourse (Beksinska et al, 1999). Where a woman has excess vaginal lubrication ‘wetness’ 
during sex, it is believed that she is promiscuous, has engaged in intercourse with another man, 
or her vagina is not considered that of a ‘good woman’ (Scorgie, 2009). A wide variety of products 
are used, some modern or commercialised medicines, some ‘traditional’, home-made or 
traditional herbs and medicines, etc. (Scorgie et al, 2011; Kun, 1998; Low, 2011).  
 
Cultural beliefs about sexual health support vaginal practices (Scorgie et al, 2011), however 
vaginal practices have been found to intensify the risk of HIV (Beksinska et al, 1999). A recent 
meta-analysis found that various intravaginal practices such as the use of cloth or paper, insertion 
of products to dry or tighten the vagina and cleaning with soap were associated with disruption in 
vaginal flora and high rates of HIV amongst women in SSA (Low et al, 2011). As highlighted 
earlier, a disturbance in vaginal flora results in BV, which in turn causes genital inflammation and 
heightens the risk of HIV acquisition amongst women (Taha et al, 1998; Myer et al, 2005; 
Passmore et al, 2016). 
 
Moreover, the practice of dry sex may also result in friction in the genital area, disturbance and 
thinning of the vaginal walls, and a high probability of the condom tearing (Mswela, 2009). In 
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South Africa, vaginal practices are most common in KZN, which is also the province with the 
highest HIV prevalence (Mswela, 2009; Scorgie et al; 2009; Gafos et al, 2009).  
 
The practice of dry sex and vaginal practices may pose a threat to acceptance and use of future 
prevention methods such as vaginal microbicides, more so those that have lubricative properties 
(Woodsong, 2004). In the case where acceptance is achieved, these practices may limit the 
effectiveness of microbicides. A recent analysis of 3 334 genital bacterial proteins amongst 886 
women found that the tenofovir gel- an intravaginal form of microbicide was effective in preventing 
HIV infection amongst 3 out of 5 women with a healthy lactobacillus or vaginal flora, while little 
effectiveness was found amongst those with a disturbance in lactobacillus (Burgener, 
Forthcoming). Follow up laboratory studies showed that Gardnerella vaginalis, which 
predominates in the vagina when lactobacillus levels are low, absorbs tenofovir thereby reducing 
the availability of the drug to prevent HIV infection (Burgener, Forthcoming).  
 
The promotion of female-initiated prevention methods should include teaching women about the 
dangers of vaginal practices, and encourage safe cleaning of the vagina such as the use of water 
only (Low, 2011). There is a need also for better STI and BV management strategies in women 
at high risk of HIV infection (Passmore et al, 2016). 
 
Female Genital Mutilation 
African women’s biological vulnerability is also extremely exacerbated by female circumcision or 
FGM, a procedure whereby “partial or total removal of or injury to the external female genitalia 
performed for non-therapeutic reasons” (WHO, 1996: 1). This practice bears strong cultural 
meanings that are linked to women’s sexuality and reproductive roles in society (Toubia, 1994). 
The practice serves to decrease women’s sexual pleasure in an effort to discourage women from 
pursuing sexual contact, also forming part of the cultural socialisation of women into acceptable 
roles of womanhood (Toubia, 1994; Hrdy, 1987).  
 
Not only does FGM cause excruciating pain and devastating long-term physical and psychological 
effects on women, it is a violation of their human right and a serious public health problem (Toubia, 
1994); and also found to heighten their susceptibility to HIV infection (Hrdy, 1987). A much 
apparent cause of vulnerability is the conditions under which the procedure is performed, as the 
same unsterilised instrument is often used to mutilate a number of girls or women, therefore 
leaving uninfected women highly vulnerable to infection (Brewer et al, 2007). Demonstrating the 
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risks posed by FGM, Brewer and colleagues found that HIV was more prevalent amongst 
circumcised male and female virgins than uncircumcised virgins in Kenya (Brewer et al, 2007). 
 
Moreover, female circumcision increases male-to-female HIV transmissions (Hrdy, 1987). 
Mutilated women are prone to genital inflammation and bleeding during sex, associated with high 
risk of HIV infection (Masson et al, 2015; Passmore et al, 2016), as highlighted earlier. The 
reduction of the vaginal opening entails forced entry during intercourse, subjecting the woman to 
vaginal tearing which increases absorption of secretions and HIV (Hrdy, 1987; Kun, 1997).  
 
Given the discussions on cultural and gender roles and cultural practices that perpetuate the 
spread of HIV, it is apparent that women’s susceptibility to HIV is manifest through gender 
inequities (Harrison et al, 2006). The notion of gender therefore should be the initial point to 
adequately addressing the HIV and AIDS pandemic (Amazu, 2005; Burger, 2005; Prince et al, 
2005). A gender lens would allow for proper examination of how socio-cultural inequalities 
combine to create women’s vulnerability to HIV infection (Burger, 2005; Prince et al, 2005). 
Strebel et al (2012) posit that gender roles are often reciprocal and mutually agreed upon 
therefore, understanding the gender system from both men and women’s perspectives is 
essential to the success of any sexual behaviour intervention. Furthermore, addressing the 
positioning of women should be at the forefront of the HIV crisis, starting with changing men’s 
socialization practices by teaching them about women’s rights (NDOH, 2012). Women should 
also be educated about their rights in order to empower them for sexual negotiation and protection 
(Abdool and Frohlich, 2000). It is greatly imperative therefore, that gender power dynamics are 
taken into consideration when introducing a new HIV prevention method for women. 
 
Socio-behavioral factors that increase vulnerability 
Socio-behavioural factors have been noted to play a role in the increase of vulnerability of HIV 
infection in women. Such factors include multiple concurrent partners, intergenerational sex, 
alcohol consumption and so forth which will be discussed below. 
Multiple Concurrent Partners and Intergenerational sex 
Multiple Concurrent partnerships (MCPs) are increasingly recognized amongst the greatest 
factors that heighten heterosexual HIV transmission in Africa (Mah and Halperin, 2010). MCPs 
refer to having multiple or overlapping sexual partners at the same time (Astatke & Meyanathan, 
2012). The risk of acquiring infection is closely linked to the number of sexual partners a person 
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has (Morris & Kretzschmar, 1997). This is explained simply by Parker et al (2007), that the greater 
the number of individual sexual partners an HIV-negative person is exposed to, the greater the 
chance that they will encounter a person who is HIV-positive (Parker et al, 2007).  
 
MCPs increase the size of an HIV epidemic, its growth rate and its persistence within a population 
(Mah & Halperin, 2010). Mah and Kretzschmar (1997) estimated that an epidemic size could 
increase by up to 10 times in 5 years if one-half of a population’s partnerships are in concurrent 
sexual relations. This is caused by a growth in the number of people connected in the sexual 
network, and often the infected person immediately spreads beyond the initial partnership to infect 
others. The paper further asserts that in concurrent partnerships, earlier partners often remain 
connected to the subject thus they are at a risk of getting infected if the subject becomes infected 
by a later concurrent partner (Morris and Kretzschmar, 1997).  
 
Having a partner with a history of having many sexual partners is also associated with higher 
levels of HIV acquisition (UNAIDS, 2016). MCPs are closely linked to the high widespread trend 
of intergenerational sex (IGS) in South Africa. IGS describes a sexual relationship where the 
partners have a 5 to 10 year age difference (Gregson et al, 2002). IGS mainly occurs between 
older men and younger women, due to a similarly prevalent and harmful trend of transactional 
sex (TS) which is to be explained further in the discussion. Older men are highly likely to have 
engaged in many sexual relations with people who may also belong to other sexual connections, 
which indirectly broadens the sexual networks in which younger women engage (Rangathanan 
et al, 2016). Similarly, Karim and Humphries (2008) observed that the risk of infection in AGWY 
is increased by the age of the men they have sex with, who are much older and are likely to be 
infected and to have other sexual relations with whom they are less likely to use condoms. IGS 
therefore places younger women at a heighted risk of acquiring HIV. 
 
A study conducted with UKZN female students indicated that young women engage in sex with 
older men and are often unaware of their multiple and concurrent sexual relationships therefore 
increasing their expose to risk of HIV infection (Mutinta, 2012). The study further notes that the 
age gap in such relationships also means that these young women have other sexual relations 
with men in their age groups, which renders more complications and further amplifies the risk and 
speed of infection within the sexual network (Mutinta, 2012).   
A national survey in 2015 found an HIV prevalence of 29.5% amongst 15-19 year old women 
who’s partner was five years or older, compared to 19.3% of those whom had partners within the 
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five years age range (Shisana et al, 2005). Years later, the survey found a prevalence of 33.7% 
amongst female adolescents (15- 19) with partners more than five years their senior, compared 
to only 4.1% amongst their male peers in South Africa (Shisana et al, 2012).  
 
Recent findings from a community-wide phylogenetic study conducted by CAPRISA in KZN offers 
a comprehensive description of the severity of IGS and MCPs in increasing the risk of infections, 
particularly amongst AGYW (de Olivier et al, 2016). An HIV genotyping linked 123 women to 103 
men, and only 18 (30.0%) men aged 18-25 were linked to the 43 infections amongst women of 
the same age groups, while 37 (61.7%) was linked to men aged 25-40 years, and 5 (8.3%) were 
aged 41-49 years. 16 (39.0%) of 41 probable men linked to women younger than 25 were also 
linked to women aged 25-40 years (de Olivier et al, 2016). The study concluded that older men 
who engage in sexual relations with multiple younger women are the key feature that drives the 
sexual networks of transmission in KZN (de Olivier et al, 2016). Addressing MCPs and IGS trends 
amongst older men and younger women therefore is an important element in addressing the high 
infection rates amongst AGYW.  
 
Alcohol consumption 
Numerous studies have shown that alcohol consumption is associated risky sexual behaviours 
including unprotected sex, multiple partnering and commercial sex (Fritz et al, 2011; Kalichman 
et al, 2007; Watt et al, 2012; Bryant et al, 2007). Alcohol consumption has an impact on sexual 
decision-making or the capability to negotiate safe sex practices, as it often impairs judgement 
and diminishes risk perceptions and therefore increasing the likelihood of unsafe sex (Bryant et 
al, 2010; Cook and Clack, 2005).  
 
South Africa is estimated amongst the highest alcohol consumption rates in the world (Parry, 
2005). Alcohol is used as a form of socialising, which includes irregular heavy drinking during 
weekends (Ramjee et al, 2016). Implications of these trends are associated with high risky sexual 
behaviours such as unprotected sex (SANGONeT, 2012). For example, a study found in Cape 
Town, South Africa found that alcohol intake creates a desire for sex, which often results in 
unprotected intercourse as it would be unanticipated (Watt et al, 2012). In another study (Strebel 
et al, 2014), the use of alcohol was found to undermine intentions to use condoms by both 
partners. Findings from another study amongst men and women receiving STI treatment in Cape 




Alcohol serving establishments (shebeens, taverns, night clubs) are said to be meeting places for 
sexual partners (Watt et al, 2012). According to Watt et al (2012), these venues are often male 
dominated, therefore, they are largely characterised by gender dynamics. Sexual exchange for 
alcohol is normal and acceptable, sexual harassment is also a common feature in these venues. 
Moreover, while the consequences of alcohol use are often generalised amongst men, women 
also experience the social harms of alcohol in multiple ways including intimate partner violence 
(IPV), sexual coercion and unprotected sex (Fritz et al, 2011; Dunkle et al, 2004). 
 
Given such behavioural trends, it is critically important to understand the epidemiological context 
of HIV. This is “the current state and trends in the behavioural and biological factors that determine 
the transmission dynamics of a given disease and the impact of a specific intervention” (Aral and 
Cates, 2013: 338). Similarly, Abdool-Karim and Humphries opine that effective prevention of a 
disease can be achieved if prevention programmes are designed and implemented based on full 
knowledge of the local epidemic context. For example, the key to risk reduction behaviour 
amongst South Africans lies in addressing the prevalence of alcohol consumption through 
interventions aimed at reducing drinking behaviour (Pitpitan et al, 2013). Alcohol- serving 
establishments should be the main points for such interventions, where such behavioural trends 
are most prevalent (Kalichman et al, 2007). 
Intimate Partner Violence (IPV)  
High rates of IPV cases are identified as the strongest risk factors for HIV infections amongst 
women in South Africa (Pitpitan et al, 2013; Lanham et al, 2010; Strebel et al, 2012). IPV refers 
to “physical or sexual assault, or both, of a spouse or sexual intimate” (Campbell, 2002: 1331) 
that is often subjected upon women (Fritz et al, 2011; Dunkle et al, 2004; Dworkin et al, 2012). 
According to Ramjee and Daniels (2013), adopting a healthy behaviour (sexual abstinence, 
condom use) can reduce susceptibility to HIV, however, this is not a reality for many women who 
have limited control over their lives.  
 
In a South African township, IPV was found to be very common amongst KZN men, carried out 
for sexual coercion, or to force women into doing certain things they do not wish to do (Harrison 
et al, 2006). Another study conducted amongst 15-24 year olds across the 9 provinces in South 
Africa revealed that lack of sexual and relationship power was associated with inconsistent 
condom use (Pettifor et al, 2004). In this study, women with low relationship control were often 
subjected to IPV, and they were highly likely to experience sexual coercion and condom-less sex 
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(Pettifor et al, 2004). In support of this study, various studies (Ramjee and Daniels, 2013; Duffy, 
2005; Lanham et al, 2014) found that women lack sexual agency, as they often incur abuse for 
initiating sex, the use of condoms or denying men’s sexual advances. As a result, women who 
experienced IPV are less likely to use protection therefore they often have a heightened HIV 
incidence and prevalence (Jewkes et al, 2010). IPV and sexual coercion limit their autonomy to 
use preventive methods through fear and intimidation and abuse (ICAD, 2006; Strebel et al, 
2012). 
 
Social norms influence perception of risk  
Social norms and collective behaviour contribute to a rise in an epidemiological situation, standing 
as the greatest factor that influences decision-making and behaviour (Hoffmann (2010). Social 
norms are defined as “beliefs, values, and practices of a specific group that are external to 
individuals, and which exercise pressure on individuals to make them behave in pre-determined 
ways” (Hoffmann, 2010: 13). Research shows that a person’s beliefs play a major role in 
determining their acceptance of a new prevention method (Mantell et al, 2006).  
  
The ongoing transmissions are perpetuated by misconceptions of low risk of HIV infection, despite 
high-risk sexual behaviours (Thana Khawcharoenporn et al, 2014). People often disregard their 
risk to HIV infection, thinking of HIV as another person’s problem (Karim and Humphries, 2008). 
In 2012, a national survey found that 79.2% of the people who took part on a national antenatal 
survey believed they were not at risk of acquiring HIV in South Africa (Shisana et al, 2012). 
Examining the South African context, Karim and Humphries (2008) assert that false perception 
or risk and lack of personalization of the virus perpetuates risky behaviours such as having 
multiple sexual partners and lack of condom use. 
 
Most concerning is the detrimental norm amongst people in marital and long-term relationships 
who do not consider themselves to be at risk of acquiring HIV. This misconception is mainly 
influenced by notions of trust, familiarity, and commitment in such relationships (Smit, 2008; 
Crowell and Emmers‐Sommer, 2001; Woodsong, 2004). This often result in the misconception 
that barrier methods such as condoms are only ideal for use in short-term or casual relationships 
(Stern and Buikema, 2013; Kelly et al, 2015; LaCroix, 2013; Maharaj 2009; Maharaj and Cleland, 
2005). Requesting the use of condoms is often perceived as lack of trust or love for your partner, 
as found in a study in the Western Cape (Strebel et al, 2012). As a result, social norms dictate a 
norm of discontinuing condom use in longer-term partnerships or marriages, which then impedes 
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the effectiveness of condoms in the fight against STIs and HIV (Beksinska et al, 2012). Women 
therefore may feel constrained by these norms, as their ability to protect themselves is often 
related to their perception of what will be supported by the community (Cain et al, 2014). 
  
This trend is apparent even amongst young people. The Mpondombili project revealed that rural 
South Africans adolescent boys did not perceive themselves to be vulnerable to HIV, and were of 
the belief that they could identify the level of HIV risk by a girl’s appearance (Mantell et al, 2006). 
The study also found that condoms were not used with steady partners, only with girls they 
considered likely to be infected. In a similar study in the township of Khutsong, near Carletonville, 
low perceived risk; peer norms; adult attitudes to condoms and sex; gendered power relations 
and the economic context of adolescent sexuality were amongst the factors that hindered condom 
use amongst youth aged 13-25 (MacPhail and Campbell, 2001).  
 
Contrary to this belief, findings indicate that new HIV infections in women are prevalent in 
marriages or long-term relationships (UNFPA and PATH, 2006). Women within these 
relationships are unable to suggest condom use even when they suspect their husband has 
multiple partners as doing so is associated with infidelity or suspicion of infidelity (Sedibe et al, 
2014). For example, the use of condoms was found to be a problem in a study in the Western 
Cape, where it is believed that ‘real men’ do not use condoms, therefore it was often difficult for 
women to negotiate the use of condoms (Strebel et al, 2012). Although there has been 
considerable progress in women’s empowerment for sexual negotiation in some contexts, some 
women, particularly married and cohabitating women are compelled to rely on monogamy for 
protection against HIV infection (Woodsong, 2004). Condom use has proven to be an ineffective 
recommendation amongst people with such beliefs, particularly for women as being in a 
monogamous relationship does not guarantee much protection against HIV as they get infected 
by their husbands (Fleischman, 2004; Cohen, 2004). 
 
The Khutsong study (MacPhail and Campbell, 2001), found evidence that although some young 
people attempted to behave in counter-normative and health-enhancing ways, this was hampered 
by the dominant sexual norms in the community. Hoffmann (2010) postulates that health enabling 
social norms and collective behaviour must be introduced within communities, this means 
addressing health detrimental social norms while offering supportive norms and behaviours that 
empower and enable the expression of healthy behaviour. There is a need also for further 
research on understanding how social norms of relationships influence sexual behaviour. 
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According to Becker et al (2004), exploring and addressing the prevalent norms and attitudes 
regarding long-term married couples and steady partnerships and the use of protection would be 
useful for future prevention methods. 
  
Structural and economic factors that perpetuate women’s vulnerability to HIV 
Over the years, economic and structural disadvantage has been associated with the high rates of 
HIV amongst women (Ackerman and de Kerk, 2002; Beksinska et al, 2012; WHO, 2007; 
Mbirimtengerenji, 2007; UNAIDS, 2016). These factors have much complexities which vary 
amongst individuals (Ackerman and de Kerk, 2002). In this study, the focus is much on poverty 
amongst women, linked closely to lack or limited access to education which consequently creates 
unemployment and in turn financial dependence on men (Jangu, 2014; Mbirimtengerenji, 2007). 
 
Educational constraints  
Limited access to education and economic opportunities is amongst the key factors that 
increase women’s vulnerability to HIV infection (Jangu, 2014; Abdool Karim and Frohlich, 2000). 
The WHO (2007) observes that generally men have greater wealth, greater political influence, 
more educated, with fewer restrictions on behaviour as compared to women. Many women are 
deprived of access to basic education, pressured to leave school due to financial constraints 
which require them to contribute to household chores or income generation (ICAD, 2006). In 
some African societies, girls are withdrawn from school when they reach puberty as a means to 
protect them from sexual contact from male pupils or teachers (Mbirimtengerenji, 2007).  
 
Cultural gender roles of male dominance are still very pervasive in South African communities 
(Strebel et al, 2012). In their study, Strebel et al (2012) found that generally women stay at home 
and raise families while men work and provide for their families. In turn women were expected to 
be submissive to their husbands and men to be the decision-makers in the household (Strebel et 
al, 2012). For women, denied access to education translates into poverty and in turn financial 
dependence on men (Mbirimtengerenji, 2007). This is especially true in countries such as South 
Africa, where about 80% of young women have not completed secondary education while a third 
are illiterate (Avert, 2015). Consequently, South Africa has high unemployment and low economic 




Moreover, a person’s level of education influences their capability to practice health-promoting 
behaviors, the greatest determinant being access to resources, as education often secures better 
standard of living (Cutler and Lleras-Muney, 2010). People with little or no education often have 
limited access to safe-sex information such as condom use, prevention of STI’s and HIV, etc 
(Buvé, 2002). Results from a demographic and health survey conducted in SSA associated early 
sexual debut amongst 15-19 year old girls with lack of education (Doyle et al, 2012). In South 
Africa, this is evident in the prevalence of risky behaviours such as having multiple sexual partners 
and lack of condom use, the decline in voluntary counseling and testing (VCT) (Abdool Karim and 
Humphries, 2008). Amongst young women, this is made apparent by high cases of teenage 
pregnancy and untreated STIs (Karim and Humphries, 2008).  
 
UNAIDS (2016) asserts that increasing girls’ and young women’s educational achievement can 
result in better HIV, sexual and reproductive health outcomes, as schools are efficient vehicles 
for comprehensive sexuality education. Similarly, ICAD (2006) asserts that basic education is 
imperative in empowering girls to adopting productive and positive health behaviours that limit 
their susceptibility to infection. A combination prevention strategy that blends the biomedical, 
behavioural, and structural factors in HIV prevention interventions is of urgent need (UNAIDS, 
2016). Accordingly, the 2030 Agenda for Sustainable Development (ASD) aims to empower 
young girls and women by improving socio-economic and structural opportunities- greater access 
to education, health care, greater access to good-quality education, employment, health care and 
achieving gender equality (UNAIDS, 2016).  
 
Transactional sex 
The HIV epidemic is intertwined with gender relations and poverty in South Africa (Ackerman, 
2008). As a result, phenomena such as Transactional sex (TS) are widespread and are largely 
identified as a key drivers of HIV particularly amongst AGYW (UNAIDS, 2016). “Transactional sex 
is defined as a non-commercial, non-marital sexual relationship whereby sex is exchanged for 
money and/or gifts” (Rangathanan et al, 2016:1). TS therefore entails a sexual sex relationship 
between people who are either regular or main partners (Dunkle et al, 2010). TS mainly occurs in 
intergenerational partnerships. As highlighted earlier, such relationships often involve an older 
men and younger women (Gregson et al, 2002; Karim and Humphries, 2008).  
 
A study in a rural community in rural South Africa found that over 14% young women between 
the ages of 13-20 reported engaging in TS (Rangathanan et al, 2016). While 21.1% of participants 
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who took part in a study exploring determinants of HIV in Soweto also agreed to having sex with 
a non-primary male partner in exchange for material goods or money (Dunkle et al, 2004). It is 
evident that in TS, it is predominantly men who provide the material benefit and women receiving 
them in exchange for sex, a reflection of many HIV prevalence communities (Macpherson et al, 
2012; Dunkle et al, 2004). TS therefore is an expression of the economic imbalance between men 
and women in South Africa. 
 
While TS is often perceived negatively, Murphy asserts that the motivation for commercial sex is 
mainly due to the need for survival (Scott et al, 2005; Buvé, et al, 2002). Many households in 
Africa are headed by unemployed women, who due to unemployment or low paying jobs, they 
often resort to commercial sexual transactions as a means to provide for their families 
(Mbirimtengerenji, 2007; Ackerman and de Kerk, 2002). TS is also heightened by the high rates 
of migration within South Africa, where men often leave their places of birth in search of 
employment in neighboring countries or regions. They often have other partners in the cities they 
work in, which sometimes leads to divorce or reduction in monetary remittances to their families, 
in which case women resort to TS to support their families in the men’s absence 
(Mbirimtengerenji, 2007). For women with limited access to recourses, TS is used to help advance 
their education, gain employment or business opportunities (Dunkle et al, 2007). It is apparent 
that poverty is a key determinant of sexual trade in South Africa, compelling women to engage in 
risky sexual behavior in pursuit of money and resources for survival (Mbirimtengerenji, 2007). 
 
In some cases however, the decision to engage in TS has little to do with poverty as it would be 
oriented around financial or luxurious lifestyle gains, such as obtaining expensive clothing or 
expensive cellular phones, as found in a study amongst young women in Durban, KwaZulu-Natal 
(Leclerc-Malala, 2004). Similarly, a study in the Eastern Cape found that women engaged in TS 
to achieve higher status in youth cultures which prioritize conspicuous consumption (Dunkle et al, 
2007). Material deprivation therefore seems to be the key driver of sexual risk taking behaviour 
amongst young South African women (Kamndaya et al, 2014). 
 
Moreover, Parker (2012) asserts that power dynamics are determined by money in sexual 
relationships. The one who has money, in this case men, have the power to control when, where 
and how sex occurs, while women are lacking of such power (Parker, 2012). A study in Swaziland 
found that young women who engage in TS do not initiate condoms as it is understood as the 
man’s decision as they pay for the sex, while in unprotected sex works as leverage for an even 
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higher payment (Tobias, 2001). Kaufman and Stavrou (2010) refer to this as sexual leverage, 
where the person providing the money or gifts somehow feels a sense of entitlement to the 
receiving person’s body. A study exploring the predictors of TS in the Eastern Cape, South Africa 
found that women believed that accepting financial assistance from a man meant they had to 
accepting sex on his terms, which often meant non-condom use (Dunkle et al, 2007). It is evident 
that women find it difficult to negotiate condom use where there is financial gain, as doing subjects 
them to violence or the greatest consequence of financial deprivation (Rangathanan et al, 2016).  
 
According to Dunkle et al (2004) women involved with abusive partners and had less economic 
stability were more likely to report transactional sex, as compared to those who had a post-
secondary education. Women therefore are pressured to stay with abusive partners and engage 
in risky sexual behaviour due to the economic consequence of leaving (ICAD, 2006). Moreover, 
the above-mentioned study amongst women in Durban found that MCPs were a common feature 
in transactional relationships (Leclerc-Malala, 2004). The women reported being aware of men’s 
unfaithfulness, however maintaining a modern lifestyle overshadowed the risks associated with 
partaking in such partnerships. Young women also had multiple sexual partners in order to widen 
material procurement from men (Leclerc-Malala, 2004), a behaviour that exposed them to various 
sexual networks and therefore leaving them vulnerable to HIV infection, as highlighted earlier. 
 
It is evident that institutionalized economic inequalities deny women structural and economic 
freedom, with some resorting to survival sex which in turn limits their power to negotiate for safe 
sex practices (Murphy et al, 2006). Women’s ability to engage in protected sex therefore is 
manifest in gender relations, and reinforced by broader contexts of socioeconomic inequalities 
that allow men to exert power over women by regulating or making decisions on their behalf 
(WHO, 2007; Beksinska et al, 2012).  
 
Mbizvo and Basett (1996) assert that disregarding the underlying factors that influence behaviour 
can cause more damage, resulting in people not acting on the knowledge they have (Mbizvo and 
Basett, 1996). Elaborating this, Kaufman and Stavrou (2010) assert that educational campaigns 
and health messages will remain futile in addressing HIV amongst young women if sex on their 
partner’s terms (unprotected sex) may be their only option for survival. With the multiplicity of 
challenges faced by women in impoverished conditions, HIV is often not considered the greatest 
challenge in the hierarchy of survival amongst women (Ramjee and Daniels, 2013; Banzhaf and 
Bellamy; 1998; Mbirimtengerenji, 2007). The need to sustain their livelihoods precedes the need 
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to adopt safe sex behaviours (Mbizvo and Basett, 1996). This supports various observation of the 
‘C’ recommendation of the ABC approach not being plausible, especially for women who have no 
control over the logistics of intercourse due to various factors such as financial dependence 
(Murphy et al, 2006; Fleischman, 2004). 
 
The Human Rights Watch (HRW) (2001) observed that lack of fair structural and economic 
opportunities amongst women results in the lack of power over their bodies and their sexual lives. 
Financial dependence therefore greatly contributes towards vulnerability to infection amongst 
women as it is a compelling determinant for women to engage in unsafe sex practices Parker 
(2012). Current HIV prevention programmes have had limited impact in reducing HIV incidence 
amongst young women. Empowering women for sexual protection requires a combination 
approach that combines biomedical solutions with structural interventions that seek to address 
the underlying socio-economic and structural factors that deny women the ability to adopt barrier 
methods such as the condom (Avert, 2016; de Olivier et al, 2016).  
 
Addressing structural and economic determinants of HIV  
Over three decades since the inception of the HIV epidemic, effective prevention methods are still 
limited to biomedical interventions (Pettifor et al, 2012). The field of HIV prevention however is 
shifting towards a different paradigm. Given the previously stated structural and economic 
determinants of HIV, intervention programmes are now exploring the use of cash payments and 
incentives to address risk factors such as poverty to encourage positive health behaviour, 
particularly amongst young people (UNAIDS, 2016). This approach is informed by the 
combination social protection theory, which identifies that HIV-risk behaviors are influenced by 
various challenges of a person’s life, such as the lack of financial and social support (Cluver et al, 
2016). As such, combination interventions offer support in various spheres of an individual’s life.  
 
This strategy has yielded positive results amongst adolescents and young people in South Africa, 
where engagement in money-driven sex had declined 11% without intervention to 2% for when 
financial support, free education and support services were provided (Cluver et al, 2016). Risky 
sexual behaviours such as unprotected, casual or multiple sexual partnerships also declined from 
15% without interventions, 10% with either school feeding or parental monitoring, and up to 7% 
when provided with both incentives (Cluver et al, 2016). Similarly, a meta-analysis of 16 cash 
transfer programmes amongst adolescents in various developing countries found that majority of 
these programs have achieved reductions in sexual behavior. Another large trial has also 
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documented a difference in HIV prevalence between young women getting cash transfers as 
compared to those who were not on the programme (Pettifor et al, 2012). Transfers included 
school attendance, school completion, poverty alleviation, and completion of health promotion 
activities, such as STI/HIV testing however, they differed across studies (Pettifor et al, 2012). A 
number of other studies have also yielded successful results in various settings in developing 
countries (Baird et al, 2012; Thornton, 2008). According to Pettifor et al (2012), cash transfers 
could help to increase testing for HIV and in turn the uptake of new prevention technologies such 
as microbicides that necessitate individuals to test for HIV prior to use.  
 
The studies above indicate that a combination programme is much more effective than an isolated 
effort to addressing the HIV crisis amongst young people. However, various concerns have been 
raised in response to this approach particularly when implemented in large scale (Padian et al, 
2011). A recent review of 165 studies covering 65 cash transfer programmes found that cash 
transfers often provide relief in certain aspects however they do not address other important 
aspects (Hagen-Zanker et al, 2016). For example, cash transfers may raise school attendance 
and increase women’s decision-making powers and choices however it does not always result in 
improved learning outcomes or reduce emotional abuse (Hagen-Zanker et al, 2016). In some 
instances, cash transfers actually increased emotional abuse or controlling behaviour, while some 
studies suggested that cash transfers were counterproductive as they are found to actually 
increase that certain behaviour they are encouraged against (Hagen-Zanker et al, 2016). This 
indicates that cash transfers and incentives do not always result in a change in behaviour. 
  
HIV prevention methods and strategies: The female condom within the ABC 
approach 
Various biomedical methods have been explored in efforts to prevent the spread of HIV, this 
includes the production of the condom as a primary method for HIV prevention (AMD), 2010). 
Early implementation of this prevention method was complimented by strategies that placed great 
emphasis on individual behaviour change, pushing forth “Abstinence, Being faithful and Condom 
use” (the ABC approach) (Avert, 2015). For a long period since humanity had been exposed to 
HIV, much reliance for the effectiveness of this approach was placed on the male condom as the 
only safe and effective HIV prevention method (Higgins et al, 2010). As a result, the decision 
whether or not to use the male condom came to be understood as the male partner’s responsibility 
(Higgins et al, 2010). The challenge with this prevention method is that men are often against the 
use of condoms, while women find it difficult to initiate or enforce safe sex practices with their 
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male partners (Ray et al, 1995; Prince et al, 2005; Macpherson et al, 2012; Bodibe, 2013, Murphy 
et al, 2006).  
 
In light of this limitation, a safe and effective female condom was first introduced in 1993 (Peters 
et al, 2010; KFF, 2016) as an optional method for women in cases where men was against using 
the male condom (UNFPA & PATH, 2006). The idea behind the production of this method was to 
empower women to better facilitate the ‘C’ recommendation of the ABC approach. Research 
however reveals that women face various challenges with adoption and use of condoms, as they 
often have limited control over their sexual relationships (Murphy et al, 2006). 
Despite widespread knowledge of the ABC strategy, HIV continues to spread at an alarming rate 
especially among women in developing countries (WHO, 2016). Research reveals that there are 
various challenges with adoption and use of both the male and female condoms, particularly for 
women who often have limited control over their sexual relationships (Murphy et al, 2006). Various 
studies (Ryan et al, 2015, Karim and Baxter, 2012, Macpherson et al, 2012; Ryan et al, 2015) 
show that like the male condom, the female condom requires male partner cooperation for use 
because to a large extent, its design does not allow for discreet use. The female condom therefore 
is considered an impractical prevention method, providing no sense of empowerment or agency 
for women (Macpherson et al, 2012; Bodibe et al, 2013; Karim and Baxter, 2012; Ryan et al, 
2015), as it encourages women to adopt preventative behaviours that they have very limited 
power to implement (Ackerman, 2008).  
 
Gender power dynamics, often characterised by male dominance are key barriers to achieving 
potential effectiveness of barrier methods such as condoms (Mantell et al, 2006; Bermudes and 
Ribiero, 2004). Gender norms have established power inequalities between women and men, 
therefore denying women the power to negotiate safe sex practices; thus leaving them vulnerable 
to HIV infection (Lanham et al, 2014; Bridgette Prince et al, 2005; Eleanor Macpherson et al, 
2012; Khopotso Bodibe, 2013). 
  
Despite having a successful male and female condom distribution (Avert, 2015), South Africa’s 
epidemic continues to grow rapidly (UNAIDS, 2015). Taking into account the widespread 
exploitation of girls and young women through early marriages, the practice of polygamy, sexual 
assault and IPV, (Murphy et al, 2006; Fleischman, 2004) as highlighted earlier in the discussion; 
the ABC approach does not adequately address women’s sexual practices (Moodley, 2007). Such 
practices show that women’s risk of infection is exacerbated through culturally sanctioned gender 
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systems that nurture gender power imbalances and disempowers women of the ability to enforce 
the use of preventive methods such as the condom (Strebel et al, 2012). The ABC approach 
however treats the epidemic as a homogeneous phenomenon, as it offers linear and rigid 
behaviour change recommendations that do not consider the influence of gender on women’s 
sexual behaviours (Green and Herling, 2006). A number of studies revealed that in most cases 
women are unequipped for sexual decision-making as they often have no control over the 
decision to abstain from intercourse, to be in monogamous relationships or the use of condoms 
(Murphy et al, 2006, Macpherson et al, 2012; Kline and Oken 1992; Lear 1995; Fleischman, 
2004). The three recommendations encompassed in the ABC approach are therefore insufficient 
in the prevention of HIV and other sexually transmitted infections for women (STIs) (AMD, 2006; 
Kline and Oken, 1992). Its limitations are due to disregarding the underlying factors that influence 
sexual behaviour (Ogunlela, 2014; Green and Herling, 2006). 
 
It is apparent therefore that a one-size-fits all approach to HIV prevention does not work (Cohen, 
2004) as the determinants of HIV transmission differ with each context (Aral and Cates, 2013). 
There remains a great need for FIPM that overcome the gender-based barriers, and grant women 
full autonomy over their protection against HIV prevention (Ryan et al, 2015). New prevention 
methods should take into account the gender-related factors that affect women’s ability to adopt 
and/or adhere to health intervention programmes such as condoms.  
 
Accessibility of the female condom  
Despite gender power dynamics being the greatest barrier to utilisation; the decline in female 
condom use is also attributed to inaccessibility of the female condom in many parts of the world 
(UNFPA & PATH, 2006 Peters et al, 2010; Avert, 2015). The Center for Health and Gender Equity 
(CHGE) (2011) reported that investment in procurement of programming of female have been 
insignificant in comparison to other prevention methods such as the male condom, hence the limit 
in access and availability of FC (Bodibe, 2013). As a result, only a limited number of countries 
were able to launch and maintain the female programme over time (Warren and Philpott, 2003). 
  
In Previous years, there has been an inadequate supply and uptake of female condoms, 
especially in countries that are most stricken by the HIV and AIDS epidemic (UNFPA and PATH, 
2006). Approximately 10 male condoms were made available to each man (15-64 years), and 
only one female condom per eight women in sub- Saharan Africa in 2013 (UNFPA, WHO, and 




Despite having a highly established female condom programme worldwide, there remains 
discrepancies in condom distribution in South Africa (Beksinska et al, 2012). 2015 showed 
distribution levels of 723 million male condom to 20.7 million female condoms, while targets for 
2016 were set at 1 billion male condoms and 25 million female condoms (Avert, 2015). South 
Africa’s male condom programme was widespread across public facilities since 1992 while the 
female condom programme was only made available in selected sites across the 9 provinces 
1998 (Beksinska et al, 2012), about 5 years after being licensed in 1993 (FFK, 2016). Moreover, 
although the United States showed a considerable increase in international shipment of condoms 
from 1 109 000 in 2003 to 14 676 000 in 2009, the female condom only represented 3.2 percent 
of the overall condom shipment (CHGE, 2011). Over a couple of decades after its invention,  
accessibility of the female condom remains limited; with some people having no knowledge of it, 
while those who do are unable to obtain it (Peters et al, 2010; Avert, 2015). 
 
The high cost of the female condom is regarded as the primary factor that hinders its uptake 
(UNFPA & PATH, 2006; Ray et al, 1995; Peters et al, 2010; Welbourne, 2006). UNFPA, WHO & 
UNAIDS, (2015) reported that international funding for condom procurement in sub-Saharan 
Africa has stagnated in recent years. The female condom cost 25 Zimbabwean cents to 10 
Zimbabwean cents for one male condom, while the latter is also freely accessible in government 
and municipal health care facilities (Ray et al, 1995). Similarly, the limiting factor for the use of 
female condom is the high cost in South Africa, costing approximately 18 times more expensive 
than the male condom (Beksinska et al, 2012), thus posing a barrier to use. 
   
UNAIDS (2015) advises that safety, efficacy and effective use of condoms can be achieved when 
condoms are manufactured according to international standard, specifications and quality 
assurance procedures established by WHO, UNFPA and the International Organization for 
Standardization (IOS). They also state that condoms should, be freely available or procurable at 
affordable or subsidised prices, further recommending that the female condom in particular should 
be made widely available in HIV stricken locations, and integrated into community and health 
service delivery programmes, while also addressing stigma (UNAIDS, 2015). Similarly, uptake of 
future prevention methods can be encouraged by ensuring reliable, affordable and widespread 
access, however taking precaution that necessary precaution measures such as pre-testing for 




Inadequate implementation of the female condom 
There is correlation in the promotion of a product and positive perception linked to it (Mantell et 
al, 2005). A review of more than 40 acceptability studies conducted by WHO across different 
countries in 1997 found that the acceptance of the female condom would be determined by 
information, training, support during its introduction (Peters et al, 2010). A study found that the 
introduction of the female condom, its design, packaging features, marketing and implementation 
processes were inadequate, thus resulting in low acceptance levels as compared to the male 
condom (Mantell et al, 2005).  
  
In South Africa, a number of developments have been implemented since the establishment of 
the male condom in efforts to increase condom use (Beksinska et al, 2012). Beksinska et al (2012) 
cites the rebranding of the Choice condom in 2004, promoted through Khomanani (caring 
together), an information-based mass media campaign. Recent developments include the ‘Safe 
Sex Campaign’, yet another rebranding of the Choice condom into colorful packaging and 
improved scented male condoms to be distributed over the next three years (SANAC, 2015). A 
couple of studies conducted amongst students at the University of KwaZulu-Natal found that the 
students observed discrepancies in the promotion and accessibility of the female condom 
(Ogunlela, 2014; Nota, 2016).  
  
Thus far, efforts towards increasing the use of the female condom have placed much emphasis 
on its design, evident in the production of the second-generation FC2 female condom (Beksinska 
et al, 2013). While very little effort is placed to the female condom’s promotion, low acceptance is 
linked the media’s negative portrayal of this barrier method as having an unappealing appearance 
and design (Beksinska et al, 2013). The female condom remains a mystery to some women, who 
either have no knowledge of it, or are unable to obtain it (Peters et al, 2010), due to lack of 
knowledge about the selected distribution facilities (Beksinska et al, 2012).  
 
Lessons should be drawn from the failure of past prevention methods such as the female condom 
to assist planners and policy makers of effective strategies and approaches to presenting and 
implementing future prevention technologies such as microbicides. Ongoing media campaigns, 
educational campaigns, community-based information sources should be made accessible in 
order to promote familiarity and knowledge of new prevention products (Becker et al, 2004). While 
there are limitations to the use of male and female condoms, new prevention methods of HIV 




New HIV prevention methods: Pre-Exposure Prophylaxis (PrEP) 
“PrEP refers to antiretroviral medicines prescribed before exposure or possible exposure to HIV” 
(SANAC, 2014). PrEP offers HIV-negative individuals the use of anti-HIV medications called 
ARVs to reduce their risk of infection during exposure to the virus (San Francisco AIDS 
Foundation, 2015; Bekker et al, 2016). The drugs used in PrEP products are meant to block 
pathways that HIV uses to set up an infection, preventing the virus from establishing a permanent 
infection (CDC, 2016). 
 
Currently, PrEP consist of an ARV-based tablet called truvada, containing 300 mg of tenofovir 
disproxil fumarata (TDF), alone or in combination with 200 mg of emtricitabine (FTC) (Marrazzo 
et al, 2015). Truvada is designed to be taken as a daily oral dosage by HIV negative persons at 
an increased risk of HIV infection (CDC, 2016). PrEP is particularly relevant for people who are 
unable to control their risk of acquiring HIV with currently available prevention methods and 
strategies such as condoms or the ABC approach (UNAIDS, 2016). The pill provides effective 
protection for both men and women (SFAF, 2015), reducing chances of infection from sexual 
transmission by more than 90% if taken consistently (UNAIDS, 2016), and can be used with other 
prevention methods for increased protection (CDC, 2016). Although showing high prevention 
rates when used consistently, any form of PrEP is idealistically used in conjunction with condoms 
and other prevention methods for greater protection (CDC, 2016; Bekker et al, 2016). An HIV test 
is also required before and every three months while taking PrEP (UNAIDS, 2016). Unlike the 
ARV treatment for HIV, PrEP may be used only during periods of perceived HIV acquisition risk, 
rather than continually and lifelong (Bekker et al, 2016). 
  
Success of PrEP in clinical trials 
PrEP has been tested in several randomized controlled trials across Africa, Asia, South America, 
and North America, and has shown positive outcomes in HIV reduction (Bekker et al, 2016). 
These trials involved various people considered to be at an increased risk of acquiring HIV; men 
who have sex with men (MSM), heterosexual women, transsexual women, heterosexual 
serodiscordant couples, female sex workers (FSW), and people who inject drugs (UNAIDS, 
2016).  
The Pre-Exposure Prophylaxis Initiative (iPrEx) study was carried out in six countries (Peru, 
Ecuador, South Africa, Brazil, Thailand, and the United States) amongst transgender women, 
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MSM and bisexual men (Grant et al, 2010). In this study, Truvada was compared with a placebo 
pill, in which results revealed 42% risk reduction on Truvada, as compared to the group that was 
taking placebo (Venter et al, 2015). Amongst high adherent users up to 90 % risk reduction was 
achieved (UNAIDS, 2016).  
In Partners PrEP, a study amongst 4500 heterosexual serodiscordant couples in Kenya and 
Uganda, risk reduction was particularly good. Truvada reportedly reduced HIV acquisition by up 
to 70%, and up to 90% for those with increased consisted use (Francois Venter et al, 2015). On 
the other hand, a similar yet smaller scale study-TDF2, amongst 1200 heterosexual men and 
women in Botswana, risk reduction was up to 62% TO 70%, and up to 90% amongst participants 
with high adherence (UNAIDS, 2016).  
 
The Bangkok Tenofovir Study also tested oral truvada amongst people who inject drugs, were 
2400 participants were enrolled, also testing Truvada against the Placebo pill in Bangkok, 
Thailand (Choopanya et al, 2013; UNAID, 2016). Given the results from this trial, 49% risk 
reduction in IDU participants, and 74% increased protection amongst participants who during 
observed clinic visits, it remains unclear whether truvada prevents parenteral HIV (HIV acquired 
through injection) (AIDS Fact, 2015). Despite the different results in trials, Truvada is deemed to 
be the most efficacious and effective PrEP product thus far, having been licensed for use in some 
countries (to be explained further later in the discussion). 
 
Unsuccessful PrEP trials 
Although a number of studies demonstrated the effectiveness of PrEP in reducing the risk of 
infection, Fem-PrEP, a study that was meant to assess the effectiveness of PrEP amongst 
heterosexual women in Kenya, South Africa and Tanzania was discontinued after some months 
of trial due to low levels of adherence; thus yielding no difference in effect between Placebo and 
Truvada (Van Damme et al, 2012, AIDS info, 2012). Similarly, the Vaginal and Oral Interventions 
to Control the Epidemic (VOICE) study, was discontinued due to low adherence and therefore not 
showing any difference between Placebo and Truvada (Marazzo et al, 2013). More than 5000 
women in 15 sites across South Africa, Zimbabwe and Uganda were enrolled in this trial, having 
5 different groups, each administered either the tenofovir gel, placebo gel, oral tenofovir tablet, 




The failure of the VOICE trial was attributed to challenges with taking a daily treatment given the 
social risks and lack of support from partners, unknown efficacy in the context of placebo 
controlled trials, and the social stigma associated with using ARV-based products appeared to 
discourage adequate product use (Van den Straten et al, 2014). “Insight into social and behavioral 
factors that influence the acceptability, use, and adherence to PrEP can inform the development 
of drug regimens and PrEP counseling strategies for individuals initiating a course of this 
prevention medication in the future” (Van der Elst, 1993: 3). The question remains for socio-
behavioural researchers to understand the reasons behind poor adherence in trials, more than 
the effectiveness of PrEP itself (AIDS Fact, 2012).  
 
The licensing of PrEP 
2012 marked the year for the approval of truvada as a PrEP agent in the United States of America, 
and in 2015 for South Africa and Kenya (GILEAD, 2015). The use of oral truvada has also been 
licensed in France (UNAIDS, 2016). The licensing of PrEP provides more HIV prevention options 
to minimise the likelihood of HIV infection as HIV infections are decreasing at a very slow rate 
while remaining at a substantial peak amongst key populations such as AGYW (UNAIDS, 2016). 
PrEP however, is currently only recommended as an additional tool for people at an increased 
risk of infection, i.e. sero-discordant relationships, MSM and FSW, where they are unable to 
achieve consistent condom use (UNFPA, WHO & UNAIDS, 2015). Given evidence of the 
effectiveness and acceptability of PrEP, the recommendation now includes all population groups 
at substantial risk of HIV infection as part of the comprehensive prevention approach (WHO, 
2016). This includes pregnant and breastfeeding women if they remain at risk of infection, uptake 
however will be monitored for negative effects during this period (UNAIDS, 2016). PrEP should 
however still be prioritised for populations with an HIV incidence of about 3 per 100 person-years 
or higher as an additional prevention choice in a comprehensive package of services that include 
HIV testing, counselling, male and female condoms, lubricants, ARV treatment for partners with 
HIV infection, voluntary medical male circumcision and harm reduction interventions for people 
who use drugs (WHO, 2016). So far, South Africa is the only country in Africa to implement this 
recommendation into national policy (WHO, 2016). For women, the licensing of PrEP entails 
autonomous use of an HIV prevention method that does not require partner negotiation at or 
around the time of sex (AVAC, 2016). Unlike currently available methods such as the male and 





Currently, various topical and longer-acting PrEP products are being investigated, these include 
monthly vaginal rings and three-monthly injections among others, in an attempt to increase 
prevention options and improve long-term adherence. Of focus in this study is the aforementioned 
daily oral truvada, three-monthly injectable, the dapivirine ring and the tenofovir gel for reducing 
the risk of HIV amongst women, to be discussed below. 
 
A female-centred approach to PrEP: Introducing microbicides  
The production of microbicides is a response to the significant need to empower women for 
independent sexual health decision-making (Banzhaf and Bellamy, 1998). The argument was that 
there is great need for a variety of safe, effective and highly discreet products (IPM, 2016). 
Microbicides are topical PrEP products, such as gels, capsules, tablets, films, and intravaginal 
rings that can be applied to the vagina or rectum with the intention of reducing the acquisition of 
STIs, including HIV (Abdool Karim et al, 2010; Shattock and Rosenberg, 2012; Vanpouille et al, 
2012). They are designed to be used either around the time of coitus, on a daily basis, or to deliver 
product over a prolonged period of time (Shattock and Rosenberg). Presented as the first female-
initiated HIV prevention method that will allow them control over their sexual health, microbicides 
are meant to reduce women’s reliance on male partner’s cooperation for protection against 
sexually acquired HIV (Stein, 1990). This is meant to be achieved through discreet use, allowing 
women to use the products without male partner’s knowledge or consent (Ryan et al, 2015; Kelly 
et al, 2015). Although microbicides only offer partial efficacy, the availability of options can still 
curb HIV transmission substantially amongst women (Mantell et al, 2005). 
 
Given the various socio-cultural influences that affect women’s health decisions, the development 
of these prevention technologies is constantly evolving over the past two decades. Early 
developments on microbicides focused on nondrug-based products which worked in various 
ways, such as by inactivating pathogens, strengthening the body’s natural defenses, or blocking 
virus from getting into healthy cells (CONRAD, 2016; Shattock and Rosenberg, 2012). It became 
apparent that over the counter medicines were ineffective in disrupting the integration of HIV, thus 
leading to exploration of ARV-based microbicides (Shattock and Rosenberg, 2012). ARV-based 
microbicides contain one or a combination of ARV that work in different steps of the HIV life cycle, 
to ensure increased effectiveness of microbicides (IPM, 2016). According to GCM, ARV-based 
microbicides work by targeting the receptors of on the outside of HIV susceptible cells (white 
blood cells); preventing the virus from replicating itself after it has entered the white blood cell. 
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Although some ARV-based microbicides have demonstrated effectiveness and safety in trials (to 
be explained further in the discussion). 
 
Microbicide clinical trials 
There are various phases of clinical research, each serving a different purpose towards the overall 
research (AIDS info, 2016). The initial stage in a microbicides trial enrolls, Phase I enrolls 20 to 
50 healthy, low-risk women over several weeks or months to evaluate safety and to determine 
any negative effects (Tallis, 2012). In phase II, a larger group (100- 300), potentially at risk female 
candidates are enrolled (Tallis, 2012). This phase, referred to as the expanded Safety Trial (EST), 
conducts further evaluation of the safety of the drug over a longer period of time. In phase IIb or 
proof-of-concept trial, the products that do not demonstrate potential to prevent HIV are 
eliminated. This trial is often only half the size of a full-scale Phase III trial. Phase III or 
effectiveness trial is the final stage of a microbicide clinical trial, which enrolls thousands of women 
across several sites (Shattock and Rosenberg, 2012). This trial measures whether or not the 
microbicide actually works to prevent HIV, evaluating long-term safety and efficacy (Tallis, 2012). 
Figure 2.2 shows a picture of the stages in microbicide clinical trials; 
 
 




Several microbicide candidates have been tested in clinical trials, many being ruled out for further 
assessments as an HIV prevention due to various factors ranging from effectiveness, safety and 
efficacy and adherence (Tallis, 2012). A review of the development of microbicides in 2008 
indicated that a total of 188 studies (73 pre-clinical and 45 clinical trials) had been conducted 
(Cutler and Justman, 2008). In 2015, there were nine microbicides in phase one, four and three 
in the second and third phase respectively, and a couple of ancillary studies (AVAC, 2015).  
 
A number of microbicide agents are still undergoing various states of testing in clinical trials 
(AVAC, 2016). More ARV drugs are also being explored for the production of more microbicides, 
this includes dapivirine, rilpivirine and non-nucleoside reverse transcriptase inhibitors, etc. 
(Abdool Karim and Baxter, 2012; Vanpouille et al, 2012). The need for a variety of formulations 
that offer different dosing strategies is also of great consideration in the development of 
microbicides. Low adherence in trials, as noted earlier, indicate that there is still a need to match 
potential users with a variety of products (Nota, 2016). A wide range of barrier methods is the 
primary factor in achieving safer sex practices (Peter et al, 2010). Product formulations that are 
ongoing in development include the monthly injectable, suppositories, vaginal rings, etc (Lanham 
et al, 2014). New developments have also extended focus to developing multi-purpose 
microbicides that will protect against HIV, STIs and pregnancy, non-ARV microbicides as well as 
less user-reliant products that can be taken once after an extended period of time (Abdool Karim 
and Baxter, 2012; Lanham et al, 2014; UNAIDS, 2015). The development of long-acting 
microbicides will increase adherence as there will be no requirement to plan for each sexual act 
or to use the product on a daily basis, while multiple formulations will give women the choice of 
an approach that best fits their various circumstances (Shattock and Rosenberg, 2012). 
 
Demonstrated efficacy in trials 
Currently there are only two microbicide products that have demonstrated efficacy and safety in 
clinical trials, these being the tenofovir gel (CAPRISA, 2010) and the dapivirine ring (IPM, 2016), 
however, there is still no safe and effective microbicide licensed for public use (AVAC, 2016). 
 
The tenofovir gel 
Tenofovir gel is a vaginal gel containing 1 % Tenofovir- an ARV drug, used primarily for treatment 
of HIV (Abdool-Karim et al, 2010). The dosing regimen involves applying the gel once, up to 12 
hours prior to anticipated intercourse and once, up to 12 hours post sexual encounter- which could 
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include several acts of intercourse, however, no more than two dosages in 24 hours (Rees, 2015). 
This is called the ‘Before and After’ dosing strategy (BAT-24) (CAPRISA, 2010). Figure 2.3 shows 
a picture of the tenofovir gel; 
 
 
Figure 2.3: The tenofovir gel 
 
In 2010, the first results to demonstrate an effective microbicide were issued by the Centre for the 
AIDS Program of Research in South Africa (CAPRISA) (Ryan et al, 2015), giving hope that HIV 
management amongst women can be achieved. The CAPRISA 004- phase IIb clinical trial had 
found the ARV-based Tenofovir gel to have reduced up to 39% new HIV infection rates among 
heterosexual, sexually active women aged 18- 40 in KwaZulu-Natal , South Africa (CAPRISA, 
2010; Philpott et al, 2011; Mureithi et al, 2012; Vanpouille et al, 2012). The tenofovir gel was 
assessed against placebo gel, which was packaged and dispensed in the same pre-filled vaginal 
applicator (Abdool Karim et al, 2010). 
 
High adherence reported 54% low HIV incident rate to 38% and 28% immediate and low 
adherence respectively (Abdool-Karim et al, 2011). The results also demonstrated unanticipated 
results, in the reduction of acquisition of the Herpes simplex virus type 2 (HSV-2) by 51% 
(International Journal of Women’s Health, 2012; Karim and Baxter, 2012). In South Africa alone, 
mathematical estimates suggests the gel to have a potential to prevent up to 1·3 million new 
infections and 8000 HIV-related deaths during the next 20 years (Lancet, 2010). Adversely, follow 
up trials such as the MTN (008),  FACTS 001, and the VOICE trial showed negative results, failing 
to replicate the CAPRISA 004 trial (AVAC report, 2013; AVAC, 2015; UNAIDS, 2015). Lack of 
adherence is understood to have hindered evaluation of the gel’s effectiveness (UNAIDS, 2013), 
a trend most likely to occur in real life settings. However even though the tenofovir gel did not 
show confirmation results for HIV prevention in the FACTS 001 trial, it is still effective in reducing 
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HSV-2 acquisition in women as found in the CAPRISA 004 HSV-2 Sub-study (Abdool Karim et al, 
2015).  
The dapivirine ring 
The dapivirine ring is a monthly vaginal ring containing the ARV drug dapivirine (IPM, 2016). The 
ring is made of flexible silicone that discharges dapivirine drug over a period of four weeks (AVAC, 
2015). The ARV drug- dapivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTIs) that 
prevents the HIV enzyme from duplicating itself inside a healthy cell (IPM, 2016). This is 
scientifically referred as reverse transcriptase, working by preventing HIV from multiplying and 




Figure 4.3: The dapivirine ring, Loxley (2016) 
 
In February 2016, the long anticipated results from the phase III ASPIRE and the Ring Study were 
released at the Conference of Retroviruses and Opportunistic Infections (CROI) (AVAC, 2016). 
These were independent studies assessing the efficacy and effectiveness of the monthly 
dapivirine vaginal ring (AVAC, 2016), enrolling 2629 (ASPIRE) and 1959 (the ring study) women 
AGED 18-45 respectively (IPM, 2016). ASPIRE conducted research across 15 sites Malawi, 
South Africa, Uganda, and Zimbabwe, while the Ring study assessed the ring’s efficacy across 
six sites in South Africa and one site in Uganda (IPM, 2016).  
 
Results from ASPIRE and the ring study showed an overall effectiveness of 27 and 31 percent 
efficacy respectively, with a close relation to age (Avert, 2016). ASPIRE showed 0 percent 
effectiveness and efficacy for young women aged 18-21, while 56 and 61 percent effectiveness 
was achieved for women above 21 and 25 respectively. The Ring Study on the other hand 
reported 37 percent efficacy for women over 21 (AVAC, 2016; Avert, 2016). Contrasting other 
microbicide trials, these studies showcased very similar results, therefore offering potential to 
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what has been described as a modest effectiveness (AVAC, 2016). Designing a long-acting 
dapivirine ring was efforts to address adherence challenges faced in previous PrEP trials such as 
the tenofovir gel, however, challenges with adherence were persistent in trials, particularly 
amongst younger women (CAPRISA, 2016; Baeten et al, 2016; AVAC, 2016).  
 
In the same year a new analyses of the dapivirine ring was announced at the 2016 AIDS 
conference, linking a 56% and 75% risk reduction to two separate groups of women who used 
the ring consistently (IPM, 2016; MTN, 2016). These recent findings are said to indicate that high 
adherence can result in high effectiveness of the dapivirine ring (IPM, 2016). According to The 
Well Project (2016), these findings may be an indicator that these women may have needed to 
become familiar with this new technology. 
 
In light of these developments, further advancements will include follow up studies (the HOPE 
and DREAM open-label extension trials), “to determine when, why, and how women use the ring, 
and to develop effective ways to support its consistent use, or adherence” (IPM, 2016; MTN, 
2016). Acknowledging various preferences in HIV prevention methods, these studies aim also to 
identify indicators of the contexts and the type of women who are likely to use the dapivirine ring, 
and why (MTN, 2016). This is a step forward to understanding the various contexts, to allow for 
the development and implementation of relevant, viable and context-specific products that women 
can actually use.  
 
It is therefore critically important that the epidemic in all contexts, taking into account women’s 
socio-cultural, structural and economic contexts in order to understand which prevention method 
would best be suitable for a particular context (Ramjee and Daniels, 2013). A variety of options 
should be made available, in order to match potential users with a variety of products to choose 
from (Nota, 2016). The variety of products are supposed to increase use and adherence, and 
thus increase protection and reduce new infections amongst women. There remains a need to 
explore women’s profiles in order to prescribe suitable methods that are consistent with their 
lifestyles so as to eliminate inconsistent use.  
 
Acceptability of microbicides  
As microbicides are gaining momentum as promising barrier methods that will provide increased 
protection towards females, assessing the product’s acceptability requires an understanding of 
how social processes, such as the sexual partner, health care providers, and key opinion leaders, 
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may have an impact on acceptability of microbicides amongst women and men (Mantell et al, 
2005). Acceptability of a product includes both perceived acceptability, i.e. satisfaction with the 
product’s features and demonstrating willingness to use it correctly and consistently, or 
recommend it to someone, and actual use of the product during intercourse (Ramjee et al, 2001; 
Ramjee et al, 2005; Ventuneac et al, 2010). Acceptance is also influenced by various 
demographics and socio-cultural background, therefore it differs across diverse populations 
(Zhang et al, 2016). While microbicides have the potential to empower women for protection 
against sexually acquired HIV, their effectiveness may not be realised if the underlying factors 
associated with microbicide acceptability are not understood and addressed (Schuler et al, 2013).  
 
Acceptability of microbicides are discussed under the following headings: (1) perceived efficacy, 
(2) partner dynamics, (3) perception of risk, (4) behaviour/ lifestyle patterns; each discussed with 
examples from various microbicide clinical trials as well as qualitative studies. 
 
Perceived efficacy 
Acceptability of microbicides has yielded different results in diverse study populations. Evidence 
from previous microbicide studies suggests that women’s acceptance and adherence is 
influenced by a number of factors; ranging from product preference, relationship dynamics, 
gender roles, vaginal practices, social acceptance of product use (van der Straten et al, 2014). 
Shattock and Rosenberg (2012) assert that a microbicide product must demonstrate a significant 
degree of efficacy in real-world situations, however, evidence from clinical trials proves adherence 
to be a challenge, which is indicative of a possible trend in real-life settings. 
 
Efficacy refers to a person’s belief or perception of their capacity to achieving desired results 
(Bandura, 1994). People’s beliefs about their capabilities affect their choices, how much effort 
they dedicate to something, and how long they will persevere when they are in challenging 
situations (Bandura, 1994). In terms of PrEP product acceptance and use, efficacy differs 
amongst individuals (Montgomery and Pool, 2011). These prevention technologies are used in a 
complex social world which involves unequal gender relations and other determining factors such 
as sexual practices (douching and insertion); which may affect product efficacy. These factors are 
to be explored to understand factors that reduce women’s efficacy, which in turn may affect 




For example, low perceived efficacy in microbicide products discouraged adequate use amongst 
participants in the VOICE trial (van der Straten et al, 2015). An acceptability study amongst female 
students at University of KwaZulu-Natal in Durban, South Africa found that a product’s 
characteristics has great influence on acceptability and attitudes around it (Nota, 2016). In this 
study, the students demonstrated high acceptability of the dapivirine ring when compared to the 
tenofovir gel. The dapivirine ring was perceived to be more practical than the tenofovir gel as the 
gel’s dosing regimen (BAT-24) would make it difficult to use for every sexual encounter (Nota, 
2016). In further demonstrating the above observation by Montgomery and Pool (2001) of the 
difference in individual efficacy in PrEP use, the VOICE-C study found that women who lived with 
their partners experienced difficulties using the tenofovir gel consistently compared to those who 
live alone or with their parents (van der Straten et al, 2014). This was because women who lived 
alone would often be anticipate intercourse thus allowing for sufficient time to apply the gel while 
sex amongst women who live with their partners would often be spontaneous; which would often 
impede application of the product (van der Straten et al, 2014). In the case of the dapivirine ring, 
high efficacy levels were achieved amongst older women than in younger women in ASPIRE and 
the Ring study (AVAC, 2016). These findings indicate the importance of understanding women’s 
contexts in acceptance and use of a prevention method, as the same intervention can produce 
different results in different contexts because the factors that determine HIV transmission differ in 
each context (Aral and Cates (2013). It is evident that women’s ages, socio-economic status and 
cultural backgrounds are to be considered when introducing a new prevention method (Palmeira-
de-Oliveira et al, 2014). The need to meet women with a variety of products is also of utmost 
importance to curbing the sexual transmission of HIV (Mantell et al, 2006). 
 
In further discussing the issue of efficacy, much controversy continues with regards to partial 
protection offered by microbicides; which entails partial efficacy against HIV acquisition (Becker 
et al, 2004). In trials, participants are informed that the administered product has unknown efficacy 
therefore it may or may not provide protection, and that that they may have been assigned to use 
a placebo (Woodsong et al, 2013). In the iPrEx PrEP study, the participants who were 
unknowingly administered oral truvada were reluctant to take the pill as they believed it to be the 
ineffective placebo (PrEP Facts, 2015). This suggests that unknown efficacy may make people 
feel they do not have much influence over their health, and thus engaging more risky sexual 
behaviour than adopting a positive health behaviour (Varga, 2001). Furthermore, partial protection 
poses challenges with proper use of these products as revealed in various studies (Shattock and 
Rosenberg, 2012; Woodsong et al, 2013), where the requirement to be used in conjunction with 
45 
 
a condom has resulted in confusion and uncertainty about microbicide products. A study in an 
urban setting in Cape Town found that respondents had concerns about a partially effective 
microbicide, however, they felt that partial protection would help in fighting the HIV crisis amongst 
women (Orner et al, 2016). This underscores the importance of exploring how partial efficacy of 
microbicides is received through pilot studies and early introduction programs to identify and 




Heterosexual sexual relationships involve two people, therefore partner/ gender dynamics need 
to be considered when assessing acceptability of a new prevention method (Poo et al, 2005). 
Furthermore, men maintain a great level of influence over women’s decisions to accept and 
adhere to female-centred programmes (Lanham et al, 2014).  
 
A number of microbicide studies found that women are more concerned about satisfying their 
male partner’s sexual pleasure than protecting themselves from infection (Mantell et al, 2009; 
Nicolson and Burr, 2003). As highlighted earlier in the discussion, cultural practices of dry sex 
often perpetuate the practice of vaginal insertions which could then prohibit acceptability of 
microbicide products such as the tenofovir gel due to its lubricative properties (Woodsong, 2004). 
The great need to heighten men’s sexual pleasure through dry sex therefore may decrease the 
incentive for protection (Nicolson and Burr, 2003). For example, women who took part in the 
VOICE study confessed having discontinued use of the tenofovir gel if the male partner had 
complained about the vagina being too wet (Van der Straten et al, 2014; Montgomery et al, 2015). 
Product acceptability therefore is largely determined by the male partner’s reaction, as the study 
found that in the absence of complaints from the male partner, women would continue using the 
gel as it meant the gel did not interfere with their relationships (Montgomery et al, 2015). In another 
acceptability study, women’s assessment of the gel strongly related to their perception of how the 
added lubrication would influence personal and sexual pleasure (Hoffman et al, 2010). Van der 
Straten et al (2014) concluded that male partners’ dissatisfaction with a product indirectly 
influenced women’s willingness to continue using the product. They further noted that keeping 
their relationship surpassed the need for protection, as participants would discontinue trial 




Intimate partner violence (IPV) is also identified as posing a threat to microbicide acceptability 
and use. Taking into account the widespread occurrences of IPV in South Africa, “trials of female-
controlled technologies for HIV prevention such as microbicides may increase the possibility of 
social harms” (Stadler et al, 2014: 49). For example, more than a third of 150 women enrolled in 
a social science sub-study, nested within a Microbicide Development Programme (MDP) trial in 
Johannesburg, South Africa reported to have experienced IPV (van der Straten et al, 2014). 
Similarly, some women in the Aspire study were subjected to or feared abuse from their male 
partners (MTN, 2016). The report from MTN (2016) further states that acceptance levels of the 
dapivirine ring increased from 1.5 to 2.5%, depending on how recent the women may have 
experienced abuse. Such trends may occur in real-life settings, where women may be subjected 
to IPV as a result of attempting to adopt microbicides as a prevention method. 
 
Perceived risk of infection  
Low perception of risk can have an impact on acceptability of microbicides. According to Shisana 
(2005) an individual’s perception of their risk to illness or disease influences them to adopt risk-
reduction behaviour or preventive strategies. Adding to this, Mantell et al (2006) assert that a 
person’s beliefs play a major role in determining their acceptance of a new prevention method. 
As previously stated, false perception of risk amongst long-term partners prevents the use of 
barrier methods (Stern and Buikema, 2013).  
 
Similarly, low perception of risk has been found to have great influence in acceptance and use of 
microbicides (Khawcharoenporn et al, 2014; Smit, 2008). Findings suggests that microbicides are 
perceived as prevention methods suitable only for uncommitted people who engage in casual 
relationships (Lanham et al, 2014). Results from a microbicide complimentary research study 
found that some men perceived women’s use of microbicides as a sign of suspicion that he was 
unfaithful (Lanham et al, 2014). Another study found a high probability of rejection amongst people 
who do not use condoms (Carballo-Diéguez et al, 2007). Relationship norms therefore are seen 
having a great impact on the type of women who should use microbicides, thus affecting how 
acceptable they will be (Lanham et al, 2014).  
 
While not disregarding the other contextual determinants, microbicides can be adopted as an HIV 
prevention method if women are aware of their vulnerability to HIV infection (Libingi and Sitali, 
2015). For example, a microbicide acceptability study in an urban setting outside of Cape Town, 
South Africa found that awareness of the risk posed by sexual coercion, rape and unplanned sex 
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were key concerns that influenced acceptability of microbicides at a personal or community level 
(Orner et al, 2006). The much required steps in ensuring the effectiveness of these new 
prevention technologies therefore rests in understanding how individuals contemplate their own 
risk of infection (Eaton and Kalichman, 2007). This should extend to facilitating awareness on 
perception of HIV risk amongst married and cohabitating couples (Maharaj and Cleland, 2001).  
 
Furthermore, Blashil et al, (2015) suggested that future prevention methods should consider 
psychosocial problems such as internalized stigma, which may hinder the use of pre-exposure 
prophylaxis (PrEP). He explains that some women may disregard using these methods because 
in other contexts it may be viewed as admission that one engages in risky sexual behaviour, or 
that they are HIV positive (Blashil et al, 2015). In the VOICE-C, the daily intake of ARV-based 
products was found challenging, as ARVs were associated with sickness, therefore the women’s 
partners and families were suspecting that they were HIV positive (Montgomery et al, 2014). This 
also contributed to internal struggles about taking HIV treatment when healthy (van der Straten 
et al, 2014). 
 
Behaviour/ lifestyle patterns 
Behavioural and lifestyle factors are also to be taken into consideration when assessing 
acceptability of a new prevention method. High rates of alcohol consumption in South Africa not 
only increases the risk of infection (SANGONeT, 2012). That also poses a threat to the success 
of emergent biomedical HIV prevention technologies such as microbicides as it may have 
challenges with correct and consistent use (Bryant et al, 2010). For example, women in the VOICE 
–C study reported missing doses during weekends to avoid mixing them with alcohol (van der 
Straten et al, 2014). It is therefore critically important to understand the epidemiological context, 
defined as “the current state and trends in the behavioural and biological factors that determine 
the transmission dynamics of a given disease and the impact of a specific intervention” (Aral and 
Cates, 2013: 338). Accordingly, the field of microbicides has since extended focus to conducting 
socio-behavioural research, focusing on understanding behavioural and biological efficacy of 
microbicides (UNAIDS, 2015).   
 
For the purpose of this study however, acceptability of microbicides is measured on participant’s 
willingness to use products based on product features, taking into account various contextual 
factors and their perception of risk, as study participants were not administered any microbicide 
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products to use. The study merely explored the perceptions on participant’s willingness to use 
microbicide products.  
 
Covert use of microbicides 
Motivation for the development of microbicides results from the high infection rates amongst 
women, due to their inability to use available HIV prevention methods such as the male and 
female condom (Morrow et al, 2010). The goal is to reduce reliance on male partner’s cooperation 
for protection against sexually acquired HIV through covert use (Stein, 1990). Microbicides hold 
great promise in reducing the HIV rates amongst women through products that cannot be seen 
or felt by the male partner, thereby increasing women’s control over protection by enabling them 
the option to use microbicides more discreetly (Hoffman et al, 2010). Much controversy has 
emerged regarding the quality of covert use, as it is perceived both as a barrier and incentive to 
microbicide use (Becker et al, 2004), when taking into account diverse cultural backgrounds and 
existing social harms such as IPV experienced by women. 
 
For some women, covert use is a much needed approach to achieving protection. Common 
reasons for the decision to use microbicide discreetly include fearing a negative repercussions 
ranging from objection, violence, or simply not seeing the need to disclose as they feel the partner 
does not need to know, particularly in casual relationships (Lanham et al, 2014; Becker et al, 
2004). A study amongst students at the University of KwaZulu-Natal found that covert use was 
the most appealing feature about microbicides (Nota, 2016). A number of studies also found that 
women appreciate a prevention method that allows them discreet use, preferably one that can be 
completely unnoticeable by the male partner (Orner et al, 2006). 
 
Covert use however may not be practical for all women. Evidence from various female-centred 
programmes, including microbicides revealed that efforts to disregard the often dominant role of 
men in sexual decisions are ineffective (AIDS Fact, 2016, Lanham et al, 2014; Gómez and 
VanOss Marín, 1996). The VOICE-C study revealed that women who took part in the Voice study 
experienced IPV, were suspected of infidelity, and they were unable to use products consistently 
due to fear of being discovered by male partner (Montgomery et al, 2015; van der Straten et al, 
2014) In reality, covert use can be a challenge to acceptance, utilisation and adherence in the 





Moreover, in some contexts covert use may be deemed as culturally inappropriate as a product 
that provides women with more power and control over their sexuality may be going against 
traditional and cultural norms (Becker et al, 2004). Ultimately, a woman’s decision whether or not 
to use microbicides, and whether to use them covertly will be influenced by cultural norms for 
behavior (Woodsong, 2004). Male acceptability studies found that men are against covert use of 
microbicides, as they don’t believe women should be allowed the ability to use protective products 
without the male partner’s knowledge (Woodsong, 2004). Similarly, a study amongst men and 
women found that men opposed to covert use, emphasing the need to maintain trust in a 
relationship, while women in long-term partnerships asserted that social expectation to have no 
particular need for microbicides, and that attempting to use would result in relationship problems 
(Poo et al, 2005). The introduction of microbicides should thus be sensitive to diverse cultural 
contexts, as “marketing strategies could either encourage or discourage covert use, discourage 
use altogether or alienate male partners, which could make the discovery of covert use more 
perilous for women” (Woodsong, 2004: 127).  
 
Male involvement in a female-controlled prevention method 
Gender inequity is identified amongst the factors that impede women’s acceptance, utilisation and 
adherence to women-centred health programmes (Lanham et al; 2014; Burger, 2005). A large 
volume of studies have documented women’s limited capacity to negotiate the use of prevention 
method such as condoms and family planning (Aransiola et al, 2014), however there is very limited 
research exploring a male’s perspective, or the ways in which men can be employed to promote 
acceptance and uptake female-centred intervention programmes.  
 
Drawing from family planning as an example, Mbizvo and Basett (1996) found that men were 
more often responsible for the decision to use contraception than the women themselves, even 
though the decision for use is meant to be the female partner’s. Similarly, social research on 
microbicides found that men had great influence (directly or indirectly) on women’s acceptance 
and use of microbicides (Montgomery et al, 2015; van der Straten et al, 2014).  
 
Although women understand the possibility of covert use for microbicides, studies reveal that 
most women, especially those in marriage or long-term relationships prefer to talk to their partners 
about using the products (GCM, 2010; Van Damme et al, 2008; Ryan et al, 2015). Women’s 
response to microbicides is largely influenced by the male partner’s perception and their ability to 
negotiate use with them (Ryan et al, 2015). Similarly, men want to be involved in the decision to 
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use microbicides and on the choice about which microbicide product to use. About 80% of men 
who took part in an acceptability study amongst South African men want to be informed about 
their partner’s choice to use microbicides (Ramjee et al, 2001).  
 
According to Schuler et al (2013), acceptance and adherence to microbicides can be achieved 
through male involvement from the early stages of introducing microbicide products. The Partner’s 
PrEP trial is a great indicator of this, having reduced up to 70% to 90% infection risk amongst 
heterosexual sero-discordant couples (PrEP Facts, 2016, Venter et al, 2015). Similarly, a study 
amongst 1200 heterosexual men and women in Botswana reported up to 62% risk reduction 
(PrEP Facts, 2016). Evidence from various microbicide trials found acceptance and consistent 
use to be higher amongst women whom their partners had knowledge of their use of the products 
(Salter et al, 2008, Montgomery et al, 2010; Mngadi et al, 2014). An evaluation of the VOICE 
study found that supportive partners contributed positively towards women’s use of PrEP, as they 
reminded them to use the products and provided money to travel to the study clinics (van der 
Straten et al, 2014). It has become apparent therefore that a prevention method is likely to be 
used effectively when both partners are aware of its use (Ramjee and Daniels, 2013). 
 
Moreover, men reported having a sense of responsibility when involved in female-centred 
programmes, and are thus encouraged to actively participate towards its success (Edwards, 
1994). In microbicide trials, male involvement has been found to increase community acceptance 
and reduce stigma around microbicides, improve communication about sexual matters and 
increase shared responsibility for protection (Woodsong, 2006; Montgomery 2011; Schuler et al, 
2013).  
 
Access to product information has also been found to play a major role in men’s acceptance of 
microbicides as a prevention method for their female partners (Kelly et al, 2015). A study 
conducted in various settings in South Africa revealed that lack of product information amongst 
men can result in rejection of the products, as they expressed their concerns about their female 
partners using a product they are not properly informed about (Kelly et al, 2015). A systematic 
review of various HIV prevention trials including microbicides concluded that adherence support 
programs need to consider involving intimate partners in pre-enrollment visits as this may reduce 
suspicion, encourage women to use products more openly, and also make it possible to get their 
partners to remind them of product use (Ambia and Agot 2013). Studies on female-centred 
intervention programmes such as microbicides should have complementary studies dedicated to 
51 
 
understanding men’s positions and impact on acceptance and use (Mbizvo and Basett, 1996; 
Edwards, 1994). Encouraging couples’ and male partners’ studies have the potential to facilitate 
acceptance and support of product use for women, particularly those in stable partnerships (Van 
der Straten et al, 2014).  
 
Drawbacks of male involvement 
Given the growing studies indicating women’s preference for men to be involved in microbicide 
research and use in real-life contexts, it is critically important to note that disclosure of microbicide 
use may not always translate into male partner’s acceptance and support.  
 
Many African countries are patriarchal, entrenched deeply in ideologies that enforce gender 
differences which define how women should interact with men (James, 2008). In some contexts, 
women are not expected to initiate or deny a man’s sexual advances, let alone suggest the use 
of protection (Duffy, 2005). Violent consequences such as IPV often result from doing so because 
it is perceived as contravention of cultural roles and norms (ICAD, 2006; Strebel et al, 2012 
Jewkes et al, 2010 Pettifor et al, 2004). Highly discreet products that offer women uncontested 
protection may subject women to IPV, as they may be perceived as posing a threat to men’s 
dominant positions in relationships and in sexual decision-making (Mantell et al, 2005; Nota, 
2016). Studies therefore warn against the possibility of diminishing women’s autonomy to decide 
whether or not to use microbicides covertly through male involvement (Lanham et al, 2014; 
Moodley, 2007).  
 
Male involvement can also result in risk compensation, defined as “the theoretical risk that 
individuals commencing PrEP will neglect other safer-sex measures, and put themselves at 
increased risk of HIV exposure” (Bekker et al, 2016: 9). Drawing from the risk homeostasis theory 
(Wilde, 1982), Eaton and Kalichman (2010) postulates that while prevention technologies offer 
much needed increased protection against HIV, it is critically important to examine the impact of 
increased efficacy on sexual behaviour. For example, a social science study on Medical Male 
Circumcision (MMC) found a high probability of risk compensation, as men demonstrated a 
likelihood to increase the number of sexual partners and potentially discontinue condoms after 
undergoing circumcision (Mantell et al, 2012).  
 
Similarly, HIV new prevention technologies (microbicides, ARVs, etc.) are perceived to have the 
potential to lower the perception of risk and thus alter risk-related behaviors (Eaton and 
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Kalichman, 2007). An acceptability study found that consistent condom users were likely to 
substitute condoms with microbicides (Orner et al, 2016). Women who may choose to disclose 
microbicide may be at an increased risk of incurring infection as some men may discontinue 
condom use due to misconception about the protection offered by microbicides (Woodsong, 
2004). Woodsong’s study further draws on the impact male involvement may have on women’s 
autonomy for protection, as women may be forced into using them unwillingly by men who prefer 
microbicides over condoms (Woodsong, 2004).  
 
The success of microbicides as an HIV prevention method for women relies greatly on policies 
and programmes acknowledging and addressing the impact of gender inequalities in acceptance 
and utilisation of microbicides amongst women (Lanham et al, 2014). Brief risk reduction 
counseling should also be implemented alongside the introduction of these products, to ensure 
acceptance and optimal protection (Eaton and Kalichman, 2007).  
 
Identified gaps in literature 
The issue of context has been identified as a key area to explore for effective prevention and 
management of HIV. In keeping with this notion, the research aims to draw a comparison between 
the perceptions of people from a province that has undergone microbicidal clinical trials (KZN) 
and one that has not had any exposure (MP).  
 
Moreover, KZN is amongst the few provinces that have undergone microbicide clinical trials in 
South Africa, this including Gauteng, North West and the Western Cape. The high prevalence of 
HIV in other regions indicates the need for trials to extend to other regions of the country in order 
to get insights from various contexts. The study seeks to identify if there is a difference in 
perception and acceptance between men and women from these provinces.  
 
Furthermore, the need for this study is based on observation that while women express lack of 
power in negotiating safe sex practices with their male partners, there is only limited research 
exploring a male’s perspective on this matter. There remains a gap on literature regarding men’s 
views on the subject of microbicides. This study explores a male’s perspective to identify if male 






The preceding chapter has provided a detailed case of the severity of HIV amongst women, the 
biological, sociocultural, structural and economic factors increasing women’s susceptibility to HIV. 
The chapter has presented the failed attempts of the ABC approach (male and female condom) 
in preventing HIV infections amongst women, while highlighting the urgent need for prevention 
methods that provide women full control over their protection against HIV. Moreover, the chapter 
emphasised the importance of investigating a male’s perspective on microbicides, and to 
investigate its impact on women’s acceptance and utilisation of microbicides as an HIV prevention 
method. Moreover, in presenting the prevalence of HIV in KZN and MP, the researcher hopes to 
have made a strong case regarding extending microbicide studies to other regions plagued by 
the epidemic such as Mpumalanga. This was meant to demonstrate the importance of 
understanding the diverse epidemiological contexts, so as to identify the type of microbicides 
women are willing to use. 
 



















CHAPTER THREE: THEORETICAL FRAMEWORK 
 
Introduction  
Understanding health behaviours of a diversely cultured country such as South Africa, with 
complex relationships requires more than just a single theory (Mathew, 2012). As such, this 
study draws from two theoretical frameworks; the Social Ecological Model for Communication 
and Health Behaviour (SEMCHB) (Kincaid et al, 2007) and the Culture-Centred Approach 
(CCA) (Mohan Dutta, 2008) to examine the perceptions of men and women regarding 
microbicides as HIV prevention methods for women. The SEMCHB is employed in this study as 
a holistic approach, suitable for studying the interrelated socio-cultural, economic, and structural 
factors that need to be considered when investigating men and women’s perceptions towards 
microbicides. CCA is employed in this study to examine the cultural views (values, beliefs) of 
men and women in order to identify the barriers and facilitators of microbicides as a new female-
initiated prevention method (FIPM). These theories will be explored in the context of health 
communication. 
 
Communication in HIV  
The field of health communication has a growing relevance and importance in every aspect of 
health and well-being, including disease prevention, health promotion and quality of life (WHO, 
2009). Health communication is defined as “the study and use of communication plans and 
strategies to inform and influence individual and community decisions in ways that improve health” 
(Rensburg and Krige, 2011: 77). Given the global challenges posed by major health threats such 
as HIV, health communication scholars and practitioners recognize the importance of prevention 
and, with it, the need to understand human behaviour through the prism of theory (WHO, 2009).  
 
Responses towards the HIV and AIDS outbreak in the early 1980’s were centred only on 
biomedical approaches (Parker, 2012), while placing great focus on promoting individual health 
behaviour change (Airhihenbuwa, 2005). HIV however is a multifaceted disease, intertwined with 
various sociocultural, economic, structural, political and gender factors (Durden and Govender, 
2012). Addressing the health aspect while disregarding these underlying influential factors may 
impede the effectiveness of any intervention programme that seeks to curb the epidemic 
(Airhihenbuwa and Obregon, 2001). For example, the discussion on the female condom in 
chapter two highlighted that effectiveness of biomedical interventions and individual behaviour 
change cannot be achieved in isolation from these above-mentioned factors (Storey and 
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Figueroa, 2012; Walley et al, 2001; Chasi, 2004). An individual’s health behaviour is shaped and 
influenced by socio-cultural, economic, structural and gender related factors therefore it is 
critically important that they are explored, modified or addressed to create a health enhancing 
environment that encourages support of the proposed intervention (Durden and Govender, 2012; 
Airhihenbuwa, 2005; UNAIDS, 2016). Communication therefore has an important role in 
examining how the various factors meet to influence behaviour change (Airhihenbuwa, 2005). 
 
Given the complex nature of HIV and AIDS, health communication approaches have been revised 
to explore the health aspect together with the individual, community, societal influences of the 
epidemic (Govender, 2011). As a result, the field of health communication has since shifted focus 
from theories enforcing individual behaviour to more holistic and culture-sensitive approaches 
that strive for social behaviour change (Durden and Govender, 2012). Current social change 
approaches such as the Culture Centred Approach (CCA) and the Social Ecology Model of 
Communication and Health Behaviour (SEMCHB) are more sensitive to the environmental 
contexts within which intervention programmes are applied (Airhihenbuwa and Obregon, 2000).  
 
Moreover, HIV prevention methods such as microbicides are regarded as both biomedical and 
social science products therefore they require health and social motivation across all levels of 
society (Montgomery and Pool, 2001; van der Straten et al, 2014). Socio-behavioural research 
must be should be at the centre of all developmental stages of these new prevention technologies, 
as studying human behaviour allows to identify any barriers and facilitators regarding acceptance 
and use of a new prevention method. 
  
Understanding the SEMCHB 
Society is a complex entity that constitutes of interrelated organisms that are dependent on one 
another for survival (WHO, 1986). This is illustrated in ecology, which refers to “the complex 
interrelationships among organisms and the environment in which they live” (Storey and Figueroa, 
2012: 74). As an approach that stems from the social ecological perspective, the SEMCHB takes 
into account the complexity, interrelatedness and wholeness of components within a complex 
adaptive system, rather than particular components in isolation from the systems (Storey & 
Figueroa, 2012: 76).  
 
The core principles of the ecological model are based on the belief that perceptions about health 
are influenced by multiple influential factors that often include intrapersonal, interpersonal, 
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organizational, community, physical environmental and policies (Sallis et al, 2008; McLeroy et al, 
1988). These levels are illustrated in table 3.1, below: 
 
Table 3.1: The Ecological Perspective: Multiple Levels of Influence (McLeroy et al, 1988) 
CONCEPT (FACTORS) DEFINITION/DESCRIPTION 
Intrapersonal Individual traits and characteristics, such as 
knowledge, attitudes, beliefs, and personality 
traits, that influence behaviour 
Interpersonal Interpersonal processes, and primary groups 
including family, friends, peers, that provide 
social identity, support, and role definition 
Institutional These would be rules, regulations, policies 
including informal structures such as 
Universities, schools and colleges. 
Community Social networks and norms, or standards, 
which exist as formal or informal among 
individuals, groups, and organisations. This 
level also combines the institutional and 
public policy levels since these are part of 
“social structure”. 
Public Policy Local, provincial, national policies and laws 
that regulate or support healthy actions and 
practices for HIV prevention 
 
 
More immediate determinants of perceptions are identified through the three levels of the 
SEMCHB; Social networks, the community and societal structures (Storey and Figueroa, 2012). 
These levels are interrelated, they overlap and facilitate influences across all levels of the social 
system. Perceptions therefore can be best understood within a social ecological framework that 
takes into account the interconnected influences of social networks, community and society on 
behavior (Sallis and Owen 2002; McKee et al, 2014; Sallis et al, 2008; Storey and Figueroa, 
2012). As such, multi-level interventions are required to effectively understand and address health 




Research shows that the HIV and AIDS epidemic is an ecological entity (Parker, 2012), its 
persistent spread is intertwined with socio-cultural, economic and structural inequalities, as it is 
to behaviour (Hemer and Tufte, 2005; Parker, 2004). It has become a widely acknowledged notion 
that health communication messages need to look beyond the health aspect of a health problem, 
as the individual, social, community and societal influences of an epidemic are as much of concern 
for effective prevention (Durden and Govender, 2012). Women are part of much broader systems, 
this includes their social networks, communities and society at large (Storey and Figueroa, 2012; 
Mutinta, 2012). Their efforts to protect themselves against HIV infection (health behaviour) are 
therefore influenced by these larger structures.  
    
The SEMCHB is encompassed in two key attributes of “embeddedness, a state in which one 
system is nested in a hierarchy of other systems at different levels of analysis, and emergence, 
in which the system at each level is greater than the sum of its parts” (Storey & Figueroa, 2012: 
76). As a meta-theory, each level of the SEMCHB is assigned behavioural theories that are 
applicable to it (McKee et al, 2014; Storey & Figueroa, 2012). In health promotion, a social 
ecological theory is meant to understand how diverse personal and environmental factors 
influence human health and illness (Stokols, 1996). Such a multi-faceted approach is thus suitable 
for this study that seeks to examine barriers of facilitators to women’s acceptance and utilisation 
of microbicides from various levels of influences in the society. The element of “embeddedness” 
entails that each level is allowed other behavioural theories therefore each level contributes to a 





Figure 3.1: The Social Ecological Model of Communication and Health Behaviour. Source 
Storey and Figueroa (2012: 75). 
 
Since women are part of larger societal structures, introducing a new female-initiated prevention 
method requires creating an enabling environment, that is, addressing possible barriers at the 
household, community, organizational, and policy levels (Storey and Figueroa, 2012; Mutinta, 
2012). The study resonates with the notion that the levels of the SEMCHB model (social networks- 
intimate partner and family), community and the society are sites of negotiating health decisions 
therefore, health messages targeted at the individual in isolation are impractical and highly likely 
to be ineffective (Dutta, 2011). In using the SEMCHB, this study explored men and women’s 
perceptions within a wider socio-ecological perspective, exploring how the interconnected 
influential structures impact on women’s decisions to accept or use microbicides. Figure. 3.1 is 
an illustration of the SEMCHB. 
  
The different levels of influences 
The SEMCHB consists of four interconnected levels of the social system, namely, the individual, 
social networks, community and the societal level. These levels are interrelated and embedded 
within a broader discourse of understanding behavior change (Storey and Figueroa, 2012). For 
the purpose of this research, only the first three levels will be explored as the purpose of this 
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research is to identify the factors that could hinder acceptance and use of microbicides and not 
on developing implementation policies, which the societal level concerns itself with.  
 
The individual level  
The individual level of the SEMCHB is specifically focused on individual behaviour change. In this 
level, theories such as the HBM and SCT are employed. An example is the introduction of the 
ABC approach, which encouraged individual to adopt and practice abstain from sex, use condoms 
or be in monogamous relationships. The ABC approach relied on an individual to adopt and 
practice these recommended behaviour however, the decision to abstain from intercourse, have 
one sexual partner, or to use condoms occurs within a broader context and not only on an 
individual’s choice to adopt/revisit an existing or new behaviour.. For women specifically, 
individual targeted interventions such as the female condom have failed because social networks 
(intimate partners) are not in support of its use, while larger socio-cultural community norms have 
expectations of submissiveness and subservience amongst women, therefore denying them the 
ability to contest the male partner’s decision for non-condom use.  
 
Individual level interventions therefore are often short-lived, due to lack of sustainability from 
larger structures of the social system such as social networks, family and the community (Storey 
and Figueroa, 2012; Sallis et al, 2008). The failure of such intervention programmes is a result of 
barriers that emanate from higher levels and structures of the social system (WHO, 1964).  
 
The core concept of the SEMCHB however informs that individuals may be responsible for 
initiating a positive health behaviour however, maintenance of a particular health behaviour is 
determined to a large extent by social environments in which they emanate (Storey and Figueroa, 
2012; McKee et al, 2014). In cases where an individual attempts to adopt a health enhancing 
behaviour, their behavioural efficacy may be undermined by larger influential structures (Stokols, 
1996; Storey and Figueroa, 2012). For example, in a community with widespread norms of non-
condom use in long-term relationships (MacPhail and Campbell, 2001), although some youth 
attempted to go against the dominant norm and adopt condom use, their efforts were hindered 
by the prevailing sexual norms in the community. Sustainability of new behaviour relies greatly on 
support and encouragement of the family, peers, community and society, introducing individual 
change in isolation from other levels therefore may not achieve sustainable results. Effective 
individual behaviour change is best achieved when it is introduced within the overall context from 
which an individual emanates (Storey and Figueroa, 2012). 
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Social networks level 
The social networks level is made up of interpersonal relationships; family members, intimate 
partners, friends, neighbours, colleagues, etc (McLeroy et al, 1988). There has been an extensive 
focus on individual behavioral HIV prevention interventions with individuals (Trickett, 2005), 
however, behavioral HIV prevention interventions have little effect on behavior change with 
individuals when protective sexual behaviors are not supported by their social networks (Latkin 
and Knowlton, 2005). Social relationships are important aspects of individual behaviour, for 
example, a teenage boy who has a close friend who smokes cigarettes is also highly likely to be 
a smoker.  
 
Health interventions that employ the social networks level thus often seek to change individual 
behaviour through their social relationships while neglecting facilitation of change in group norms 
(McLeroy et al, 1988). Moreover, such interventions are often limited to specific groups of people, 
for example a group of women who partake in a woman’s community book club (Storey and 
Figueroa, 2012). This restrains an intervention programme from reaching the larger population 
within the community as it leaves it vulnerable to constraints from larger structures in the 
community. 
 
The community level 
A community is defined as a group of people living in the same place, who have common 
characteristics, interests, attitudes and beliefs (Rifkin et al, 1988). This entails that people from a 
community are likely to share the same views and perceive things the same way, due to the 
influences within the environment. Community can also refer to the mediating structures or 
primary social groups to which individuals belong, these include family, informal social networks, 
voluntary associations, churches etc, which create social resources and identities (McLeroy et al, 
1998). These interconnected result in the construction of social norms defined as “beliefs, values, 
and practices of a specific group that are external to individuals, and which exercise pressure on 
individuals to make them behave in pre-determined ways” (Hoffmann, 2010: 13). In this research, 
the concept of community will be explored as holding the greatest influence on perceptions on 
microbicides and the decision to seek health information and acceptance and use of microbicides 
(Cialdini and Trost, 1998). 
 
For example, in a study investigating risky sexual behaviours amongst students at the UKZN, the 
behavioural trends were found to be a result of a multi-systemic construction within the university 
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campuses (Mutinta, 2012). The university campuses formed a community with certain sexual 
norms, which in turn influenced individual student’s sexual behaviours. Addressing these risky 
sexual behaviours would require an understanding of these sexual norms within the university 
campuses. 
 
The community level can be more influential, having the power to reach a larger audience as it 
extends to both the individual and social networks within a community (Storey and Figueroa, 
2012). As noted earlier, effective and sustainable change can be realised when higher social 
levels support and encourage a newly adopted behaviour (Sallis et al, 2008). The implementation 
of the healthy-living project, with the primary goal of creating capable community development 
associations (CDAs) achieved successful results (Storey and Figueroa, 2012). The project aimed 
to mobilise communities to promote adoption of services such as family planning and reproductive 
health. Trained female volunteers from within the communities were agents of change, employed 
to develop activities tailored to the local contexts. An increase in women who utilised antenatal 
and reproductive health services had increased substantially by the end of the project (Storey and 
Figueroa, 2012).  
 
This example indicates that community targeted interventions are necessary to counteract any 
disabling influential factors to behaviour change. As apparent in the example above, the 
community is the greatest determinant of health outcomes therefore creating a health competent-
environment is important for interventions to hold at a community level (MacQueen et al, 2001). 
A health competent-environment is one in which people have the knowledge, skills, resources 
and attitudes needed to improve and maintain a health behaviour (Storey et al, 2006). 
Furthermore, the healthy-living project (Storey and Figueroa, 2012) illustrates that social norms 
are linked to the formation of collective efficacy for social action (Lee, 2010). Collective efficacy 
is defined as the shared belief in the capability of a group to address a certain problem when it 
acts conjointly (Bandura, 1997). In turn, collective efficacy influences collective action as it is a 
determining factor towards a group’s perceived ability to influence individual behaviour change 
(Lippman, 2007). Interventions that encourage collective efficacy and collective action can thus 
be beneficial to HIV prevention programmes (Cain et al, 2014; McLeroy et al, 1988). 
 
Despite the success of community programmes, an intervention that targets only the larger 
structures may not ensure sustainability at the individual level (Sallis et al, 2008). For example, 
South Africa’s female condom programme is amongst the biggest in the world, however, its 
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availability in some public health facilities had very little impact in its use amongst women. This is 
because often they are not empowered to initiate or negotiate the use of condoms as individuals. 
The success of an intervention programme therefore relies on an approach that takes into account 
all the levels of the social system (Storey and Figueroa, 2012).  
 
As indicated earlier, this study focuses on the first three levels (individual, social networks and 
community level), as the purpose of this research is mainly on assessing possible barriers and 
facilitators of microbicides by women at a community level. The society level therefore was not 
examined. 
 
Employing a multi-level approach to introducing microbicides 
The current paradigm in the field of HIV management and prevention places much emphasis on 
combination strategies that takes into account the social, behavioural and structural factors that 
influences adoption and adherence to intervention programmes (UNAIDS, 2016). Accordingly, 
this research will employ a multi-level approach, exploring how the social networks and 
community levels influence on the individual level (women’s decisions to accept or utilise 
microbicides). In doing so, the research aims to identify specifically how the family, intimate 
partners and various social relationships, as well as social norms and beliefs of the community 
may impact women’s decision making to accept and utilise microbicides as an HIV prevention 
method.  
 
Furthermore, Sallis et al (2008) asserts that a multi-level approach is most suitable for behaviour 
change in response to a health problem such as HIV that is influenced by multiple factors that 
often include intrapersonal, organizational, community, and public policy. A health intervention 
programme that focuses on any one level on the other hand underestimates the effects of the 
other levels on behaviour change (Stokols, 1996). For example, a recent study showed that 
encouraging young women to stay in school and refrain from economic-based sex was much 
more effective when informational (knowledge about HIV and STIs) and biomedical interventions 
(HIV testing) were accompanied by social support from parents and school teachers as well as 
economic incentives (money and food) (Cluver et al, 2016). In this study, the individual level, 
social networks level (family), and community levels are taken into account. Moreover, structural 
and economic factors are being addressed. This shows that a multi-level approach can work to 
holistically ensuring a health competent environment, where individuals, social networks and the 
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larger social structures are supportive and encouraging of healthy behaviour (Storey and 
Figueroa, 2012). 
 
Another example can be drawn from the implementation of the ABC approach in the Ugandan 
context, where behaviour change and the reduction of HIV is said to have been a result of national 
HIV awareness campaigns which were supported by various sectors (public and private, civil 
society -religious bodies, employers, labour organizations, etc) (Murphy et al, 2016).  
 
In this study, the individual level is examined within the social networks and the community levels 
in order to identify the impact these larger structures may have on women’s decision to accept or 
use microbicides. The social networks level served to explore specifically the trends that emanate 
from various social relationships or group settings, in order to determine how such these spaces 
may impact on women’s decision to accept or use microbicides. The community level was 
employed to identify the larger social beliefs and norms that emanate from these communities, 
which may have an impact in women’s acceptance and uptake of microbicides. As health 
influential factors are understood to emanate from across all levels of the social system (Sallis et 
al, 2008). The community level also seeks to encourage collective efficacy and action, in 
facilitating positive norms and collective action towards identifying and addressing possible 
barriers while encouraging an enabling environment for women to use microbicides. A multi-level 
approach therefore is the most probable as it allows for identifying possible barriers and facilitators 
to microbicide within and across all the levels of the community (Storey and Figueroa, 2012). 
Furthermore, multiple level interventions broaden the scope of options for health interventions 
(Sallis et al, 2008). Using an ecological approach to microbicide introduction therefore will allow 
for multiple solutions to facilitating acceptance and use amongst women. 
 
Background of the Culture-Centred Approach 
The field of health communication is informed by communication for development theories which 
have been in a state of flux due to constant shift in socio-cultural structures. The infant stages on 
development communication was informed by the modernization paradigm, an approach nested 
in ‘top-down’ communication between the benefactors and beneficiaries of an intervention 
programme approach (Waisbord, 2001). This approach was characterised by imposition of 
interventions whilst upholding detachment and disinterest with needs as perceived by the 
community itself (Louw and Tomaselli, 2007). The lack of change was associated with a lack of 
information in underdeveloped nations (Waisbord, 2001). Accordingly, the field of development 
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communication transitioned to adopt the ‘knowledge, attitude and practice’ (KAP) approach in the 
late 1960s, also stimulating change in the field of health communication (Durden and Chasi, 
2012). The assumption was that providing people with knowledge would change their attitudes 
and therefore result in a change in behaviour (Durden and Chasi, 2012). Early stages of the health 
communication field employed the diffusions of innovations theory (Rogers, 1969). This approach 
was not very effective, this has particularly been apparent in the failed attempts to combat the 
HIV crisis around the world and in South Africa during the 1990s (Quarry and Ramirez, 2009; 
Govender, 2011). Early HIV communication was focused exclusively on disseminating 
information and knowledge about the epidemic while disregarding the underlying socio-cultural 
and structural contexts in which the communication takes place (Govender, 2011). Failure of this 
approach demonstrates that information alone cannot ensure behaviour change. Moreover, 
another challenge with this approach was particularly because the dissemination of information 
was a one-way process, where people were provided information however they were not offered 
platform for feedback (Waisbord, 2001).  
 
The late 1980’s saw a change in health promotion, as communication messages moved away 
from just promoting knowledge and information to encouraging behaviour change through 
Behaviour Change Communication (BCC). Theories such as the Health belief model (HBM) and 
the Social cognitive theory (SGT) were employed, with much emphasis on individual behaviour 
change (Airhihenbuwa and Obregon, 2000). Accordingly, the BCC approach was employed for 
HIV communication in South Africa during the mid-1990s however, it proved to be ineffective in 
combating HIV infections (Govender, 2011). The shortcomings of the BCC approach were 
attributed to generalization and homogenization of HIV, while the epidemic varies with each 
context (Airhihenbuwa and Obregon, 2000). This demonstrated that individual behaviour change 
must be examined within various structures of the social networks, community and society at large 
(Durden and Chasi, 2012). Specific to the South African context BCC failed to address the cultural, 
socio-economic and structural conditions that influence an individual’s health choices (Govender, 
2011).  
 
In light of such limitations, responses to health communication strived for social change, applying 
theories such as the Social Change Communication in the late 1980s (SCC) (Davids, 2005). This 
paradigm advocated for community involvement and partnership through theories such as 
Communicating for Social Change (CFSC) and Communicating for Participatory Development 
(CFPD) (Govender, 2011). This shift encouraged a more interactive communication approach, 
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whereby there is dialogue between the sender and receiver of information (Govender, 2011). 
Impetus for change was motivated by the realisation that beneficiary communities were 
knowledgeable and have the capability to identify their needs therefore people’s voices were to 
be taken into account when developing or introducing an intervention programme (Tomaselli and 
Chasi, 2011). In South Africa, the SCC approach was introduced during the late 1990s in HIV and 
AIDS communication, through campaigns that encouraged community involvement rather than 
awareness or individual behaviour change (Govender, 2011). SCC allows for understanding 
behavior in context which is very important for new prevention technologies such as microbicides. 
 
The Culture-Centred Approach  
CCA extends on the participatory paradigm, introducing the value of the cultural aspect in health 
intervention programmes. The CCA concerns itself with marginalised subaltern voices, defined 
by Dutta (2008) as the silenced or marginalised groups within social systems. Dutta asserts that 
subalternity occurs at multiple levels, reinforced through communicating ideologies and 
discourses that favor the elite while conditioning subalterns in inferior positions (Dutta, 2006). In 
this study, the marginalised group would be women, as people who have limited power over their 
decision for protection against sexually acquired HIV due to various socio-economic and cultural 
factors that come together to constrain their sexual agency. 
 
According to Dutta-Bergman (2005), health is constituted within the three key components of 
culture, structure and agency while communities are spaces within which these structures are 
carried out. As such, the CCA is embodied amongst these three components, while also 
constituting 5 characteristics namely; voice and dialogue, structure, context and space, values 
and criticism. This study focuses only on the three elements of CCA, as well as ‘voice and 





Figure 3.2: The Culture-Centred Approach to Health communication. (Dutta, 2008:5) 
 
Culture  
Culture refers to the learned beliefs and practices, perceptions and attitudes, passions, and 
expressions that distinguishes a group from another (Hill, 2011). Culture can also be understood 
as a phenomenon that results from active participation of community members in creating 
meanings (values and beliefs) with which they collectively identify (Dutta, 2008). As highlighted 
earlier, cultural beliefs and norms influence perceptions of illness and health seeking behaviors 
(Nandoya, 2014; Peterson, 2009). 
 
During the modernization paradigm, culture was perceived as an obstruction to effective 
development, therefore cultural values and beliefs were to be eradicated as a prerequisite for 
effective development (Servaes, 1995; Waisbord, 2001; Tomaselli, 2011). Given the failures of 
this paradigm, culture started gaining prevalence as an effective tool for development and health 
communication in the 1990’s (Dutta, 2008). The potential for culture to be used as an asset in 
development and health communication was fostered by the need to respond to the changing 
cultural landscapes (Dutta, 2008). 
 
CCA advocates that the community’s cultural context should be at the core of health intervention 
programmes (Dutta, 2008), in that they must be designed to be consistent with a community’s 
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and its people’s cultural landscape (Airhihenbuwa, 1995). In the CCA approach, cultural beliefs 
are viewed not as barriers but rather as effective vehicles to bringing about effective and 
sustainable health behaviour in traditional societies (McKee et al, 2014; Dutta, 2008 and 2011; 
Airhihenbuwa et al, 2004). The effectiveness of a health programme in fact rests upon its 
consistence with the community’s cultural landscape (Airhihenbuwa, 1995). What may be 
perceived positively in a Western community may be viewed as a disturbance of cultural practices 
and way of life in a traditional setting (Willis, 2005). Furthermore, cultural contexts are not 
homogenous entities therefore, prescribing similar health intervention programmes may not 
produce consistent results (Servaes, 2000; Melkote and Steves, 2001). Similarly, Quarry and 
Ramirez (2009) assert that the community’s context is critically important when introducing an 
intervention programme therefore, solutions need to be designed specifically to suit the needs of 
each community.  
 
Development planners often overlook local cultural contexts. Such oversights can lead to failure 
of potentially effective prevention methods such as microbicides because cultural norms have 
great influence on people’s health choices. For example, potential threats towards certain cultural 
beliefs such as the practice of dry sex may impede acceptance of microbicides that have 
lubricative properties such as the tenofovir gel as it is observed in various microbicide trials 
(Hoffman et al, 2010 Woodsong, 2004; Van der Straten et al, 2014; Montgomery et al, 2015).  
  
In keeping with this notion, this research explores the acceptance of microbicides within the 
cultural frameworks of the designated study settings (Airhihenbuwa, 1995). Identifying culture as 
an ally to development is useful in a study about microbicides because it can assist in identifying 
cultural values and beliefs that influence people’s sexual behaviours. In that way, this study will 




Structure refers to the organisation of a society through various structures and systems that 
govern how it functions, people’s behaviour amongst each other and in response to these 
structures and external factors, etc (Dutta, 2008). 
 
Exploring community structures is key to effective prevention and management of HIV. A recent 
study in KwaZulu-Natal found that poverty and lack of social protection was a key determinant for 
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adolescent girls to engage in economic-driven sex, which placed them in substantial risk of 
acquiring HIV (de Oliviera et al, 2016). Furthermore, various studies revealed that structural and 
economic imbalances between men and women determine decision-making powers for protection 
in heterosexual relationships (Rangathanan et al, 2016 WHO, 2007; Beksinska et al, 2012).  
 
Understanding that HIV is a complex epidemic, the study instigated dialogues on the various 
structures that influence safe-sex practices in order to understand the factors that influence safe-
sex behaviour amongst women in the various study settings. The research therefore explored the 
cultural aspect of the communities along with social, structural, economic and gender factors in 
the context of HIV prevention.  
 
Agency 
The CCA stands in recognition that people have agency, “the capacity of human being to interact 
with structures in order to create meanings; such meanings provide scripts for interacting with the 
structures, for sustaining these structures, and for transforming them” (Dutta, 2008: 61). This 
means that people not just accept or adopt something, they have the ability to question and 
evaluate what is presented to them, and thereafter decide whether to accept or disregard it. This 
applies in all spheres of life including health, as postulated by Dutta (2011) that people understand 
their health needs and they are capable of identifying suitable solutions for these needs.  
 
The primary goal of an intervention programme is to empower the people it is designed for 
(Ledwith, 2011). The structures that govern the organisation of the society and people’s 
behaviours however are also determinants of the enactment of agency (Dutta, 2011). For 
example, cultural ideologies and beliefs affect women’s capability to adopt preventive methods 
such as condoms. As highlighted in chapter two, the failure of the female condom was due to its 
insensitivity to women’s socio-cultural positions in sexual decision-making. Gender-systems, 
rooted in cultural and social norms, as well as the socio-economic structural imbalances prevent 
women to utilise the female condom for HIV prevention. This prevention method therefore is an 
ineffective intervention programme because it does not provide much empowerment and agency 
for women (Murphy et al, 2006; Ryan et al, 2015, Karim and Baxter, 2012, Macpherson et al, 
2012; Ryan et al, 2015). Similarly, this study is based on microbicides, products designed to 
empower women to have greater control over their protection against sexually acquired HIV, in 
cases where men are against the use of condoms. This study explored women’s ability to utilise 
microbicides within the various structures, processes and systems that define women’s positions 
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in society in order to determine whether these prevention technologies will in fact empower them 
for HIV prevention. 
  
Voice and dialogue 
The shortcomings of the modernization paradigm is attributed to imposition of outside ideologies 
without gaining thorough understanding of the needs of people in their respective contexts (Chasi, 
2011). Given this limitation, the goal of the CCA is to promote the voices of previously 
marginalised cultural values and beliefs in discursive spaces in dialogues about intervention 
programmes (Dutta, 2008). This is meant to achieve a deeper understanding of the subaltern’s 
perspective, and the best way to achieve this is through facilitating dialogue amongst community 
members (Dutta, 2008). Dialogue is “a conversation between two or more people in which 
participants seek to clarify what each one thinks and believes” (Kincaid and Figueroa, 2009: 
1313).  
  
In the CCA the importance of the dialogue process rests upon facilitating a two-way 
communication process between the subaltern communities and the researcher, in order to 
understand the ways in which health messages are received, interpreted and understood (Dutta, 
2008). The researcher assumes the role of a listener and participant, engaging in equal dialogue 
with the beneficiaries of an intervention programme (Dutta, 2008). In this process, theory strives 
to promote the inclusion of previously marginalised voices in dialogues pertaining intervention 
programmes in order to facilitate relevant and suitable interventions (Dutta, 2008). Dialogue 
therefore is a form of empowerment (Ogunlela, 2014), as it encourages people to actively 
participate and be agents of their own change (Servaes, 1999). Dialogue not only allows people 
to express themselves, it also allows them to ask question so as to better understand what is 
presented to them (Obregron and Tufte, 2006). 
 
This approach is informed by Brazilian educator Paulo Freire’s (1979) writings on empowerment 
education, where he emphasises the importance of a problem-solving approach which 
encourages facilitation of critical thinking rather than a banking system that treats people as 
passive receivers of information. In opposing ideologies of the modernization approach, Freire 
emphasises the use of education to liberate and provide people ownership over their lives.  
 
Through dialogue, this study encouraged men and women to actively participate and engage 
about microbicides in relation to their cultural context, to collectively identify possible barriers and 
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facilitators to acceptance and use within their communities, and thereafter identifying sustainable 
solutions (Dutta, 2008). A bottom-up communication was central in this study as the purpose of 
the research was on learning about the community’s perspectives about microbicides. Although 
the study introduced microbicides as part of existing barrier methods such as condoms, they are 
promoted as part of existing prevention methods that aim to empower women by providing them 
with more options to choose from in terms of HIV prevention. Microbicides serve as an alternative 
for impractical methods that women are often unable to enforce. Therefore, in as much as this 
research is based similar to existing products therefore its purpose does not take away from the 
purpose of is to introduce a marginalised population group (women) to a method they can either 
use alone or in combination with other barrier methods.  
 
The participants were provided with a detailed explanation and demonstration of the products 
prior to the focus group discussions. In keeping with the CCA’s bottom-up approach, they 
participants were allowed a chance to process and evaluate the products in relation to their 
respective settings, to ask any questions, and thereafter to share their views related to the 
presented microbicide products (Dutta, 2008). This was done in order to allow the participants to 
identify practical and effective solutions they believe would promote and ensure uptake of 
microbicides by women in their respective settings. The researcher encouraged active 
participation and critical thinking, and for participants to collectively identify the possible barriers 
and suitable solutions to acceptance and uptake of these new prevention technologies in their 
respective contexts (Dutta, 2011). 
 
Application of the SEMCHB and the CCA  
As a study that explores the perceptions of microbicides within a community setting, examining 
the overall context is critically important to identifying and understanding any possible barriers to 
the acceptance and use of these new prevention technologies. While the SEMCHB (Storey and 
Figueroa, 2012) explores the perceptions of microbicides within the community level in this study, 
the CCA is used to explore the cultural context which according to Dutta (2008) is the key aspect 
to effectively introducing a new health intervention programme. The CCA therefore allows for 
exploration of the cultural norms within each community, which are said to inform people’s health 
decisions (Nandoya, 2014; Peterson, 2009). Employing both theoretical perspectives therefore 
allowed the study to acquire deeper insight on the possible barriers to women’s acceptance and 




The various theories and concepts reviewed in this chapter enabled the researcher to explore 
influential factors that affect women’s sexual behaviour through exploring various aspects of their 
lives. As a multi-level approach, the SEMCHB allowed the researcher to explore the 
environmental factors which include the individual, social networks and community levels of 
society in order to identify possible barriers to acceptance and utilisation of microbicides at a 
community level. The CCA is also discussed, and its perspectives on the influence cultural beliefs 
and norms have on health behaviour. The theory is discussed to showcase the importance of 
culture in the success of health intervention programmes such as microbicides. The CCA is also 
explored as a facilitator of dialogue as an empowerment tool to bring about collective participation, 
problem identification and collective action for change. The next chapter presents the research 




























This chapter discusses the methods that were used to conduct the study. It highlights the research 
paradigm in which the study is premised.  Thereafter, a brief review of the methodological tools 
used to collect data, the research design and sampling techniques are presented.  
 
Research paradigm   
This study is located in the Interpretive Social Science (ISS) is described as “a tradition within 
social science, composed of efforts to understand, to construct meaning, to tap into the subjective 
experiences that people have” (Goodsell, n.d: 3). This theoretical perspective differs from the 
positivism approach which uses detached observation “rather than close and intimate observation 
that interpretivists employ in attempts to understand and explain human social reality” (Grotty, 
1998: 66). ISS has provision for human interests and aims to probe for deeper meanings while 
positivist’s interest rests only on factual information and considers the world as an external object 
that has no association to human experience (Porta and Keating, 2008). Central to ISS is the 
importance of context and the belief on acquiring meanings that are beyond face value, therefore 
much emphasis is placed on conducting a close, detailed reading of a text in order to obtain a 
much deeper and richer understanding (Neuman, 2003). There can be several valid viewpoints 
and meanings to phenomena that cannot be reached by merely studying its obvious features but 
rather through exploration of the underlying features it encompasses. This sets a strong basis for 
the adoption of the interpretive approach, as it enables exploration of microbicide acceptance and 




The study employs a qualitative research approach which stems from the ISS paradigm. 
Qualitative research explores a subject in real world, context-specific settings (Golafshani, 2003). 
This research method is an interdisciplinary discipline associated to a number of research 
methods such as observation, interviews, focus groups, content analysis and archival source 
analysis (Struwig and Stead, 2013). Unlike quantitative research, qualitative research recognises 
the existence of multiple realities in which knowledge varies amongst individuals and according 
to various contexts (Guba and Lincoln, 2005). While quantitative research studies the quantity 
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(e.g. how many people behave in a certain way), qualitative research studies how and why people 
behave in a certain way (Hancock et al, 2009).  
 
This approach is largely characterised by the interest to acquire and understand the research 
participant’s views regarding the issues being researched, while also considering the environment 
and/or social context in order to understand what influences their thoughts and behaviours 
(Struwig and Stead, 2013). In this study, understanding the underlying contexts was key to 
understanding participant’s perceptions and views around the acceptance and utilisation of 
microbicides. In employing qualitative approach, it was possible to explore the socio-cultural, 
structural, economic and gender-related factors that may prevent women from accepting and 
utilisation microbicides as a female-initiated HIV prevention method. 
 
Another important distinguishing feature of qualitative research that also stands as motivation for 
this study is the flexibility and less structured nature of qualitative research (Struwig and Stead, 
2013). This allowed for open discussions that stimulated participants to have in-depth discussions 
on a range of issues, therefore getting more insights that address the goals and purpose of the 
study (Struwig and Stead, 2013). The goal of population studies is to understand complex issues 
using cost-efficient methods such as FGD, which was employed as a data collection method in 
this study.  
 
Research Design 
This study takes the form of a case study, a research design that allows an exploration of 
individuals or organizations through complex interventions, relationships, communities, or 
programs (Yin, 2003). A case study facilitates exploration of a phenomenon within its context 
through a variety of data sources such as documents, artifacts, interviews and observations 
(Baxter and Jack, 2008). This ensures that phenomena is explored through various lenses to 
allow for a thorough exploration and understanding of its various features (Baxter and Jack, 2008). 
According to Yin (3003) a case study should be considered when the focus of a study is to address 
the questions “why” and “how”, when the goal of a study is not to manipulate but rather to gain 
understanding of the behaviours of those who are taking part in a study and when the researcher 
aims to examine the contextual factors as relevant and important features to acquiring full 
understanding of what is being studied. As a case study, this research sought to understand the 
“why’s” and “how’s” of this research; these being men and women’s decisions to acceptance and 
utilisation of microbicides and the factors that inform their decisions. Furthermore, the decision to 
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accept or utilise microbicides cannot be explored in isolation from the socio-cultural, economic, 
structural and gender-related factors that influence their sexual behaviour. 
This study employed a descriptive case study within a qualitative approach. A descriptive case 
study is used to describe an intervention or phenomenon and the real-life context in which it 
occurs (Yin, 2003). In this case, acceptance and utilisation of microbicides is explored within the 
various community contexts whereby the decisions to accept or utilise occur. The objective is not 
only to gain knowledge and understanding perceptions about microbicides but also to explore the 
factors that determine how these perceptions are built or shaped. According to Maree (2007), a 
case study design can help to facilitate platform for the voiceless and marginalised, allowing them 
to speak for themselves. In this study, the powerless are women who are unable to negotiate 
safe-sex practices with their male partners who were allowed to articulate the challenges they 
face in relation to adopting and facilitating the use of prevention methods for their protection 
against sexually acquired HIV. However it is important to note that microbicide products are not 
designed only for powerless women but for all women who want to use them. The need to 
empower women who cannot negotiate protection however remains the greatest focus of these 
prevention technologies. This research design is therefore suitable for exploring the possible 
barriers to microbicide acceptance and use in multiple ways, therefore allowing for in-depth 
understanding and identification of measures to be taken in addressing them.  
 
Study Setting and Context 
As a study informed by the ISS paradigm and theoretical perspectives of SEMCHB and CCA, the 
environmental background/ context is identified as a key factor to acquiring thorough 
understanding of phenomena. This section provides a brief history of the selected research areas 
in order to understand the socio-cultural and economic context, explained throughout the 
discussion as having a strong correlation to the HIV pandemic.   
 
The research was conducted in urban and rural settings in KwaZulu-Natal, Durban and 
Mpumalanga province, in Nelspruit. The research settings include a semi- rural community of 
Matsafeni/Mataffin and a peri-urban township called Tekwane South in Nelspruit, as well as semi-
rural Umnini and a peri-urban township called Umlazi in Durban. KZN is the biggest province in 
the country which constitutes of eleven districts; Amajuba, Ethekwini, uMgungundlovu, 
uMkhanyakude, uMzinyathi, Uthungulu, Uthukela, Ugu Zululand, Ilembe and Sisonke district 
(South African Local Government Association, 2011). Eight of these districts are listed amongst 
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the ten districts with the highest HIV prevalence in South Africa (NDOH, 2012). The province’s 
metropolitan municipality, Ethekwini is amongst the highly infected districts in KZN. Due to this 
aspect, this district was selected as one of the study areas for this research. The Mpumalanga 
province constitutes of only of three districts: Ehlanzeni, Gert Sibande and Nkangala region 
however it has remained the second highest HIV infected population province in the country for 
over two decades (NDOH, 2012; UNFPASA, 2014). Within the Ehlanzeni district, Mbombela was 
amongst the highest infected sub-districts in the country, with a 43 per cent prevalence (UDP, 
2012). The study settings explored in the study are located within the Mbombela municipality. 
 
KZN was the highest HIV infected province at 16.9%, followed by Mpumalanga (MP) at 14.1% 
prevalence rates in 2012, while about 15% of each of the province’s populations were living with 
HIV in 2014 (UNFPASA, 2014). According to the NDOH (2012), KZN has reported stable HIV 
prevalence (37.4%) amongst 15- 49 year old for more than 23 years, followed by MP and Free 
State, with a prevalence rate greater than 30%. KZN therefore is the hub of the HIV epidemic in 
South Africa.   
 
Despite being highly urbanized, rural communities are found on the outer edges of the west, south 
and north parts of the Ethekwini district due to insufficiency in services delivery (KwaZulu-Natal 
Department of Health, 2015). An estimated 36% of the district’s population is living in poverty, 
while the unemployment rate was estimated at 30.2 % in 2011 (KZN DOH, 2015). In MP the 
Ehlanzeni district was explored, with focus on one of the five sub-districts called Mbombela 
(Ravhura et al, 2014). Despite being the economic centre of the province, Mbombela is 
characterised by “high poverty levels, low literacy levels, limited infrastructure and limited 
economic growth” (Adams and Moila, 2004: 2). Mpumalanga was ranked the third most rural 
province in South Africa; approximately 60.9% of the 600 000 population living in rural areas in 
2010 (Bender and Gibson, 2010; Peltzer et al, 2010). Unemployment is said to be highest 
amongst the youth, women and people with disabilities in MP (Mbombela Local Municipality, 
2013).  
 
The rationale for the choice of these provinces lies in the high prevalence of HIV prevalence in 
both provinces (Ackerman, 2008; Muula, 2008), as highlighted above. South African townships 
and rural settings also have high HIV prevalence, particularly amongst women KZN and MP (Cain 
et al, 2014; Kharsany et al, 2014). Moreover, KZN is amongst the few provinces that have 
undergone microbicide clinical trials in South Africa. Given the high HIV infection rates in other 
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regions such as Mpumalanga, there is a need for clinical trials to extend to other regions in the 
country. The statistics above therefore show Mpumalanga and KwaZulu-Natal to have the ideal 
locations for a microbicide study.  
 
The research areas semi-rural Mataffin/ Matsafeni and a peri-urban township, Tekwane South. 
Matsafeni is a predominantly black, Swati speaking community of 1250 households and 3723 
residents (Census, 2001), situated approximately 4.37 kilometers outside of Nelspruit, 
neighboring the controversial Mbombela stadium (Hartdegen, 2008). The village is characterised 
by low income households and very poor living conditions due to a lack of basic services (Young, 
2014). Majority of the community members are unemployed, dependent on pensioner’s income 
or child grants, while for some, the only source of income is obtained through seasonal 
employment from the farm’s produce. This indicates destitution within the Mataffin community, as 
most households are unable to sustain themselves financially. Tekwane South is also within the 
Mbombela municipality, a newly established setting of over 1000 households, through the social 
housing initiative in the late 1990’s (Mayoral Report, 2002). An initiative meant to create spatial 
and economic link between the historically black and white towns, Tekwane South is located 
about 19 to 20 kilometers from Nelspruit. Majority of residents within this community depend on 
the city and white-owned farms for employment opportunities (Adams and Moila, 2004). In KZN, 
two settings Umlazi and Umnini, within the Ethekwini district will be explored. Umlazi is a 
predominantly black Zulu speaking community. Described as the most densely populated 
township in the country, with an estimated 404811 population and 104914 household (CENCUS, 
2011), the township is home to over 16% of the Ethekwini district’s population (KZN DOH, 2015). 
This township is described as a peri-urban area with both formal and informal housing (Jackson, 
2007). Umnini is a rural community of 17416 households, situated 43 kilometers from Durban 
(CENSUS, 2011). Umnini forms part of sub-district four, which only makes up 4% of eThekwini’s 
population (KZN DOH, 2015). High unemployment rates, poverty, low level of education, low 
service delivery, lack of proper housing, etc. are said to increase vulnerability to diseases in the 
province (KZN DOH, 2015). Also noted earlier, there is a close correlation between these factors 
and the HIV epidemic.  
 
Sampling  
The main reason for sampling in research is to narrow down the population size so that it can be 
studied much quicker than large population groups (Fink, 2003). This is achieved through a 
selection of cases, such as people that closely represent the features of interest or live in 
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circumstances that hold characteristics that are relevant to the phenomena being studied (Al-
Busaidi, 2008). The aim of sampling in qualitative research is to identify specific groups of people 
who hold characteristics or live in circumstances relevant to the phenomena being studied. The 
sample is then examined in detail, and the findings then applied to understand much larger cases 
of a similar nature (Neuman, 2003). Sampling varies across every study, the sampling method is 
determined by the type of research to be conducted, not according to the researcher’s preference 
(Neuman, 2003).  
 
This study used purposive sampling. In purposive sampling, participants are selected based on 
certain characteristic(s) of interest to the researcher (Struwig and Stead, 2013). The fundamental 
feature of snowball sampling technique is the reliance on the interconnectedness of people, 
through direct or indirect linkages (Neuman, 2003). For this study, snowball sampling 
complimented purposive sampling in the recruitment of male and female participants in the 
different study settings for focus group discussions as will be later discussed in this chapter. The 
researcher identified a few key individuals in each research area, who then referred her to 
additional respondents who met the specified criteria (Struwig and Stead, 2013). Participant 
recruitment was therefore reliant on interested candidates to recommend other people within the 
specified characteristics of interest.  
 
Sampling criteria 
For this study, the characteristics of interest included heterosexual men and women between the 
ages of 18-49 who have not undergone any microbicide clinical trials. All selected participants 
reside in the specified urban and rural settings in Durban and Nelspruit; demonstrated in the table 
below:  
 
Table 4.1: Sample population  
Province Urban/ Rural Study setting 
 
FGD groups: male/female 
Mpumalanga Rural Matsafeni/ Mataffin MP rural females & MP rural male 
Mpumalanga Urban Tekwane South MP urban females & MP urban males 
KwaZulu-Natal Rural Umnini KZN rural females & KZN rural males 




The specified age groups are relevant to this study because HIV prevalence is said to be high 
amongst people of reproductive age (15-49) particularly women in South Africa (STATS SA, 
2015). Due to ethical considerations concerning the products in question, participants below the 
age of 18 could not be included in this study as microbicides have not been tested for safety and 
efficacy amongst younger people. The rationale to involve men in this study was due to a large 
volumes of findings on women’s challenges with adherence to female-centred programmes due 
to relationship and gender inequality, however, there is very limited research on a male’s 
perspective regarding these findings. Part of the objectives of this study is to examine the impact 
of male involvement in acceptance and utilisation of microbicides amongst women. Involving men 
in this study therefore explores a male’s perspective in order to gain deeper insight on the possible 
barriers and facilitators of microbicide use amongst women. These populations and age groups 
therefore are believed to have the data needed for this study (Nieuwenhuis, 2007). 
 
Recruitment strategy 
Various recruitment methods or strategies can be undertaken in qualitative research (Office of 
the Human Resource Protection Program, 2012). In this study, three recruitment strategies were 
employed namely, direct recruitment, word- of-mouth and referrals.  
 
One of the most successful recruitment strategies in qualitative research involves working in 
partnership with key community members who are trusted by the potential research participants 
(Felsen et al., 2010). In Umnini (KZN rural), participants were recruited through the Faith and 
Hope Non-Governmental Organisation (NGO). The facilitators assisted in connecting the 
researcher with the Umnini residents who formed the study population. However, the participants 
were not part of this organisation, they were participating in their individual capacity. The 
organisation only assisted in facilitating the meeting between the researcher and the study 
population as they work from within the Umnini community. In Umlazi (KZN urban), and Matsafeni 
(MP rural) snowball sampling was employed. The researcher made contact with a small number 
of potential participants who referred her to other people who met the study’s characteristics of 
interest and whom they thought would be interested in taking part in the research. Direct 
recruitment was mostly used in Tekwane South (MP urban), whereby the researcher went door-
to-door recruiting participants on the day of the research. This was due to the participants not 
showing upon the set day of the focus groups. Through collaborating with the these key individuals 
in Matsafeni and Tekwane South, the researcher managed to recruite a sufficient number of male 




None of the study participants belonged to any organisation, they were approached in their 
individual capacity recruited to share their own views therefore gate keeper permission was not 
required. An informed consent form however was provided to be signed by the study participants. 
The consent form stated the nature of the research, as well as informing respondents that their 
participation in the study was voluntary, thus they could withdraw from at any given time during 
the research proceedings. The findings elicited from this study therefore to an extent, can be 
generalised to represent the views of other 18-49 year olds from similar contexts (Struwig and 
Stead, 2013).  
 
Data Collection Method 
The data was collected through focus group discussions. “Focus groups are a form of group 
interview that capitalises on communication between research participants in order to generate 
data” (Kitzinger, 1995: 299). FGD consist of small groups of people, who share a common 
characteristics that is central to the topic of interest (Morgan and Krueger, 1988). In this method, 
the researcher poses a question and encourages participants to talk to one another, as questions 
and comment on each other’s experiences and points of view (Kitzinger, 1995). 
  
The interaction amongst participants facilitate unique and unanticipated insights that can 
contribute towards the richness of the data regarding the issue being researched (Curry et al, 
2009). This also allows for clarification of issues among the participants in ways that would be 
less easily accessible in one to one interviews (Kitzinger, 1995; Morgan, 1988). The rationale for 
the use of FGD therefore is that they more flexible and less formal than other data collection 
methods such as one on one interviews (Neuman, 2011). Some questions had to be rephrased 
to allow for better comprehension amongst participants. Unanticipated issues such as the 
discussions on vaginal practices came up as relevant topics on acceptance and use of 
microbicides amongst women in one study setting. FGDs therefore allowed the researcher to 
solicit deeper insights on the factors that can impede women’s acceptance and use of 
microbicides as prevention methods for HIV. Furthermore, this data collection method is 
particularly useful in exploring shared experiences and norms, to uncover differences or 
similarities in perspectives, as well as to understand the factors informing people’s opinions and 




A total of 8 FGDs were conducted, this making up two FGDs in each of the selected study settings. 
The number of FGDs was to accommodate any internal or external factors the group may be 
subject to, and more practically, to compensate for groups that did not run smoothly due to 
participant’s reluctance to participate or inability to interact well (Hancock et al, 2009). Most 
importantly, the number of FGDs allowed the study to explore the same questions in various 
contexts therefore allowing for deeper examination of the questions being explored in the study 
(Hancock et al, 2009). 
 
Each designated setting had two FGDs with 10-12 participants; this size was chosen so that the 
researcher would be able to closely interact and monitor and not lose any vital details provided 
by the participants. In each study setting the first FGD session was made up of only female 
participants and the second was made up only male participants. The rationale for the different 
sessions was to allow both study populations to express themselves freely, as the goal of this 
research was to obtain deeper insights on the factors that may impact on women’s decisions to 
accept and utilise microbicides. Involving men in a study based on a female-centred product is 
through recognition that there is a different dynamic that would come out regarding the subject of 
microbicide acceptability and use when exploring a male’s perspective. Moreover, part of main 
objectives of this research is to examine how male involvement can impact on women’s decisions 
to accept and utilise microbicides. 
 
The focus group sessions were held in comfortable venues with seats arranged in a circle, with 
the researcher forming part of the circle to provide a sense of equality with the research 
participants. Before each focus group discussion begun, all the participants had to each sign an 
informed consent that was written in the setting’s local language; Swati in MP settings and Zulu 
in KZN settings) (see appendices 3-5). With permission from all participants, after the researcher 
had explained the need to record the proceedings, all FGDs were recorded using a mobile phone. 
The mobile phone was placed on the table to ascertain participants that the device was used only 
for audio recording and not for video recording. Each FGD session started with the introduction 
of the researcher and the purpose of the FGD; participants were also given the opportunity to 
introduce themselves. Each FGD session ranged between1hour and 30 minutes. 
 
According to Maree (2007), research participants should be fully aware of what the research 
entails and what kind of information is required from them before the FGD commences (Maree, 
2007). As this research investigates people’s perceptions regarding products that are still 
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undergoing clinical trials, the first 30 minutes in each FGD was used to provide detailed 
information on the products. The researcher presented and demonstrating how the products are 
used while diligently reminding the participants that the products being researched are not 
licensed for use, and are undergoing clinical trials. The participants were given a chance to ask 
any clarity seeking questions, in order to ensure that they are able to engage in a discussion 
about products they fully understand. This was made clear also in the informed consent form (see 
appendices 3-5).  
 
The duration of the FGDs therefore allowed for introductions between the researcher and the 
participants, a detailed explanation of the products and sufficient time for the actual data collection 
process. The FGD were conducted in the aforementioned local languages, which were sometimes 
mixed with English. Since the researcher is fluent in all three languages, there was no need for a 
translator during the discussions. Each session ended with participants being offered light 
refreshments.   
 
Validity and Reliability and Rigour  
“Reliability and validity are ideas that help to establish the truthfulness, credibility or believability 
of findings” (Neuman, 2011). Stemming from the positivist approach, these concepts of validity 
and reliability have been problematic to apply in qualitative research (Golafshani, 2003). Patton 
(2001: 14) states that credibility in quantitative research depends on instrument construction while 
for qualitative research the researcher is the instrument. This could mean an unquestionable 
credibility of a quantitative research while that of a qualitative research is scrutinized due to it 
being measured only through the researcher’s effort (Golafshani, 2003). Despite the difference in 
approach, qualitative research should also be able to test and demonstrate its credibility 
(Golafshani, 2003). 
 
Reliability, previously known as a concept used for testing and evaluating research is now also 
used in qualitative research (Golafshani, 2003). This means that the given the methods, using the 
same participants, within the same environment, the results would be reiterated by other 
researchers (Morgan and Drury, 2003). Most naturalistic scholars introduced different 
terminologies to explain qualitative research’s reliability and validity (Shenton, 2004). In qualitative 
research the terms dependability or confirmability are used to describe the notion of reliability 
while credibility and transferability are used to describe validity (Golafshani, 2003). Confirmability 
refers to the level or extent to which the research findings directly show what was found and 
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collected in the field (Babbie, 2015). Transferability on the other hand refers to the extent to which 
research findings can be transferrable in another context with other participants (Babbie, 2015).  
 
Rigour, understood as representing quality, is what is used to measure validity and reliability in 
research (Struwig and Stead, 2013). In qualitative research rigour includes procedures taken at 
different stages of the research process including during data collection and analysis (Al Busaidi, 
2008). This is to say that rigour measures dependability and confirmability of a study. In ensuring 
this, the steps, procedures and decisions took during the data collection process are clearly stated 
and justified. The data was also reviewed several times to compare and contrast the codes and 
to ensure that all aspects of the data that fit into the identified themes were noted and covered. 
Moreover, the questions asked during the research proceedings were carefully constructed, 
evaluated and approved by my supervisor, Dr Eliza Govender and the UKZN ethics committee.   
 
Another way to provide valid evidence from a study is through triangulation, through the use of 
various data sources, several investigators and different methods (Struwig and Stead, 2013). In 
social science, a phenomenon is studied from multiple perspectives than from a single angle 
(Neuman, 2003). Although this study employs one method of data collection, the quality of this 
research is validated by the number of FGDs (8) that were conducted. The various settings that 
were explored, ranging from two highly infected provinces also stand to verify the findings of the 
research. The study also investigates the different voices in a community, providing both male 
and female participants platform to express their views regarding microbicides as a female-




The protocol for the study was approved by the University of KwaZulu-Natal ethics committee in 
November 2015. The purpose of the study was explained prior to each FGD proceeding. Ethical 
considerations included providing each participant with an informed consent form to sign prior to 
the focus group discussions. The consent forms were comprehensive, stating the nature, process 
and purpose of the research, what the data will be used for and what is expected from the 
participants. The form also explicitly stated that respondents were not compelled to be part of the 





Appropriate steps were taken to guarantee the anonymity of the participants. The form also 
emphasised issues of confidentiality, stating should the research participants not wish to have 
their names mentioned, pseudonyms would be assigned. Participants were also urged not to 
disclose or answer any questions they were uncomfortable with, and that responses would be 
treated in a confidential manner. Participants were made aware that they would not be offered 
any compensation or any form of payment for taking part in the study as it would be voluntary, 
however their contribution would help to identify the factors that need to be addressed in order to 
ensure the success of microbicides as a HIV prevention method for women. Participants were 
given opportunity to ask any question and declaration that they are comfortable with the conditions 
of the research before the FGD sessions commenced. Permission was obtained from the 
participants prior to audio-recording of the sessions. Respondents were also informed that the 
final project would be presented to them for confirmation and approval should there be a need to 
publish, and a copy of the research would be made available to them should it be required. The 
information obtained through the focus groups would be kept as both electronic and hard copies 
in the custody of our discipline for a period of five years only and once completed, it will be 
destroyed by shredding.  
 
Limitations of the study 
Due to the fact that the focus groups took place during the day, getting the participants to meet in 
one place may have been a challenge, due to commitments such as work or school. The 
researcher arranged for dates, times and a meeting venue that was convenient for all participants.  
 
The number of FGDs was to accommodate any internal or external factors the group may be 
subject to that the researcher may have been unaware of, and more practically, to compensate 
for groups that did not run smoothly due to participant’s reluctance to participate or inability to 
interact well (Hancock et al, 2009). The researcher encouraged participation by repeating the 
question, and ask whether or not they share the same views as the other participants, and what 
informs their views in order to obtain much detailed responses. Moreover, as contingency, the 
researcher arranged for more than the required number of participants (10-12), to ensure an 
adequate sample size in each FGD.  
 
Gathering the participants for MP urban males group proved to be a challenge as only two 
participants showed up at the venue. To overcome this problem, the researcher went into the 
community and managed to gather six male participants for the discussion. Enthusiasm and 
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active engagement of all the participants that took part in the discussion also compensated for 
this limitation. Moreover, age groups were balanced as four participants were aged between 30- 
45, and two were in their early twenties. In some settings however, the number of participants 
were more than the required sample (12-15), the researcher however had to proceed with the 
discussions. 
 
Majority of participants had no knowledge of microbicides, with an exception of KZN urban and 
rural, who had knowledge (although limited) of the tenofovir gel. Two participants from MP rural 
also admitted to having heard of oral truvada on the radio however their knowledge was 
insufficient to engage in a detailed discussion. In addressing this limitation, the researcher 
dedicated 30 minutes to providing detailed information on the products while demonstrating their 
use prior to each FGD. The participants were also given a chance to ask any clarity seeking 
questions, in order to ensure that they are able to engage in a discussion about products they 
fully understand. The researcher diligently reminded the participants that the products being 
researched are not licensed for use, and are undergoing clinical trials. The purpose of this 
research is merely to gain insight into what they think about the product, and whether they would 
consider using or, in the case of men, encourage its use by women if it were to be available.  
 
Since the subject of HIV is central to microbicide products, the researcher was aware that this is 
a sensitive topic that still attracts stigma in certain regions and population groups. Therefore, the 
researcher encouraged a relaxed environment by explaining that participation in the study was 
voluntary and that they may withdraw from the research at any time without any negative 
consequences. Participants were made aware that they are not forced to speak, or to answer any 
questions they were uncomfortable with. The researcher provided a consent form stating that the 
data will be used only for the purposes of the research, and assurance of anonymity if requested 
by the respondents. Participants were also urged not to disclose any personal information. 
Despite these challenges, I managed to collect all the required data sufficient for analysis. 
 
Data analysis 
“Analysis of data in a research project involves summarising the mass of data collected and 
presenting the results in a way that communicates the most important features” (Hancock et al, 
2009: 24). Qualitative research has what is called “the big picture” or the major findings in its 
research findings, this being the summarized data after thorough analysis (Hancock et al, 2009).  
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In looking for “the big picture”, this study employed a thematic analysis approach. Thematic 
analysis is a qualitative research practice which includes looking through data to identify any 
recurrent patterns. Identifying the common themes that emerged during the data collection 
process was key in the data analysis process (Braun and Clarke, 2006). The themes were later 
analysed according to gender (men and women), the type of setting (urban and rural), as well as 
amongst the two provinces/ cities (Mpumalanga and KwaZulu-Natal).  
 
Braun and Clarke (2006) explain two approaches of thematic analysis namely; inductive and 
theoretical. For the purpose of this study, theoretical analysis at a latent or interpretative level was 
adopted. The research goes beyond the surface meanings of the data, thus used theory to explain 
the underlying ideas, assumptions and ideologies that shape the explicit data (Braun and Clarke, 
2006). This choice is motivated by the researcher’s theoretical and analytic interest in the area of 
research (Braun and Clarke, 2006). Manual coding was employed for this study, through writing 
notes on the data being analysed. The themes are more theory-driven, as the researcher had 
particular questions in mind before the coding process (Braun and Clarke, 2006). Braun and 
Clarke’s (2006) guide to thematic analysis was employed, illustrated in the table below was 
employed; 
 
Table 4.2: Steps in thematic analysis, (Braun and Clarke, 2006: 87) 
Phase Description of process 
1. Familiarising yourself with your 
data: 
Transcribing data (if necessary), reading and re-reading the data, noting 
down initial ideas. 
2.Generating initial codes: Coding interesting features of the data in a systematic fashion across the 
entire data set, collating data relevant to each code. 
3.Searching for themes Collating codes into potential themes, gathering all data relevant to each 
potential theme. 
4.Reviewing themes Checking if the themes work in relation to the coded extracts (Level 1) and 
the entire data set (Level 2), generating a thematic ‘map’ of the analysis. 
5.Defining and naming themes On-going analysis to refine the specifics of each theme, and the overall story 
the analysis tells, generating clear definitions and names for each theme. 
6.Producing the report The final opportunity for analysis. Selection of vivid, compelling extract 
examples, final analysis of selected extracts, relating back of the analysis to 





Once the focus group discussions were completed, the qualitative data was transcribed and 
translated into English. This entailed listening to the audio recordings while writing down what the 
participants uttered word-for-word, and later translating it into English as the FGDs were 
conducted in each setting’s local language. Each audio recording was transcribed within 2-3 days 
after conducting the FGD to allow the researcher to recall any gestures and all other relevant 
information that will be of relevance to the study. This step also included reading and re-reading 
the data, to ensure that the researcher was familiar with the data. 
 
Once the researcher was familiar with the data, the next step was to code the data. This entailed 
highlighting interesting features that were relevant to the research questions. This is illustrated in 
table 4.4, below, as explained in Braun and Clarke (2006): 
 
Table 4.3: Coded Data extracts 
Data extract Coded for 
 
“It has too much work. Most of the time sex is not planned. 
You find that you haven’t seen each other in a long time, 
it would be difficult to ask him to stop so you can go and 
put the gel” (Female participant, Urban, KZN, April 2016) 
 
 
“You can’t tell him, what if he leaves you? because now 
he won’t trust you… you know, when he takes care of you, 
he will start saying you are ungrateful and threaten to stop 
giving you money” (Female participant, Rural, KZN, April 
2016) 
 
1. Product acceptability  
2. Barriers to consistent use  
3. Impact of male involvement  
4. Barrier to acceptance 
  
In this particular extract, green was used to highlight data that was associated with product 
acceptability; pink was used to highlight data that was associated with perceived barriers to 
adherence. Yellow highlighted codes that related to male involvement, while blue highlighted data 
associated with barriers to acceptance of microbicides. The codes were then arranged 
systematically, in preparation for the third step, which is the search for themes.  
 
Searching for themes entailed identifying recurrent patterns of responses from the participants. 
The themes were generated through the systematic organization of codes. This process involved 
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generating a thematic map, where the researcher has a main theme and ‘sub-themes’ that fit into 
















Figure 4.1: Example of a thematic map 
 
The fourth step involved reviewing, defining and naming of themes. This entailed carefully going 
through the themes to narrow them down and to establish if any could be merged. Thereafter, 
numerous hours were spent analyzing the data under the identified themes. During this process, 
the researcher further reviewed and refined existing themes while also exploring other possible 
themes, so as to ensure that the data corresponds with the identified themes.  
 




Epistemological Assumption Interpretive Social Science 
Theoretical Framework Qualitative Research 
Research Design Case study 
Sampling Technique Purposive and Snowball Sampling  
Involving men in microbicide use 
 
Feasibility of covert use The impact of 
male involvement 






Males and females from urban and rural 
settings in KZN (Umnini and Umlazi) and MP 
(Tekwane South and Matsafeni); between 18- 
49 years. 
Data Collection Method Focus Group Discussions 




The data obtained from the focus group discussions was used to compare and contrast the 
perceptions about microbicides between men and women, urban and rural settings, as well as 
between the provinces, Durban and Nelspruit. This was done in order to identify possible barriers 
to acceptance and use of microbicides as an HIV prevention method for women. The next chapter 





















CHAPTER FIVE: DATA PRESENTATION AND ANALYSIS  
 
Introduction 
This chapter presents, analyses and discusses findings obtained from focus group discussions 
amongst men and women across urban and rural settings in Durban (KwaZulu-Natal) and 
Nelspruit (Mpumalanga). The study set out to explore the perceptions of men and women across 
urban and rural settings about microbicides as female-initiated prevention methods (FIPM) for 
HIV. The aim was to uncover the socio-cultural and economic factors that stand as impediments 
to women's acceptance and adherence to microbicides; in order to identify the necessary 
measures to be taken to ensure acceptance and uptake. 
 
For the purpose of effectively addressing the key questions and objectives of this study, a total of 
eight focus groups were conducted. These include four focus groups in Nelspruit (MP-urban 
males, MP-urban females; MP-rural males and MP-rural females) and Durban (KZN –urban males 
and females; KZN-rural males and females). The researcher chose to explore the two provinces 
because of the high infection rates in both provinces (NDOH, 2012; UNFPA SA, 2014). The 
majority of participants were unemployed, while a small number were working unskilled or semi-
skilled jobs within their respective communities.  
 
Prior to each focus group, the researcher provided a detailed description of each product, 
explaining the dosing and application process, while emphasizing that these are products that are 
still under clinical trials, with the exception of the daily oral truvada which was licensed for use in 
February 2016 (Avert, 2015; AVAC, 2015). This was done to ensure that every participant 
understands the products in order to be able to engage in the discussion. 
 
The data is presented to reflect two population groups (males and females) and the study setting 
(urban or rural), as well as the provinces (Mpumalanga or KwaZulu-Natal) in question. The 
purpose is to evaluate if there is any difference in perception towards microbicides from people 
residing in urban settings and those living in rural settings and particularly to understand the 
varying, if any, perceptions of men and women. This comparison also notes the difference in 
perceptions amongst the two provinces in question, to identify whether prior knowledge (through 
exposure to clinical trials) has any impact in the way people receive a new product. This will assist 
development planners to identify whether there is a need to extend microbicide trials to other parts 
of the country. 
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The data is presented through the following thematic categories:  
Perception of microbicides; Microbicide: Varying product acceptability between males and 
females; Barriers to product use; and the impact of male involvement in a female-initiated 
prevention method. 
Perceptions on microbicides 
The first thematic category explores the participant’s general perceptions of microbicides as a 
female-initiated prevention method. Research shows that understanding the perceptions and 
attitudes of current HIV prevention methods may be a key attribute in successfully introducing a 
new method (Nota, 2016). Initially the researcher posed a question about the respondent’s views 
on currently available prevention methods particularly the female condom in order to shed light 
on the broader context of this study.  
 
In general, there was a positive attitude towards microbicides as an HIV prevention method. Both 
male and female participants in urban and rural settings perceived microbicides as a necessary 
step towards reducing high HIV infection rates amongst women, given the absence of an effective 
vaccine to cure HIV and effective prevention methods women can use. This was discussed further 
in the comments below: 
 
“I think all the products are good because they reduce the chance of getting infected. 
They may not provide 100 per cent protection but at least it reduces the risk” (Male 
participant, Rural, MP, March 2015) 
 
“In my opinion, I think it is a great initiative as it contributes towards the fight against HIV, 
especially because so far there is still no cure for HIV. I think it is a good initiative” (Male 
participant, Rural, MP, March 2015) 
 
“I think these products are very good, especially for the next generation, because it is too 
late for us but the next generation can be saved from HIV” (Female participant, Urban, 
MP, March 2015) 
 
The findings suggest that participants comprehend that although microbicides will only offer partial 
efficacy, the availability of options can provide substantial protection against HIV amongst women 




Microbicides as an empowerment tool 
It is a widely acknowledged notion that women lack power and agency in various spheres of 
their lives due to a number of socio-cultural, economic, structural and gender-related factors that 
perpetuate male dominance (Murphy et al, 2006). In this study, perceptions of microbicides 
were tailored around narratives on women’s limited power in sexual relationships. Female 
participants demonstrated awareness of the risk of infection within their relationships due to lack 
of power to initiate the use of barrier methods such as condoms. Participants articulated that 
initiating condom use tends to be interpreted as a lack of trust or commitment in a relationship, 
which sometimes results in harmful consequences such as intimate partner violence (IPV).  
 
“It is okay because when the man does not want to use a condom, you can use it and be 
protected” (Female participant, Urban, KZN, April 2016) 
 
“Sometimes men cheat, but if you are using these products then you know that you will 
be protected” (Female participant, Urban, MP, March 2016) 
 
“When you say you want to use a condom the man will say that it means you do not trust 
yourself… that you are HIV positive” (Female participant, Urban, MP, March 2016) 
 
“Sometimes you ask them to use a condom but they don’t listen so I think this is a great 
initiative” (Female participant, Rural, MP, March 2016) 
 
Some people make excuses, saying that they get an irritation/ rash when they use a condom… 
Women say that as well, saying they just don’t use condoms because they get a rash, so they 
only use contraceptives to prevent them from falling pregnant, so maybe these products can 
help (Female participant, Rural, MP, March 2016) 
 
Male participants admitted to challenging women’s request to use protection despite 
acknowledging being unfaithful to their female partners. As a result, women are often subjected 




“I think it is a good initiative, considering that women get beaten up when they ask us to 
use a condom” (Male participant, Rural, MP, March 2016) 
 
“Sometimes we lie to them by saying that we are in a serious relationship so there is no 
need for a condom, when we know very well that we are cheating so at least with these 
products women can be safe” (Male participant, Rural, MP, March 2016) 
 
These findings confirm the widely acknowledged notion that the use of condoms in heterosexual 
relationships is encompassed by power dynamics, and usually it is women who lack the power to 
initiate or negotiate the use of condoms (Kline and Oken, 1992; Murphy et al, 2006; Dunkle et al, 
2004; Jewkes et al, 2010). The fear of abuse, norms of trust and commitment are associated with 
the decline in condom use (Smit, 2008; UNFPA, 2016). Furthermore, various studies confirm that 
relationship power dynamics impede the effectiveness of the condom (Lanham et al, 2014; 
Beksinska et al, 2014; Pettifor et al, 2014; Prince et al, 2005; Macpherson et al, 2012; Ray et al, 
1995). The findings suggest that participants are aware that the condom is not a sufficient method 
for HIV prevention amongst women (AMD, 2006). Microbicides therefore are perceived as a 
necessary tool to empower women for independent sexual protection against HIV. 
 
A solution to unplanned sexual activities 
Socio-behavioural factors such rape are amongst the factors that perpetuate high HIV infection 
rates amongst women. In this study, women perceived microbicides as offering protection for 
unplanned risky incidents such as rape or in cases where the condom breaks and the woman is 
left vulnerable to contracting HIV infection. In further discussing their perceptions about 
microbicides, participants commented:  
 
“It can also help in a case where a woman gets raped… they can be protected” (Female 
participant, Urban, KZN, April 2016) 
 
“You see especially for us women… when a person rapes you cannot ask him to use a 
condom. The person is fighting with you, you can’t tell him to use a condom so this 
product can help. If I know that I took my injection then I know at least I am safe” 




“I am happy about these products because now you can have hope of protection even 
when the condom breaks” (Female participant, Rural, KZN, April 2016) 
 
“At least I will know whatever happens, maybe the condom breaks or something, I will at 
least be protected” (Female participant, Urban, KZN, April 2016) 
 
The women perceived themselves to be at risk of infection due to the increased risk of infections 
posed by the prevalent culture of rape, identified as a key contributor towards the high HIV 
incidence and prevalence in the country (Armstrong, 1993). The findings in this research reiterate 
an acceptance study amongst women, in which acceptance of microbicides was facilitated by the 
perceived risk of infection from rape or sexual coercion (Orner et al, 2006). This confirms Libingi 
and Sitali’s (2005) study that acceptance of microbicides can be adopted if women are aware of 
their vulnerability to HIV infection (Libingi and Sitali, 2015). Women therefore demonstrated high 
acceptability of microbicides as they perceived their risk of infection to be heightened by the 
aforementioned risk factors.  
 
Microbicides as protection in cases of alcohol consumption 
Alcohol consumption is often associated with high risk sexual behaviours such as non-condom 
use that increases the risk of HIV transmission (SANGONeT, 2012). Narratives regarding the 
alcohol consumption and risky sexual behaviours unfolded as follows:  
 
“I think these products are good, especially in situations such as rape, especially for us 
young people, we sometimes go out to parties, where anything can happen” (Female 
participant, Rural, KZN, April 2016) 
 
“We sometimes go out to parties at night, and  some women want to have sex when 
they are drunk… and they sleep with anyone, so you find that you don’t even have a 
condom” (Female participant, Rural, MP, March 2016) 
 
“Sometimes you find that you are drunk and are unable to ask the man to use a condom” 




“Most times we get AIDS when we are out partying. When you are out having fun you 
want to have sex and you don’t have condoms, and then when you get home you also 
want to have sex with your wife and you give her HIV” (Male participant, Rural, MP, 
March 2016) 
 
These responses indicate that alcohol abuse is a problem in rural KZN and MP, perceived by 
participants as the greatest determinant for high-risk sexual behaviours within these communities. 
Most narratives on the subject of alcohol involved having unplanned sex with non-primary 
partners in alcohol serving establishments, where most sexual encounters in such places are 
likely to be unprotected, as the urge to have sex comes after having had alcohol. Participants 
articulated that they rarely carry condoms with them despite being aware of the likelihood of 
engaging in intercourse after they have consumed alcohol. In cases where the condom is 
accessible, negotiating use is affected by gender power dynamics, as women tend to dictate the 
use of protection or lack thereof. Rape is also highly prevalent in alcohol serving venues, therefore 
products such as the long-acting injectable and dapivirine ring are appreciated because of their 
consistent protection as the protective microbicide is always in the bloodstream. Microbicides 
were therefore perceived as having the potential to address the limitations of the condom in such 
incidents.  
Numerous studies have shown that alcohol consumption is associated risky sexual behaviours 
including unprotected sex and multiple and concurrent sexual partnerships (Fritz et al, 2011; 
Kalichman et al, 2007; Watt et al, 2012; Bryant et al, 2007; Simbayi et al, 2004). Also confirming 
the study findings, alcohol consumption is understood to impair judgement therefore and diminish 
risk perceptions, which then increases the likelihood to engage in unsafe sex practices (Bryant et 
al, 2010). While serving establishments (shebeens, taverns, night clubs, etc) are said to be 
meeting places for sexual partners (Watt et al, 2012). 
Moreover, SEMCHB informs that exploring the development of a health product must take into 
consideration the underlying contexts of the people for whom a health intervention programme is 
designed, to address any potential problems related to its acceptance and utilisation (Storey and 
Figueroa, 2012). In keeping with this model, the findings affirm the need to understand the 
prevalent behavioural and biological trends that influence the spread of HIV and their impact on 
the impact of a specific intervention such as microbicides (Aral and Cates, 2013). The prevalent 
trend of alcohol consumption calls for interventions aimed at reducing drinking behaviour to 
achieve reduction in sexual risk behaviors (Pitpitan et al, 2013). Accordingly, the field of 
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microbicides has since extended focus to conducting socio-behavioural research, focusing on 
understanding behavioural and biological efficacy of microbicides (UNAIDS, 2015). 
 
Variety of options for greater empowerment  
To date, HIV prevention options for women remain limited to the female condom which according 
to research, does not provide much empowerment for women as they are unable to implement 
its use due to various underlying factors that deny them the power to enforce its use. The excerpts 
below indicates participant’s understanding of the association between multiple products and 
increased protection; in that various preventive methods can address the aforementioned 
limitations of the female condom. In answering the question of whether the female condom was 
sufficient for HIV prevention amongst women, participants responded as follows:  
 
There is a need for other methods, because married women don’t use condoms because of 
issues of trust in their relationships, and it is not easy as a woman to suggest to use a condom 
with your husband… So let us say the woman is married and she knows that her husband 
sometimes goes away, she can apply her gel when she knows that her husband is coming, or 
the ring because you do not need to ask for his permission to use it because he won’t know that 
you have applied it, and he won’t feel it when you are having sex so it can be your secret. 
(Female participant, Rural, KZN, April 2016) 
 
“I think it is good that we can now have options because you can’t hide the female 
condom from him, he will feel it” (Female participant, Urban, MP, March 2016) 
   
“There is still a need for more prevention methods because even though we have the 
female condom, men don’t want to use it” (Female participant, Urban, MP, March 2016) 
 
“Yes there is a need for other products. It is difficult to ask men to use a condom because some 
men do not like using condoms because they claim that they are uncomfortable” (Female 
participant, Urban, KZN, April 2016) 
 
A cocktail of options could broaden the spectrum of choices therefore allowing women a choice 
of a method that is suitable for their lifestyles. A variety of options is also found have the potential 
to facilitate consistent use.  
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“A person can choose the option that is best suitable for their lifestyle, if you can’t take 
the injection, you can try the pills” (Female participant, Urban, MP, March 2016) 
 
“I think these products are good because they have a variety so you can be able to 
change to another product if the one you are using does not treat you right, unlike having 
just one product” (Female participant, Urban, KZN, April 2016) 
 
“If this one gives me a headache or I gain weight from the injection, then maybe I can 
use the ring, or the pill. Its good that we can now choose” (Female participant, Urban, 
MP, March 2016) 
 
“That is when you go for another product. If he knew about the pill, then you can take the 
injection because he will not know about it, the ring too” (Female participant, Rural, MP, 
March 2016) 
 
Frustration about the limitations in available HIV prevention methods for women has been of much 
emphasis throughout the discussions amongst female participants. Narratives demonstrated a 
strong need for prevention methods women can use without men’s cooperation, based on the 
challenges with initiating or introducing condom use. Drawing from other female-centred 
programmes such as injectable contraceptives, both male and female participants expressed 
concerns about side-effects such as water retention, which they believe would result from using 
the injectable contraceptives, or negative effects on sexual pleasure for the male partner for 
products that are inserted in the vagina such as the tenofovir gel and the dapivirine ring. The 
possibility of options therefore was appreciated because women believe they will have the option 
to switch to another product if the one has negative health impacts or is does not align with the 
woman’s lifestyle. A variety of microbicides is also perceived as feasible for discreet use. Female 
participants articulated that in a case where the male partner discovers frequently used products 
such as oral Truvada or the Tenofovir gel, women can have the option to switch to products that 
are used intermittently. 
 
This findings are consistent with findings from other studies that women are unable to use barrier 
methods such as the female condom due to power imbalances in heterosexual relationships (Ray 
et al, 1995; Prince et al, 2005; Macpherson et al, 2012; Bodibe, 2013; Karim and Baxter, 2012; 
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Ryan et al, 2015). The findings therefore support the widely acknowledged need for multiple 
prevention methods to meet potential users (Nota, 2016) so as to widen prevention options and 
increase women’s ability to protect themselves against HIV (Peters et al, 2010). The introduction 
of microbicides is perceived not only as having the potential to reduce women’s reliance on male 
partner cooperation for protection, but also as potentially addressing issues of comfortability and 
convenience for use; all of which may contribute to consistent uptake. 
 
Microbicides- A prevention method for all women  
In terms of perceptions of risk and susceptibility, majority of participants were of the opinion that 
all women who are sexually active are susceptible to HIV if they do not use a condom; be it in 
marriages, long-term relationships or casual relationships.  They articulated that being in a long-
term relationship does not provide guarantee that one is safe from infection as there is high 
infidelity in such relationships therefore all women, regardless of relationship status should use 
microbicides for protection against sexually acquired HIV. One of the major points that arose in 
the discussions, which was agreed upon by both males and females in both urban and rural 
settings and across both provinces, was that women’s risk of infection is heightened by men’s 
unfaithfulness. Participants expressed that the widespread practice of intergenerational 
relationships meant that all women, including married/ women in long-term relationships were at 
risk of HIV infection. Microbicides therefore are perceived as a prevention option much needed 
for use by women from any form of relationship or age group.  
 
“All women should use these products. Being a married woman does not mean anything 
because it doesn’t prevent them from cheating” (Male participant, Urban, KZN, April 
2016) 
 
“All women should use these products because anyone can get infected with HIV 
regardless of the age” (Male participant, Rural, KZN, April 2016) 
 
“The biggest problem is that young women who love dating sugar daddies, so he will get 
infected by these young girls and infect me so, married women should also use these products. 
I think prostitutes should also use them too” (Female participant, Urban, KZN, April 2016) 
 
There is no difference between married and single people because it’s a reality that women are 
always at home while men are out drinking at night, and you find yourself flirting with other 
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women. There are people who are always at home yet they get infected with through their 
partners. So I think all women should use these products 
(Male participant, Rural, MP, March 2016) 
 
“I think all women because you could find that I am married yet my husband is cheating, 
so that means I am at a risk of getting infected. All women should use these products, it 
does not matter what type of relationship they are in” (Female participant, Rural, KZN, 
April 2016) 
 
The comments above illustrate that some participants are aware of the high risk of infection faced 
by all women, including married women. The views confirm the widely spread notion of multiple 
concurrent partners (MCPs) and intergenerational sex (IGS) as key drivers of the epidemic in the 
country (UNAIDS, 2016). Consequently, this places married women in a compromising position, 
as new HIV infections are indeed prevalent in marriages or long-term relationships (UNFPA and 
PATH, 2006). 
 
These findings provide a foundation on which to build an intervention to promote microbicide use 
among women in urban and rural settings in South Africa. In this point, SEMCH and CCA inform 
that the socio-cultural context needs to be investigated, probing specifically into the shared 
relationship norms and values within the study settings and similar settings within South Africa. 
Relationship norms therefore need to be investigated further to identify the necessary measures 
to be employed in promoting acceptance and up-take of microbicides by all women. It is 
imperative therefore that the views obtained from study are considered in the implementation of 
microbicides in similar settings, to ensure acceptance and up-take. 
 
Suspicion of infidelity  
As a response to the limitations of currently available prevention methods such as the male and 
female condoms, microbicides provide women discreet protection against sexually acquired HIV. 
As such, these prevention technologies may raise argument regarding men’s dominant position 
as primary decision-makers for sexual protection (Mantell et al, 2005).  Majority of the men in this 
study had negative perceptions towards microbicides. Men expressed that their concerns are 
centered on the notion that microbicides could encourage infidelity amongst women. A male 
participant from KZN rural questioned if these products would not perhaps encourage infidelity 




“Guys don’t you think these products will encourage women to cheat? They will 
be protected but now they will not be worried about getting HIV, so they can now 
have sex with anyone and at any time. I think it would give women the right to 
cheat” (Male participant, Rural, KZN, April 2016) 
 
This view was recurrent amongst men across all the study settings; 
 
She is at a risk yes, but… it could protect her in such situations but what I am concerned 
about is, since women are very weak when it comes to being faithful, what more when 
they now do not have that element of fear, of being infected with HIV when they sleep 
around (Male participant, Rural, KZN, April 2016) 
Why must we let women to put things we do not know in their vaginas? That is giving 
them a right to cheat and sleep around. Can you imagine a woman taking out such a 
rubber from her vagina (Male participant, Rural, KZN, April 2016) 
 “I don’t want to lie, it could be a problem, because you see at home we don’t use 
a condom, we can’t use these things too. I won’t allow it” (Male participant, Rural, 
MP, March 2016) 
“No I would not allow my girlfriend to use these products. I’m afraid I would be 
giving her ideas to cheat” (Male participant, Rural, MP, March 2016) 
“That could also be an issue… that she wants to cheat, until she explains to me 
the purpose of using them” (Male participant, Urban, MP, March 2016) 
“But you see now I have to always be worried, I will always be thinking about 
what she is doing, because now she would be protected” (Male participant, 
Urban, KZN, April 2016) 
Similarly, female participants were concerned about seeming untrustworthy. This was discussed 
in the responses below: 
“He might think that I am using the products because I am having sex with other men” 
(Female participant, Rural, MP, March 2016) 
“He may end up thinking other things, maybe that I am using these products because I 
am cheating on him” (Female participant, Urban, MP, March2016) 
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“He would think that I am the one accusing him of having HIV, so I am protecting myself 
and not him” (Female participant, Urban, MP, March 2016) 
“He would be angry, and think that I am using the product because I am cheating, why 
am I using it if I am only having sex with him” (Female participant, Urban, MP, March 
2016) 
Concerns about cheating were almost universal in all the discussions. A high proportion of men 
in the discussions were against the use of microbicides by women. Men expressed that they will 
think the woman is having an affair. Although acknowledging the need for women’s protection 
against HIV, male participants disapprove of microbicides because they fear that a woman ‘she 
can have sex anytime and with anyone’ will no longer be sexually governable. They fear that 
allowing a woman to use microbicide products would be ‘giving her permission to cheat’, 
encouraging her to have multiple sexual partners, therefore they would object to it. Confirming 
men’s concerns, women also fear seeming untrustworthy to their male partners. The findings 
suggest that men think women are not engaging in multiple sexual relations because they fear 
getting infected.  
This corroborates previous findings (Mantell et al, 2005; Nota, 2016), that the great level of 
discreet use is perceived as a threat to male dominance in decision-making for sexual protection. 
The findings suggest that men are aware of the empowerment and agency microbicides would 
provide women. Unlike the female condom, microbicides will not require male partner’s active 
participation or knowledge (Woodsong, 2004), thus having a great potential to overcome male 
dominance in decision-making for sexual protection. 
 
Partial protection may affect acceptance 
Diverse views ensued regarding partial protection offered by microbicides in this study. Despite 
acknowledging the necessity of more prevention methods, male participants deemed this initiative 
as a futile attempt to HIV prevention, while female participants expressed concerns that this 
method would result in discontinuation or substitution of the condom with these new prevention 
technologies.  
 
 “So I guess it would not be wrong to decide not to use it because there is still a chance 




What they can do is to make something that makes sex more enjoyable. Most people will still 
not use condoms. They need to produce a pill that will completely prevent people from getting 
infected even when they have not used a condom... The pill you are talking about doesn’t 
provide 100 % protection from HIV, but the one I am talking about… see it is like a condom, if 
you use a condom the right way, you won’t get infected with HIV, so the pill I am talking about 
should provide 100% protection from HIV once you take it (Male participant, Rural, MP, March 
2016) 
 
In further arguing partial protection, an interesting view came from a male participants from KZN 
urban, who anticipated a misunderstanding, whereby people would disregard the chance of 
infection and only focus on the level of protection that is offered. 
 
“You said these products provide a level of protection. In most cases when such things 
are introduced, people will focus on the protection offered by a product and forget about 
the chance of getting infected” (Male participant, Urban, KZN, April 2016) 
 
“These products are okay but I am a bit confused by some of them, like you use the ring, 
and then use the condom, how then do you see that the ring works?” (Female 
participant, Rural, KZN, April 2016) 
 
The responses indicate a high probability of unacceptability amongst men who perceived a 
microbicide product that offers partial protection against HIV as a futile attempt to HIV prevention. 
Some male participants stated that the condom offers an increased protection than microbicides, 
as the latter’s protection varies with each product, while if consistently used, the condom provides 
100 per cent protection against HIV. They felt that using microbicides in conjunction with a 
condom would fail, as people would still not use the condom for the sake of getting more sexual 
pleasure from flesh-to-flesh sex. Male participants felt that a product people can accept and 
adhere to is one that will offer complete protection to HIV infection even in the absence of the 
condom. 
 
The findings confirm an observation from the VOICE study, linking unknown product efficacy to 
poor adherence as it discourages adequate use (van der Straten et al, 2015). In another study, 
partial efficacy of microbicides was found to result in condom substitution (Shattock and 
Rosenberg, 2012). Other challenges with partial efficacy include the requirement to be used in 
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conjunction with the condom, which raises confusion and uncertainty about the effectiveness of 
microbicide products. A study in an urban setting in Cape Town found that respondents had 
concerns about a partially effective microbicide however, they felt that partial protection would 
help in fighting the HIV crisis amongst women (Orner et al, 2016).  
 
In trials, participants are informed that the administered product has unknown efficacy therefore 
it may or may not provide protection, and that that they may have been assigned to use a placebo 
(Woodsong et al, 2013). In the iPrEx PrEP study, some of the participants who were unknowingly 
administered oral truvada instead of placebo were reluctant to take the pill as they believed it to 
be ineffective (PrEP Facts, 2015). This suggests that unknown efficacy may make people feel 
they do not have much influence over their health, and thus engaging more risky sexual behaviour 
than adopting a positive health behaviour (Varga, 2001). This underscores the importance of 
exploring how partial efficacy of microbicides is received through pilot studies and early 
introduction programs to identify and address possible barriers and facilitators in advance of 
product introduction (Woodsong et al, 2013). The findings demonstrate a possibility of rejection 
of these new prevention technologies, as well as a high possibility of risk compensation, based 
on how people measure the level of efficacy offered by a product. 
 
Microbicides may result in risk compensation  
While microbicides offer a much needed protection for women, it is critically important to examine 
the impact of increased efficacy on sexual behaviour. In this study, female participants expressed 
great concern that disclosing microbicide use could impact negatively on their effectiveness as it 
could increase risky sexual behaviours such as unprotected sex and engaging in multiple sexual 
relations amongst men. They expressed that men would discontinue condom use, or increase the 
number of sexual partners.  
 
If you tell him he won’t see the need to protect himself anymore, he will keep getting diseases 
and bringing them to me” (Female participant, Rural, MP, March 2016) 
 
“And once you tell him that you are using these products he may ask what they are for, 
and you’ll have to tell him that they are for HIV prevention… then he will say there is no 




“If you tell the man that you are using these products they will want to stop using a 
condom, and you said these products do not provide 100 percent protection right?” 
(Female participant, Rural, KZN, April 2016) 
 
Male participants echoed female participants views, in that they would definitely discontinue 
condom use once their female partners starts using microbicides.  
 
A condom is no longer used once she starts using this thing... The condom is not okay because 
when a man uses a condom... I just have not tried the female condom but when a man is having 
sex, it is nice to feel the woman’s vagina, but when it is covered in a condom, you cannot feel 
her warmth. So you can go on for a whole three hours and not feel anything because of a 
condom (Male participant, Rural, KZN, April 2016) 
 
“When a woman has tested negative for HIV, and they start using the product, and you 
know that you are also faithful and she trusts you, then what is the use of a condom?” 
(Male participant, Rural, KZN, April 2016) 
 
“I think it would be difficult for women to introduce these products, and I think I would 
stop using a condom once I know that she is using these products” (Male participant, 
Urban, KZN, April 2016) 
 
“Yes, the good thing about this is that you can feel the warmth of the vagina, so I can 
allow her to use it” (Male participant, Rural, MP, March 2016) 
 
Previous acceptability research also revealed that women are skeptical about disclosing 
microbicide use, as some men may discontinue condom use due to misconception about the 
protection offered by microbicides (Woodsong, 2004). An acceptability study also found that 
consistent condom users were likely to substitute condoms with microbicides (Orner et al, 2016). 
The findings confirm an observation by Eaton and Kalichman (2007), that these new prevention 
technologies may potentially lower the perception of risk and thus increase risk-related behaviors 
(Eaton and Kalichman, 2007). Woodsong further draws on the impact microbicides may have on 
women’s autonomy for protection, as men who prefer microbicides over condoms, which could 




The findings above provide the basis for questioning why men some men in this study were 
supportive of microbicides. The question on disclosing microbicide also calls into question the 
issue of gender equity as well as people’s preference for unprotected sex, which could hinder the 
effectiveness of microbicides. Moreover, the findings suggest a high probability of risk 
compensation which is the substitution of condoms by microbicides. Given these findings, there 
remains a need for educational programmes to ensure thorough understanding of the risk-
reduction benefits of microbicides.  
 
Acceptance of microbicides rely on effective implementation  
Drawing from their experiences with the female condom, male participants expressed the need 
for a strong presence (marketing and advertising); continual educational and promotional 
campaigns in the introduction of microbicides. Participants stated that they had no sense of 
familiarity to the female condom, which affected their decision to accept and/or use it. Participants 
therefore suggested that both partners need to be educated about these new prevention 
technologies, as that would facilitate acceptability amongst men and enable consistent use 
amongst women.  
 
I think what needs to be done with these products, that will be different from female condoms is 
how they present them to people because, with male condoms men were  given enough 
information but with the female condom that was not done. Some of us do not even know it. So 
we all need to be taught about these products in order to be familiar with them, because if they 
are not presented properly women will not be comfortable to use them, also I cannot let a 
woman to use something I don’t understand (Male participant, Urban, KZN, April 2016) 
 
“I think what is important is how these products will be introduced to the community, how 
the information will be presented to people and they get them to people out there. 
People must be educated on what these products are and how they work” (Male 
participant, Urban, KZN, April 2016) 
 
This is consistent with findings that noted a strong link between promotion of a product and 
positive perception of that product (Mantell et al, 2005). So far, efforts towards increasing use of 
the female condom have placed much emphasis on its design (evident in the production of the 
second-generation FC2 female condom) (Beksinska et al, 2013). Very few effort interventions 
have been placed to testing and promoting the efficacy of the female condom (Mantell et al, 2015). 
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As a result, even knowledge about the selected distribution facilities remain a mystery for most 
women (Beksinska et al, 2012). Some women either have no knowledge of the female condom, 
or they are unable to obtain it (Peters et al, 2010). Involving men in the early stages of introducing 
microbicides can improve product knowledge, and therefore increase the chances of acceptance 
and up-take, as well as encourage support from male partners (Schuler et al, 2013).  
 
This finding shows that having knowledge of a product’s existence is not sufficient for acceptance, 
familiarity and clear understanding is what promotes acceptance and utilisation. Continuous 
Information dissemination therefore should be considered a key factor when introducing a new 
prevention method. 
Varying product acceptability between males and females 
Acceptability of a product includes both perceived acceptability, i.e. satisfaction with the product’s 
features and demonstrating willingness to use it or recommend it to someone else, as well as the 
actual use of the product during intercourse (Ramjee et al, 2001; Ramjee et al, 2005). 
Acceptability of microbicides however is heterogeneous across different populations as 
demographics, socio-cultural background, high risk behaviour have the greatest influence on 
product acceptance (Zhang et al, 2016). This chapter discusses KZN and MP men and women’s 
acceptability of four microbicide products namely; the tenofovir gel, daily oral truvada, the 
dapivirine ring and injectable microbicides. 
 
Acceptance of the tenofovir gel  
Past studies indicate that the dosing strategy for the tenofovir gel is one of the critical factors that 
contribute to poor adherence to the product; as women find it challenging to adhere to the dosing 
regimen of the gel. In this study, the tenofovir gel is perceived as an impractical method. Table 








Table 5.1: Summary of responses regarding the tenofovir gel 
Sub-theme Female participants Male participants 
 Impractical dosing 
regimen  
- Female participants are 
concerned that it would be 
difficult to anticipate when 
they would engage in 
intercourse as it is often an 
unplanned activity. 
- It would be difficult to 
excuse themselves to apply 
the gel when the male 
partner wants to have sex  
- Men demonstrated an 
unwillingness to wait for 
women to apply the gel 
“You see this gel… what if I 
want her now, and she tells 
me to wait for an hour, we 
will end up not using it, 
because you see… why 
must I wait? We just won’t 
use it” 
Constant application may hinder 
consistent use 
- Female participants were 
concerned that discreet use 
of the tenofovir gel would 
be a challenge, particularly 
for women who live with 
their partners. 
- Inconsistent protection for 
rape cases 
- Constant application was 
perceived as challenging, 
particularly the post-sex 
dosage because “most 
people fall asleep after sex. 
So what happens if do not 
apply it after the 12 hours?” 
Lubricative properties may affect 







- Excessive lubrication may 
result in suspicion of 
infidelity as a wet vagina is 
associated with promiscuity 
or an unhealthy and 
damaged vagina. 
 
- Men demonstrated a 
preference for dry sex. 
Therefore the gel would 
cause excessive lubrication 
which may affect their 
sexual pleasure. 
 
Acceptance of tenofovir gel may 
be hindered by vaginal practices 
KZN rural women are concerned that 
the tenofovir gel will be mistaken for 
vaginal practices they often perform 
to enhance men’s sexual pleasure 
KZN rural men are concerned that 
vaginal practices will be concealed 
through the use of the tenofovir gel  
 
Impractical dosing regimen, a barrier to adherence  
Intercourse is often an unplanned activity which could pose challenges for adherence to barrier 
method that requires pre-coital insertion such as the tenofovir gel. The study found that the 
tenofovir gel was perceived as the most impractical method. Both male and female participants 
expressed dissatisfaction with the product’s dosing regimen which requires insertion up to 12 
hours before and after intercourse. Women expressed that consistent use of the gel would be 
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difficult, as it would be a challenge to use in the presence of the male partner, particulalrly in cases 
of unplanned intercourse.  
“It has too much work. Most of the time sex is not planned. You find that you haven’t 
seen each other in a long time, it would be difficult to ask him to stop so you can go and 
put the gel” (Female participant, Urban, KZN, April 2016) 
 
Sometimes we go to the tavern, and anything can happen there, now how can I put the gel... I 
can put it before sex but now, what happens if I go to the tavern and I meet a guy, and we want 
to have sex, and I left my gel at home… I don’t think I can use it, maybe the pill or the injection 
because its always in my bloodstream… I will take the pill before I go to the tavern, maybe 
every day in the morning (Female participant, Rural, KZN, April 2016) 
 
“Yes, you find that we are now sitting in the bedroom and you start kissing, and now you 
have to put the gel… I can’t ask him to wait. Some men want to come with you to the 
bathroom, so what would I do in such a position?” (Female participant, Rural, MP, March 
2016) 
 
“It would be a problem, for example when you go to visit your partner without an 
intention to have sex, then he asks you to sleep over but you haven’t carried the gel with 
you” (Female participant, Rural, MP, March 2016) 
 
“If I have to apply the gel before and after sex my husband will end up asking why I’m 
getting out of bed, so it would be difficult to hide it” (Female participant, Rural, KZN, April 
2016) 
 
Male participants also felt that the tenofovir gel is an impractical method, as the dosing regimen 
would pose challenges for adherence;  
 
“The problem with the gel is that she has to apply it again after sex. Because most 
people fall asleep after sex. So what happens if do not apply it after the 12 hours?” (Male 




“You see this gel… what if I want her now, and she tells me to wait for an hour, we will 
end up not using it, because you see… why must I wait? We just won’t use it” (Male 
participant, Rural, MP, March 2016) 
 
This gel is like the female condom, you still have to wait. You see women cannot use the female 
condom because they say you have to wait for hours before you can have sex, and now you 
have to wait 12 hours… How do you know that you are going to have sex? Because you can’t 
always put the gel, what if you don’t have sex? (Male participant, Urban, MP, March 2016) 
 
The responses above indicate participant’s dissatisfaction with the tenofovir gel due to its dosing 
regimen. Women are concerned that applying the gel is infeasible in cases where intercourse is 
unplanned; particularly if the woman chooses not to disclose microbicide use to her male partner. 
Women perceive the dosing regimen as having the likelihood to interfere with covert use and 
adherence. Similarly, men are against having to wait for the woman to insert the gel, stating that 
they understand sex to be an unplanned activity therefore, such a product is deemed unfeasible 
for spontaneous sex. Another concern raised is the inability to take the post- sex dosage, due to 
unforeseen circumstances such as the high probability of falling asleep after sex. They feel that 
such the dosing strategy of the tenofovir gel disregards such possibilities.  
In support of the concerns raised in the study, a number of issues ensued following the release 
of the CAP004 study, questioning how the trial participants dealt with the reality of sex often being 
a spontaneous event, however being instructed to apply the gel within 12 hours of anticipated 
intercourse (Agut et al, 2015). Furthermore, a complimentary social study of the CAP008 trial, (a 
follow up study of the successful aforementioned CAPRISA trial) found that women who chose 
not to disclose gel use had difficulties using the gel in their partner’s presence, for unexpected 
partner visits, and were concerned about the partner feeling cold or wetness (McQueen et al, 
2016). Similar to a post-trial study in For married and cohabitating women, covert use was difficult 
(McQueen et al, 2016), confirmed by a post-trial study of a cellulose sulfate microbicide gel 
amongst women in Uganda and India (Greene et al, 2010). Confirming these findings, female 
students at University of KwaZulu-Natal questioned whether adherence to such a product with a 
demanding dosing regimen would be practical in an environment where men can demand sex 




The above views therefore demonstrate that a woman’s relationship status and living 
arrangement are amongst the important factors to understand when prescribing a prevention 
method, as this could affect adherence. 
 
Lubricative properties may affect men’s sexual pleasure 
The practice of dry sex is highly prevalent in SSA, which could have an impact on the acceptance 
of microbicide products such as the tenofovir gel that have lubricative properties. Female 
participants expressed that using the gel would be a problem because it would make their vaginas 
wet. This would likely be misconstrued by men as a sign of having recently had sex, therefore it 
would raise suspicions of cheating. Female participants also feared that the gel would reduce with 
sexual pleasure.  
 
“What I can say I do not understand properly is the gel because, if my partner does not 
like a wet vagina, then it means I will not be able to use it” (Female participant, Rural, 
KZN, April 2016) 
 
“Especially the gel, he may think that you are using the gel so that he won’t feel that you 
were with another man” (Female participant, Rural, KZN, April 2016) 
 
“With the gel, it would be a problem because they would think that we are too wet” 
(Female participant, Urban, KZN, April 2016) 
 
“As a woman, you sometimes feel like that you are too wet, and it makes you 
uncomfortable. Also because it’s something you have to hide. It is better for him to 
struggle a bit when entering your vagina, than to just slide in” (Female participant, 
Urban, KZN, April 2016) 
 
“The gel, it will cause me to be too wet, I don’t think I will be able to hide it, and he will 
ask why I am too wet. Sometimes he puts his hand in my vagina because he thinks I 
was having sex with someone. He will think I am cheating” (Female participant, Urban, 
MP, March 2016) 
 
“I don’t like the gel because you will end up feeling like a styling gel” (Female participant, 




Male participants also demonstrated a preference for “dry sex” where a woman does not have 
much vaginal lubrication or fluids. Men stated that women already release lubricative fluids during 
sex, thus using the gel would over-saturate the vagina and reduce its warmth during intercourse. 
When asked which product he would prefer his partner to use, a man from MP urban responded; 
 
“I would let her to use the gel, if it doesn’t make her too wet” (Male participant, Urban, 
MP, March 2016) 
 
“The problem with the gel is that a woman already releases lubricative substances 
during sex so I think it would be too wet and I don’t like that” (Male participant, Urban, 
KZN, April 2016) 
 
“So do these products cause women to be wet, and cause us not to enjoy having sex 
with them?” (Male participant, Urban, MP, March 2016) 
 
“If she has used the gel and she does not feel the same during sex, then she tells me 
that it’s because she is using this products, I will not be happy” 
(Male participant, Urban, MP, March 2016) 
 
“And the gel, it would feel like I am not getting the real thing, like I have doubled the 
condoms” (Male participant, Rural, MP, March 2016) 
 
The findings suggest a high unacceptance of the tenofovir gel due to its lubricative properties, as 
participants feel that it would affect their sexual lives negatively, particularly men’s sexual 
pleasure. This suggests that acceptance and use of a product is greatly influenced by the 
perceived impact it has on men’s sexual pleasure. The findings reiterate a qualitative study 
amongst men attending STD clinics in South Africa, which found that men perceived the excess 
lubrication caused by the gel as an undesirable feature of the product (Ramjee et al, 2001). 
Female participant’s views reiterate the VOICE-C study, which found that women enrolled in 
VOICE trial were likely to discontinue the use of the Tenofovir gel if the male partner complained 




Other studies (Mantell et al, 2009; Nicolson and Burr, 2003) found that women were concerned 
about pleasing their male partners sexually more than protecting themselves from infection. The 
study therefore maintains the observation that men have great influence over women’s decision 
to accept and adhere to female-centred programmes (Lanham et al, 2014). These findings 
highlight the importance of obtaining both the male and female’s perspective on the product 
design and dosing regimen, as well as the assessment of context-specific preferences and their 
effects on the acceptability of a microbicide. 
 
Tenofovir gel may be mistaken for vaginal enhancement products  
Vaginal practices are common practices in SSA. In South Africa, this practice is common in KZN, 
which may have an impact in acceptance and use of microbicide products. In this study, any 
product that required vaginal insertion was perceived negatively by men from KZN rural due to 
the widespread trend of vaginal practices amongst women in the Umnini community. Men 
expressed that they are against the tenofovir gel because they were concerned women it would 
allow women to conceal performing vaginal practices with it. 
 
“You see women are very naughty, some of will now use snuff and all other things and pretend to 
be using the gel” (Male participant, Rural, KZN, April 2016) 
 
“They put things in their vaginas to boost sex, so how am I going to know that she is not using 
snuff? She will lie and say she is using the ring or the gel now” (Male 
participant, Rural, KZN, April 2016) 
 
Umnini females confirmed men’s fears about the issue of vaginal insertion. When asked what the 
men’s reaction would be if he discovered that she is using microbicides, female participants from 
Umnini answered; 
 
“If I don’t tell him he will think I am using something to boost my vagina” (Female 
participant, Rural, KZN, April 2016) 
 
A lot of things would come to his mind because as women, there are things that we are already 
using for men to love us so he may think that these products are meant for that, to prevent him 
from cheating, and for that reason he may start cheating and also lose all the trust he had for 
you (Female participant, Rural, KZN, April 2016)  
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Several studies also  revealed that the prevalence of vaginal practices in diverse rural 
communities in KZN, to enhance men's sexual pleasure and ensure men's fidelity (Scorgie et al, 
2009; Scorgie et al, 2011; Gafos et al, 2010). The findings suggest challenges with acceptance 
and support of microbicide use from men in KZN rural, particularly if they are uninformed or 
unfamiliar with these new prevention technologies. 
 
Acceptance of the daily oral truvada 
Diverse views were captured with regards to daily oral PrEP’s dosing regimen as it was perceived 
by some participants as an easy method while other felt it would be difficult to adhere to as 
following a daily routine may not always be possible. Table 5.2 presents a summary of views 
regarding daily oral truvada pill. 
 
Table 5.2: Summary of responses regarding daily oral truvada 
Sub-theme Female participants Male participants 
 Desirable application 
strategy  
- Female participants found 
the pill appealing due to the 
familiar dosing regimen 
which does not require 
insertion of foreign 
products in the vagina 
- Men demonstrated high 
acceptability of oral truvada 
as they are not comfortable 
with women using products 
they are unfamiliar with 
such as the dapivirine ring 
or the tenofovir gel, which 
require vaginal insertion. 
Oral truvada therefore is 
perceived as eliminating 
the possibility of negative 
side effects and illnesses 
such as cervical cancer 
 Perceived limitations of 
oral truvada  
- Daily intake is perceived as 
a possible challenge, 
especially for women who 
live with their partners, as 
taking the pills at a specific 
time may raise questions or 
suspicions as to what the 
pills are for.  
 
 
- Men were concerned that 
women may forget to take 
the pills everyday 
 
- Concerns that women may 
conceal the use of ARVs 
with oral truvada 
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- Oral truvada may be 
disrupted by women’s 
lifestyles or unforeseen 
commitments. 
 
- Alcohol consumption may 
affect adherence, 
 
- Some women have 
difficulties adhering to 
routine therefore consistent 
uptake may be affected  
 
Familiar dosing regimen  
Discussions on the daily oral truvada documented diverse perceptions, with a moderate 
acceptance across all settings, varying between men and women. MP rural and KZN urban men 
demonstrated a great preference for oral truvada as a preventive method they would like their 
partners to use if the products were to be licensed for public use. They expressed that they would 
be more comfortable if their partners would take the pills, as it is a product they are familiar with, 
stating concerns about long-term health problems such as cervical cancer from the use of 
products that require vaginal application such as the tenofovir gel and the dapivirine ring. 
 
“I would like her to use the pills because they are common” (Male participant, Urban, 
KZN, April 2016) 
“The pill because she won’t have to keep putting the gel or go to the clinic for an 
injection” (Male participant, Urban, KZN, April 2016) 
 
“I would prefer my partner to use the pill because I will not be comfortable with 
something I don’t know going inside my women’s vagina. The injection and the pill are 
good because she won’t have to put things in her vagina” (Male participant, Urban, KZN, 
April 2016) 
 
“The pills because they are common, these gels and rings… these things will cause 
cervical cancer, so I won’t let her use it” (Male participant, Urban, KZN, April 2016) 
 
“I would like her to use the pills because automatically when a person takes pills they go 




The findings therefore suggest a likelihood of acceptance of daily oral PrEP due to its common 
and uncomplicated dosing strategy.  
 
Daily intake may not be achievable  
Although acknowledging daily oral truvada as an appealing method due to familiarity, participants 
perceived challenges with adherence. Drawing from observations and personal experiences with 
contraceptive pills and ARV treatment, women expressed concerns about the ability to commit to 
daily up-take of the pills. For female participants, concerns were mainly tailored around the 
possibility of being discovered by the male partner. Covert use of oral truvada is perceived to 
have challenges, particularly for women who live with their partners, as taking a pill at the same 
time on a daily basis may raise suspicions amongst men. Amongst male participants, views 
demonstrated a lack of trust, as they expressed concerns that some women would conceal taking 
ARV treatment with the truvada pill. Alcohol use was also perceived as a possible barrier to using 
truvada.  
 
“The pill is a problem because it has to be taken daily, women will forget to use these 
things” (Male participant, Rural, KZN, April 2016) 
 
“She may forget to apply the gel or take the pill due to stress or other things” (Male 
participant, Rural, KZN, April 2016) 
 
“With the pill, some women will take ARV’s and pretend to be taking the prevention pill” 
(Male participant, Rural, MP, March 2016) 
 
Similar views were noted in the discussion amongst women; 
 
“The problem with the pill is that sometimes women can forget to take it on a daily basis” 
(Female participant, Rural, MP, March 2016) 
 
“The pills may be a problem too. I am on the contraceptive pills and when my daily alarm 
goes off my husband always looks at me, as if he is wondering what the alarm is for” 




“The pill… Sometimes the alarm goes off and you tell yourself you will take it later then 
you forget” (Female participant, Rural, MP, March 2016) 
 
“It’s a problem because your partner may start suspecting something if you always have 
to take the pill at a specific time” (Female participant, Rural, MP, March 2016) 
 
“The problem with the pill is that what if I take it at 8pm every day, then the time comes 
and I am not at home… what will happen then?” (Female participant, Rural, KZN, April 
2016) 
 
“I would forget to take the pill, I know myself. I had to change from using the 
contraceptive pills to the injection because I am just bad at following routine” (Female 
participant, Urban, MP, March 2016) 
 
“But taking the pill everyday can be a problem. Its very difficult to take pills every day of 
your life, that is what many people default on their HIV treatment… no its too much” 
(Female participant, Urban, MP, March 2016) 
 
“Drinking alcohol can also make you forget to take your pills. Or maybe you are taking 
Nyaope (home manufactured drug) or dagga, you may not be able to think about taking 
your pills, unlike when you are sober, you are able to take your treatment properly, or 
use your gel correctly” (Female participant, Rural, MP, March 2016) 
 
The VOICE-C study found that women were unable to incorporate oral truvada into their daily 
lives (van der Straten et al, 2014). Similar to some of the responses in this study, participants in 
the VOICE-C admitted that laziness was the main factor to not taking the pill at the set time, (van 
der Straten et al, 2014). The findings also confirm the discussion on chapter two, that alcohol 
consumption can be a possible barrier to correct and consistent up-take of some PrEP products 
such as oral truvada (Bryant et al, 2010. For example, women in the VOICE –C study reported 
missing doses during weekends to avoid mixing them with alcohol (van der Straten et al, 2014). 
The high prevalence of alcohol use in rural KZN and MP are a translation of the high alcohol 
consumption rate in the country (SANGONET, 2012). There remains a need to examine which 
microbicide product can be suitable for implementation in such contexts.  
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Acceptance of the dapivirine ring  
Diverse views ensued regarding the dapivirine ring as a long-acting prevention method towards 
HIV. Table 5.3 presents a summary of the views regarding the dapivirine ring. 
 
Table 5.3: Summary of views regarding the dapivirine ring 
Sub-theme Female participants Male participants 
 Desirable long-term 
protection  
- Long-term protection is 
perceived as an appealing 
feature 
- Allows for less clinic visits  
- Less user-reliant therefore 
it allows for consistent 
protection 
 
 The dapivirine ring is 
comparable with the 
female condom 
 
- The dapivirine ring is 
constantly compared with 
the female condom due to 
its design and the 
application process. 
-  Due to concerns about 
comfort, female 
participants stated that they 
would be worried about the 
ring falling off or the male 
partner feeling it during 
intercourse.  
- The ring’s application 
process was compared to 
that of the female condom, 
in that the woman still has 
to insert it through the 
vagina.  
 
 Unappealing application 
process 
- It is too big 
 
- Worried about how it would 
fit in the vagina 
 
- Uncomfortable with women 
inserting foreign objects in 
their vaginas.  
- Men expressed that 
“seeing these rings and 
things’ in the woman’s 
vagina would affect them 
subconsciously and 
therefore affect their sexual 
performance. 
  
- The dapivirine ring would 





Desirable long-term protection 
Challenges with adherence in microbicide trials suggest a need for long-acting, less user-reliant 
products for increased protection against HIV infection. This study found that female participants 
were drawn by the long-term protection offered by the dapivirine ring as it would eliminate the 
burden of daily application or use, which makes it highly unlikely that they will forget their clinic 
visits for their next application. The monthly dosing regimen is perceived as a convenient method 
that allows for discreet use and thus further translating into consistent uptake. 
 
“I like the ring because I don’t have to remove it, as it dissolves on its own but I would 
still forget to go and apply another one but its good because I’ll be able to use it in secret 
too because he won’t know that I inserted it” (Female participant, Rural, KZN, April 2016) 
 
“He won’t be able to see or feel the ring unless I tell him, also because it offers long term 
protection” (Female participant, Urban, MP, March 2016) 
 
“I would choose the ring because 28 days is a very long time so I won’t forget to go and 
insert another one” (Female participant, Rural, KZN, April 2016) 
 
“Because I won’t have to take it every day like the pills, and going for an injection… I’m 
scared of needles, and I don’t like taking pills” (Female participant, Urban, MP, March 
2016) 
 
Similar to these findings, the development of a long-acting dapivirine ring was perceived as having 
the potential to address adherence challenges faced in previous PrEP trials such as the tenofovir 
gel (Baeten et al, 2016; AVAC, 2016; The South African Medical Research Council (SAMRC), 
2016). Furthermore, the easy once off application is said to allow for convenience and sustained 
monthly protection against HIV (IPM, 2012).  
 
Noting a noticeably high preference for the dapivirine ring amongst KZN rural women despite the 
similar application process as the tenofovir gel; the researcher questioned this inconsistency to 
which participants answered; 
 
“It is not the same. With the gel I may have to apply it every day, whereas with the 




Participants felt that the monthly duration of the dapivirine ring makes it less invasive demanding 
when compared to the tenofovir gel. One participant from rural KZN stated that she dislikes the 
gel because her vagina being oversaturated with the gel due to constant use. In all, there is a 
modest acceptability of the dapivirine when compared to the tenofovir gel and oral truvada due to 
its long-term protection. This suggests that a long-acting vaginal ring can indeed increase up-take 
and therefore provide increased protection against HIV (Baeten et al, 2016; AVAC, 2016). 
 
The dapivirine ring is comparable to the female condom 
The introduction of a new method is subject to comparison with existing prevention methods. 
There was a recurrent view regarding the comparison between the dapivirine ring and the female 
condom, noted by those participants who are familiar with the design of the second generation 
female condom- FC2 condom which has a flexible inner ring to insert the device and keep it in 
place during intercourse. Further comparisons involved the requirement for vaginal insertion, 
which was found unappealing by majority of male participants.  
 
“What I think about the ring is that it is the same as the female condom. The 
woman still has to put it in the vagina. I think they need to develop a product that 
is easy to use” (Male participant, Rural, KZN, April 2016) 
 
“The female condom is just like the ring, you fold it, make it into an 8-shape, and 
then you push it deep into your vagina then the part that looks like an umbrella 
on top will be left outside your vaginal opening, and it will grasp your vagina” 
(Female participant, Rural, MP, March 2016) 
 
Participants also expressed concerns about the ring’s comfortability. This included the ring falling 
out in cases where women fail to apply it properly as well as its comfortability during sex. 
 
“But the ring is like the female condom, you still have to put the ring inside, what 
if I don’t put it the right way?” (Female participant, Rural, KZN, April 2016) 
 
“If you can come with the ring, they would be afraid of using it because they may 
think that it is uncomfortable, just like the female condom” (Female participant, 




The findings suggest that the application regimen is perceived as invasive and unappealing, as 
men expressed that they are uncomfortable with any product that is applied through the vagina. 
The findings suggest unacceptance of the dapivirine ring amongst men therefore there remains 
a need for a product that offers both long-term protection and a simple and less complicated 
dosing regimen.  
 
“Rings and Things” 
MP rural men demonstrated a high unacceptability of the dapivirine ring. They expressed that 
they are not comfortable with women inserting foreign objects in their vaginas as that would affect 
them subconsciously and therefore affect their sexual performance. In this regard, men explained 
how the female condom would affect their mood for sex, therefore they feel ‘seeing these rings 
and things’ in the woman’s vagina would have the same effect. One participant felt that the 
dapivirine ring would open the ‘whoezit’ (the vagina). Interestingly, a female participant from MP 
urban felt the dapivirine ring would make her uncomfortable during sex. Other female participants 
said they would be concerned about the male partner feeling the ring during sex, or the ring falling 
off if it is not properly inserted.  
 
“…seeing these rings and things would destroy that trust in a relationship” (Male 
participant, Rural, MP, March 2016) 
 
“I think this thing can affect men subconsciously, just thinking that she has a ring 
in her vagina can cause problems” (Male participant, Rural, MP, March 2016) 
 
“With the ring, as a man I feel there is something that goes before me during sex, 
so I am not okay with that” (Male participant, Rural, MP, March 2016) 
 
“This thing will open the ‘hoezit’, so it will always be open… this ring is big” (Male 
participant, Rural, MP, March 2016) 
 





“And I think the rubber things would be a turn off for me too, I have an overactive 
imagination. It would disturb me during sex because I will think maybe it will 
come out or that he will feel it” (Female participant, Urban, MP, March 2016) 
 
“I’m scared of it. I look at it and ask myself where this thing will go... and what if 
he feels it?” (Female participant, Rural, MP, March 2016) 
 
“Some women may not be able to use the rings properly. What if it falls?” 
(Female participant, Rural, MP, March 2016) 
 
“With the ring I think I will be paranoid, I will keep thinking it will fall” (Female 
participant, Urban, MP, March 2016) 
 
Concerns about the dapivirine ring in this research reiterate frequently asked questions about 
whether the ring falls off, if the male partner feels the ring during intercourse, or if it is 
uncomfortable or difficult to insert (IPM, 2016). The findings indicate that there will be a need to 
educate women on the dapivirine ring, its application regimen, the possible impacts on the body 
and intercourse, and all the relevant information with regards to the ring. Addressing such 
questions may impact positively on acceptance of the dapivirine ring. 
 
Acceptability of the three-monthly injectable  
Perceptions on the injectable were mostly positive due to the long-term protection offered by this 
method. Table 5.4 provides a summary of responses on injectable PrEP. 
 
Table 5.4: Summary of responses towards injectable microbicides 
Sub-theme Female participants Male participants 
 Practical  dosing regimen  -  Long-term protection 
therefore less clinic visits, 
and most importantly it 
allows for discreet use  
- Practical for spontaneous 
sex because it is always in 
the blood stream 
- Injectable microbicides 
offer long-term protection 
- Less clinic visits  
- No vaginal insertion 
- Allows for spontaneous sex 
 The dosing regimen 
allows for discreet use 
- The dosing regimen has 
been tested and proven to 
- Familiar dosing regimen 
which does not require 
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work through the three 
monthly contraceptive 
injection.  
- Discreet use is possible, 
the male partner does not 
need to be informed about 
its use 
 
insertion of foreign 
products in the vagina   
 Long-term effects of 
injectable microbicides 
- Concerns about water 
retention and weight gain 
 
- It may make women gain 
weight 
 
The most practical dosing regimen  
In this study, the most attractive feature about injectable PrEP is its long-term protection as this 
entails less clinic visits and intermittent use of product. Female participants expressed that the 
injection would allow them to hide their use of this method, as the dosing strategy does not require 
constant application; which will then ensure consistent use and increased protection. Participants 
were pleased regarding the long-term protection offered by injectable PrEP mainly because it 
accommodates spontaneous sex which came up as a compelling argument in all the focus 
groups, particularly in relation to the tenofovir gel. Participants rated that the injection offers the 
most reliable protection as it allows for protection even in cases of unanticipated sex, because 
the product is always in the bloodstream. Moreover, injectable microbicides are perceived as 
convenient unlike the tenofovir gel which is likely to be forgotten and disregarded due to 
unavailability (in cases where the woman has not carried it with her), or the inability to wait for 
application time when sex was unanticipated. 
 
“I prefer the injection because it lasts longer, what I would not use is the pill 
because I may forget to use them, and that would be opening a chance of getting 
infected whereas the injection stays in the blood” (Female participant, Rural, MP, 
March 2016) 
“I think that the products are good because for example the injection, they say it 
lasts up to three months right? Even when we do not have condoms, I can be at 
ease knowing that at least I have some form of protection against HIV because I 





“Because sometimes men don’t say when they come to visit, so the injection is 
always in my bloodstream. Also because it offers a long-term protection” (Female 
participant, Rural, MP, March 2016) 
 
“The injection because it is very easy to use. I won’t have to keep going to the 
bathroom, because the injection will last for three months, and we can have sex 
anytime with my husband” (Female participant, Urban, MP, March 2016) 
 
“Because with the injection, she will take it today and it lasts three months, so we 
can have fun, unlike the pill that you have to take every day, maybe one day she 
will forget to take it” (Male participant, Urban, MP, March 2016) 
 
“Because with the injection I know that she won’t put any products in her vagina. 
The injection will be in her blood stream so she will go to the clinic once every 
three months” (Male participant, Rural, MP, March 2016) 
 
A “Tried, Tested and Proven” dosing regimen 
Evidence from research indicates that women require a long-acting microbicide with a highly 
discreet dosing regimen (Hoffman et al, 2010). The production of the injectable microbicides 
therefore is a response to this appeal, and therefore are believed to achieve consistent up-take 
and thus increased protection against HIV. In this study, the three monthly PrEP injectable was 
compared with the three monthly contraceptive injection. Participants felt that the dosing regimen 
has been proven to guarantee discreet use.  
 
“I also think the injection is the best option because he can also take me to the clinic, all 
he has to know is that I am on the contraceptive injection. And we can have sex anytime, 
especially when he comes unexpectedly” (Female participant, Urban, MP, March 2016) 
 
“But we are able to hide these things… a man will not know that you are using the 
injection if you haven’t told him…He does not have to know, just as he does not know 




“I think the injection is the best method for women to protect themselves because they 
won’t have to tell their partners that they are taking the injection. You’ll have both your 
cards, the family planning card and the HIV prevention card” (Female participant, Rural, 
MP, March 2016) 
 
“Some men do not know that their partners are in family planning, so it is possible to 
keep this from them” (Female participant, Rural, MP, March 2016) 
 
“Women are already using the family planning injection, some of them we don’t even 
know they are using it, so what will stop them from using this one” (Male participant, 
Urban, MP, March 2016) 
 
“The injection because most women are already using the contraceptive injection” (Male 
participant, Rural, KZN, April 2016) 
 
“With the injection I can just go to the clinic after three months and he won’t suspect 
anything, he won’t even see it… I will go and take my injection and come back as if 
nothing has happened but I know that I am protected” (Female participant, Rural, MP, 
March 2016) 
 
“I don’t want to go to the clinic all the time… and because with the other products… he 
may end up seeing the containers in the house... the injection is good, I will go and take 
my injection and I don’t have to tell him anything because it will be in my system” 
(Female participant, Urban, MP, March 2016) 
 
“I would choose the injection because it lasts longer, and it would be easy to hide 
because he won’t question why I am going to the clinic, and he won’t know what I am 
going to do at the clinic” (Female participant, Rural, KZN, April 2016) 
 
Participants felt it would be easy to adopt and adhere to the injectable PrEP’s dosing regimen, 
especially if it were to be integrated within the family planning programme. They stated that such 
a method has been tested and proven to work, as some men are unaware that their partners are 
taking the contraceptive injection. This conforms various acceptability studies showing that 
women prefer a product that would not be noticed by the male partner to allow for discreet use 
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(Hoffman et al, 2010). This finding thus indicates a favourable acceptability and utilisation profile 
of the injectable PrEP products.  
 
Long-term effects of the injection 
The effects of the injection on a woman’s body weight came up strongly in the discussions about 
the injectable microbicides in this study. Despite the perceived advantages of the long-term 
protection offered by this method, participant’s views were distorted by some certain beliefs about 
the effects of the contraceptive injection; 
 
“I heard something about the injection, men say a woman that takes the injection 
becomes wet, so that is the problem I have with the injection” (Female participant, Rural, 
KZN, April 2016) 
 
“When you tell them, for instance with the contraceptive injection, they say things like 
your vagina is not tight enough, but when you haven’t told them they don’t notice any 
difference so, maybe they will say the same thing with this injection” (Female participant, 
Rural, MP, March 2016) 
Male participants also expressed concerns about the issue of water retention and weight gain;  
 
“The only problem with the injection could be the woman gaining weight” (Male 
participant, Rural, MP, March 2016) 
 
“I think the injection is better but sometimes it makes women gain weight” (Male 
participant, Rural, KZN, April 2016) 
 
Some concerns were raised regarding the effects the injectable. The widely spread notion of water 
retention and weight gain for women who use the contraceptive injection influenced the 
perceptions about the injectable microbicide. Even though some concerns we raised, both male 
and female participants maintained that the injection was the best option amongst the four. 
Barriers to product acceptance, utilisation and adherence 
This theme presents the various socio-cultural, economic and structural factors which emerged 
as preventing women from accepting or utilising microbicides as a female-initiated prevention 




Sexual decision-making for protection  
Views regarding covert use were mostly negative amongst male participants; as they strongly 
believed that the decision for prevention has to be approved by the male partner. Male participants 
expressed that a woman is not supposed to keep the use of barriers methods from them as they 
are equal partners in intercourse. The views below came up when the researcher asked male 
participants what their views were regarding the possibility of women using microbicides in secret:  
 
“Why am I not allowed to see them? She has to show me, I am the boss” (Male 
participant, Urban, KZN, April 2016) 
“The answer is no, a woman cannot use this product and not tell me” (Male participant, 
Rural, KZN, April 2016) 
 
“She has to first explain to me what the product is, she cannot put things in her “hoezit” 
(vagina) without telling me”. She has to tell me so that I know because its me who has to 
go in there” (Male participant, Rural, MP, March 2016) 
   
“If you can hide this from me, that means there are many other things you are hiding 
from me, so it is very important to communicate first” (Male participant, Urban, MP, 
March 2016) 
 
A low proportion of men acknowledged women’s rights to independent protection against HIV 
however they maintained that male partners should be informed about microbicide use, and also 
have an opinion regarding which product to use.  
 
“I think in a relationship, such a product, the decision is yours but you have to tell me 
because your protection involves sex and that is something we do together” (Male 
participant, Urban, KZN, April 2016) 
 





“I would allow her to use the products because it protects her from HIV, If there are no 
side effects, then she can use them so that even if she is cheating, she will be protected” 
(Male participant, Urban, MP, March 2016) 
 
An interesting view came up amongst KZN rural and urban male participants. Contrary to female 
participant’s views, expressing their inability to enforce sexual protection due to fear of abuse and 
suspicions of infidelity as indicated earlier, men from these settings were of the opinion that 
women prefer the male partner to take charge of sexual decision-making. Men from these settings 
are of the opinion that women fail to engage in any form of decision-making in the early stages of 
a relationship, which then accustoms men to dominance including sexual matters. They stated 
that they understand women’s non-use of the female condom or the inability to initiate sexual 
protection is understood as a preference for men to make a decision about whether or not to use 
protection.  
 
In my opinion, I think women are usually the ones that give men the power to make decisions in 
relationships. In most cases women ask for the man’s opinion when they want to do things, so 
we get used to telling them what to do. Even when it comes to sex, we are used to taking the 
lead and taking decisions for them. So when she comes after a long time and want to introduce 
such things I am going to question where that is coming from all of a sudden (Male participant, 
Urban, KZN, April 2016) 
 
In most cases women do not express themselves, maybe because they think they are going to 
lose the person they are dating if they say how they feel. So once I get used to her not 
questioning any decision I make, I will not understand when she wants to introduce something 
new things after eight years of dating. I will question that, and even if I asked for another man’s 
opinion, they would say that she is now cheating. So I think a woman should be open about 
using these products because if I find out she is using them in secret I will think that she is 
cheating (Male participant, Urban, KZN, April 2016) 
 
The truth is that women like men to make decisions in relationships. Even with condom use, 
most of the time it’s the man who decides whether to use a condom or not, it is very few cases 
where the woman suggests to use a condom. It’s us men who most of the time take decisions in 




Women’s passive behaviour was also interpreted as a sign of respect for men. A view shared 
amongst KZN urban men; 
 
“Let’s take this environment for example, people respect each other, and the woman 
listens to the man to show respect, whether they are married or not. The fact that you 
are in a relationship means that there should be respect from the woman to the man” 
(Male participant, Urban, KZN, April 2016) 
 
The views from male and female participants confirm that South Africa is a patriarchal society that 
is embedded in cultural and traditional ideologies that deem women an inferior status than men. 
Furthermore, this finding resonates with the notion of gender socialization, which defines how 
women are socialised to be passive and submissive while men are encouraged to take be strong, 
to be dominant in sexual matters, have multiple partners and to aggressively pursue sex, 
sometimes even to the point of coercion. As argued in chapter two, cultural norms and attitudes 
are major contributors to women’s lack of control over their own sexuality (James, 2008). The 
findings therefore affirm that expectations of sexual passivity deny women the ability to be equal 
partners in deciding the terms of sexual activities, including negotiating safe sex practices (ICAD, 
2006). Given these findings, understanding gender dynamics and the sociocultural factors 
informing them is the key to effective acceptance and utilisation of microbicides. This can help to 
understand women’s position in sexual decision-making, thus assist in developing relevant and 
feasible strategies to create acceptance and effective up-take. 
  
The findings indicate that women’s voice in sexual matters is indirectly repressed. The NDOH 
(2012) recommended that addressing the positioning of women should be at the forefront of the 
HIV crisis. The findings indicate that women’s socio-economic and cultural positions deny them 
the voice to communicate their sexual health needs. Epidemic control can only be achieved only 
when women are empowered in these aspects that epidemic control amongst women can be 
achieved (NDOH, 2012). It is greatly imperative therefore, that gender dynamics are taken into 
consideration when introducing a new HIV prevention method for women. In keeping with the 
CCA, the inconsistent views regarding women’s positions in sexual matters need to be explored 
further, to understand whether these beliefs can have an impact on women’s decision to accept 
or use microbicides. Such studies need to be done while microbicides are still in the development 




Gender poverty- a barrier to protection 
Economic and structural inequalities are amongst the key factors contributing towards women’s 
vulnerability to HIV infection. In general, men have greater wealth, they are more educated, 
greater political influence, with fewer restrictions on behaviour than women (WHO, 1997). These 
imbalances may stand as a barrier to acceptance and utilisation of microbicides as an HIV 
prevention method for women. The researcher asked female participants what their partner’s 
reaction would be if their partners discovered their use of microbicides to which they responded; 
 
“I think we would have a fight because he promised that he loves me and he does not 
want any problems, and he does everything for me… You see I don’t want to lose 
somebody who takes care of me, he gives me money and makes sure that I am well 
taken care of” (Female participant, Rural, MP, March 2016) 
 
“He will say I don’t respect him, I bring things in his home without telling him, he may 
even kick me out” (Female participant, Rural, MP, March 2016) 
 
“You can’t tell him, what if he leaves you? because now he won’t trust you… you know, 
when he takes care of you, he will start saying you are ungrateful and threaten to stop 
giving you money” (Female participant, Rural, KZN, April 2016) 
 
While not disregarding other aspects of male dominance, women perceive the lack of economic 
resources as the greatest determinant for their lack of sexual power, particularly their inability to 
use prevention methods. Women expressed that contesting the male partner’s decision for 
protection could result in a loss of financial support therefore they tend not to question the men’s 
sexual preference.  
 
Male participants also demonstrated awareness that lack of economic power places women at a 
disadvantage in negotiating safe-sex practices. When the researcher asked what type of women 
should use microbicides, KZN urban men answered; 
 
“Unemployment amongst women. If you don’t have a job you have no power to ask your 
male partner to use a condom if he does not want to, and you cannot break up with 
someone who does everything for you because he does not want to use a condom” 




“Unemployed women, because when you don’t have money you don’t have the power to 
ask your boyfriend to use a condom, what if he leaves you, so they can be protected if 
they use this product” (Female participant, Urban, KZN, April 2016) 
 
These participants are aware that factors such as poverty and unemployment make women 
vulnerable and desperate therefore they stay in relationships that expose them to risk of infection 
even when they are aware of the threat of HIV.  
 
The findings confirm reiterate previous research findings that revealed that financially 
disadvantaged women are unable to initiate discussions about sexual protection due to fear of 
losing financial assistance (Bentley et al, 2010). As argued in chapter two, money dictates sexual 
relationships (Parker, 2012), as men’s economic and structural advantage allows men to exert 
power over women by regulating or making decisions on their behalf, while women’s lack works 
as a compelling factor for women to engage in unsafe sex practices for survival (Parker, 2012; 
WHO, 2007). The findings show that women are concerned that using microbicides would result 
in economic abuse (Mouradian, 2010), whereby the male partner withholds economic resources 
or the threat of being chased from their homes. Female participants fear that using microbicides 
may be detrimental to the well-being of their relationships and pose a threat financial assistance. 
Addressing the HIV crisis therefore may be futile if women’s economic and structural positions 
are not addressed. 
 
Covert use may hinder uptake/ adherence 
Microbicides are designed to reduce women’s reliance on male partner cooperation for protection 
against sexually acquired HIV through the quality of covert use. Evidence from trials and 
qualitative studies indicate that covert use may be a challenge, particularly for women who live 
with their partners as using the products discreetly may not always be feasible. In this study, 
products such as the tenofovir gel and oral truvada were found unappealing due a demanding 
application regimen which they perceived as placing them at risk of being discovered by male 
partners. 
 
Hiding the products can prevent us from using them… like the gel, I can’t ask him to 
wait… Some men want to go with you to the bathroom, so what will I do when that 
happens? I can’t ask him to wait outside when I go to the bathroom, some men want to 
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come in with you… Some men do, he’s your partner so why not? (Female participant, 
Rural, MP, March 2016) 
 
“The pills may be a problem too. I am on the contraceptive pills but when my 
daily alarm goes off my husband always looks at me, as if he is wondering what 
the alarm is for” (Female participant, Rural, MP, March 2016) 
 
“You can’t keep such things a secret, especially if you live with him in in the same 
house” (Female participant, Rural, MP, March 2016) 
 
“The gel, it will cause me to be too wet, I don’t think I will be able to hide it, and 
he will ask why I am too wet. Sometimes he puts his hand in my vagina because 
he thinks I was having sex with someone. He will think I am cheating” (Female 
participant, Urban, MP, March 2016) 
 
“…the gel which I have to apply before and after sex. My husband will end up 
asking why I’m getting out of bed, so it would be difficult to hide it” (Female 
participant, Rural, KZN, April 2016) 
 
“You can’t keep such things a secret, especially if you live with him in in the same 
house. It won’t be a secret for long” (Female participant, Rural, MP, March 2016) 
 
The above findings also showed that although women’s control of microbicides may be achieved 
through secret use, it also has limitations as regular use may require some degree of negotiation 
between partners, which may hinder adherence. 
 
Low perception of risk may affect acceptance 
Diverse views were raised regarding the perception of risk to HIV, which thus impacts on the 
decision to whether to accept or in the case of men, to support the use of microbicides. Female 
participants demonstrated a high perceived risk of infection due to their partner’s risky sexual 
behaviours and their lack of power to enforce the use of condoms. Male participants demonstrated  
a low perception risk; as they expressed that they can detect whether or not the women they 
engage in intercourse with may be infected or not. This was demonstrated clearly in a response 




“It depends on the type of woman you are with at the time. For some women you can tell 
that I need to use a condom with this one because she is busy” (Male participant, Rural, 
KZN, April 2016) 
  
In the case of microbicides, male participants maintained that they were ideal for use by women 
in casual relationships rather than those in marriages or long-term relationships.   
 
I believe that if I am married to someone she is having sex only with me, so when she starts 
using these products saying that she is protecting herself… what is going to happen is, men 
never admit to cheating, so instead they will shift the blame to the woman, and ask why she is 
now using the products, and accuse her of not trusting him. So I would also suggest that it be 
used by young women (Male participant, Urban, KZN, April 2016) 
 
“I think those that are in casual relationships because they are the ones that are at high 
risk of infection” (Male participant, Urban, KZN, April 2016) 
 
“Sometimes when you are in a relationship with a woman for a long time, you don’t use a 
condom. And they cannot start asking you to use it after a long time” (Male participant, 
Rural, KZN, April 2016) 
 
“Once people live together, they stop using protection” (Male participant, Rural, MP, 
March 2016) 
 
“At home we don’t use a condom because she is my wife… I mean what are we 
protecting ourselves from? The condom is very tight, you can go on for hours and not 
feel anything, so my wife knows, we don’t use a condom” (Male participant, Urban, MP, 
March 2016) 
 
“What is she protecting herself from? Does she think I am sick?” (Male participant, 




“I think for married women, this things would result in divorce, so rather it be used by 
young people because they are always out at night doing things” (Male participant, 
Urban, KZN, April 2016) 
 
Interestingly, some female participants shared the same views; 
 
“In my opinion, I think prostitutes and girls that like parties, because they are usually the 
ones who have sex anywhere and anytime. I’m not saying other women should not use 
them though” (Female participant, Rural, MP, March 2016) 
 
“The truth is that men will not allow us to use these products, he will say that it means 
you are cheating, who are you protecting yourself from because you are married to 
him?” (Female participant, Rural, KZN, April 2016) 
 
Young women because they are highly infected because if you look at married women, it is 
married men who are cheating, even when they do, women can take it, but you would find that if 
a young person finds out that her boyfriend is cheating she will go and do the same thing their 
partner is doing, and when that happens the disease spreads. We also attend parties, and we 
engage in one night stands. I won’t have a problem if I engage in a one night stand when I have 
my ring on. So I think the target should be the youth (Female participant, Rural, KZN, April 
2016) 
 
These responses reiterate the argument in chapter two, that misconceptions of low risk of 
infection amongst people in long-term relationships are due to notions of trust, commitment and 
familiarity. This shows that people’s interpretations of risk are influenced by social perceptions of 
the nature of relationships they engage in. Such beliefs breed misconceptions perpetuate unsafe 
sexual behaviours (Stern and Buikema (2013), which stand as an influential factor towards 
microbicide acceptance amongst married and long-term partners. The findings are consistent with 
a study amongst female sex workers (FSW), which found consistent gel use with clients and 
casual sex partners and much less frequent with primary partners (Greene et al, 2010). These 
findings indicate low acceptance of microbicides by people in long-term relationships, and a 




Health care workers- A barrier to uptake of microbicides 
Microbicides are set to be integrated into the public health system as with existing programmes 
such as family planning and HIV treatment. However participants foresee potential hindrances in 
the uptake of microbicides due to some factors within public healthcare facilities. 
 
“Some nurses in clinics are very judgmental, especially towards young people like me. 
They will say ‘you are so young but you are already having sex’, they also threaten to go 
and tell your parents. That can make young people to be afraid to go to the clinic and get 
these products” (Female participant, Urban, MP, March 2016) 
 
Participants expressed that negative attitudes from healthcare workers could hinder the uptake 
of microbicides, particularly amongst younger women. The greatest problem is that some 
healthcare workers in local health care facilities are members of the communities they serve, 
which may cause young women to be reluctant to visit the clinics due to fear of being judged and 
the possibility of their parents and the community knowing about their sexual matters.   
 
A study amongst UKZN female students found that participants felt that if the dapivirine ring 
involved going to the clinic for insertion then that would be a point of discouragement due to past 
experience with healthcare workers (Nota, 2016). This suggests that young people, particularly 
younger women do not find local health care facilities welcoming. This discourages them from 
seeking health services particularly in local healthcare facilities where they may be familiar with 
the clinic staff; as observed in a study by Kauffman and Lindauer (2004). This stands as an 
important point that requires proper examination to make possible acceptance of microbicides 
amongst young women. First and foremost, rreviving the concept of youth-friendly health services 
seems a plausible entry point to ensuring acceptance and uptake amongst young women 
(Grimsrud et al, 2015). Responding to such dynamics, Van der Straten et al (2014) opines that 
social motivation for PrEP products must be supported across all levels of the social system, this 
includes health care workers.  
An interesting view regarding segregation of patients in health care facilities was raised by a male 
participant from KZN urban. 
 
Don’t you think these products will cause discrimination between people who are infected and 
those that are HIV negative? For example, people who are collecting their ARV’s in clinics are 
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made to sit alone, and other people can see that they are HIV positive, now there will be people 
who collect this product for prevention (Male participant, Urban, KZN, April 2016) 
 
This view suggests that HIV intervention programmes tend to perpetuate discrimination between 
HIV negative and positive people. Participants are concerned that the roll-out of prevention 
products in local clinics may perpetuate the discrimination experienced by HIV positive people, 
who are segregated according to the purpose of their visit in healthcare facilities. The major 
concern is that knowledge about people’s HIV status, as well as other related health issues such 
as STI screenings and family planning is compromised due to a lack of efficient organizational 
skills in local healthcare facilities.  
 
This finding is consistent with previous studies that found healthcare workers as the greatest 
impediment to healthcare access and utilization by community members (Nyblade et al, 2009).  
Recent research (Kubicek et al, 2015) highlighted that biomedical approaches such as 
microbicides require sustainable behaviour change and that calls for change in both the providers 
and users of the programme. Effective roll-out of microbicides therefore can be realised through 
further examination of these findings, look into simplifying the distribution process. Issues of 
comfortability and confidentiality in healthcare facilities, as well as the addressing the challenges 
posed by healthcare workers residing within the communities they serve.  
Male involvement in microbicide use  
Evidence from research informs us that women often face challenges with initiating or enforcing 
the use of barrier methods such as condoms due to power dynamics in heterosexual 
relationships. Similarly, evidence from trials indicate women’s inability to utilise microbicides, 
despite it being a FIPM for HIV, despite the possibility of covert use. This theme discusses the 
impact of male involvement in microbicides as a FIPM for HIV. 
 
Women prefer to disclose microbicide use 
The inability of women to negotiate condom use to prevent HIV is a key reason for the introduction 
of a FIPM like microbicides however, a number of studies indicate that women prefer disclosing 
microbicide use with their male partners. In this study, female participants expressed a desire for 
a prevention method that allows them total control over HIV however, they demonstrated 
reluctance to accept microbicides if it meant using them without the male partner’s knowledge. 
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This came up when the researcher asked female participants whether they would disclose or 
conceal the use of microbicides with their male partners; to which they responded: 
 
“I cannot do something he does not know, I have to tell him about it, and explain why I 
want to use it” (Female participant, Rural, MP, March 2016) 
 
I don’t think he would take it well. It would seem like I’m being unfaithful, so that’s the reason I 
said I would tell my partner. I think love grows when there is communication between two 
people. Not being able to discuss such things with the person you are in a relationship with 
means that you don’t trust them, and you also don’t trust yourself (Female participant, Rural, 
MP, March 2016) 
 
“Men in this community have an old- fashioned mind set. If you don’t tell him, he could 
take it as though you are now keeping things from him” (Female participant, Rural, KZN, 
April 2016) 
 
“I would tell him because men in this community are very traditional, so much that he 
does not come close to me when I am on my periods, so I would have to tell him 
because he has such beliefs” (Female participant, Rural, KZN, April 2016) 
 
I think if it’s a serious relationship, like a partner I live with at home then I should be open about 
using the products but if it’s not serious there is no need to tell him. You can explain to your 
husband what the product is, and that you want to use it so you can be protected because if you 
are not open about it and he finds out, it may destroy your marriage (Female participant, Rural, 
MP, March 2016) 
 
These responses indicate that despite the availability of products that demonstrate increased 
discreet use, women feel a strong sense of obligation to discuss microbicide use with their 
partners. The need to disclose microbicide use is informed by concerns for their relationships, 
while KZN rural females were concerned about going against men’s cultural beliefs. The 
importance of communication and transparency was strongly emphasised, particularly for long-




The findings confirm a large volume of acceptability studies that revealed that although women 
understand the choice of covert use, they prefer to talk to their partners about using the 
microbicides (Lanham et al, 2014). This also confirms observation that women in developing 
countries are unequipped for sexual decision- making, hence the inability to make independent 
decisions for the use of microbicides. Interestingly, the findings contradict the global plight for an 
HIV prevention method that’s grants them total control over their protection against HIV (Mantell 
et al, 2006).  
 
Pool et al (2000) argues that men’s dominance in sexual matters is linked to women’s feelings of 
disempowerment. Women do not feel that they have control over their sexual and reproductive 
health even when they would prefer to use other prevention methods like the female condom or 
microbicides. The findings demonstrate conflict between women’s sociocultural defined roles as 
wives and girlfriends and their acknowledged right to independent protection against HIV (Mantell 
et al, 2009). Cultural gender socialisation of women is apparent in this regard (WHO, 2007; DOH, 
2012; Burger, 2005), where women may have the power to have control over their protection 
against HIV, however they still require the men’s consent for use. Walker (2005) observes that 
legislated ‘constitutional sexuality’ does not necessarily lead to erosion of longstanding traditional 
values and roles, nor to immediate shifts in gender relations. Rather, Walker (2005) extends, 
traditional and modern gender norms co-exist in South Africa, as apparent in the views of women 
in this study. Drawing from one of the theories employed in this study, the CCA (Dutta, 2008), it 
is evident that women’s cultural contexts need be explored further, to understand how 
microbicides can be effectively introduced in various cultural communities.   
 
Covert use may result in unacceptability amongst men  
Male participants expressed negative views regarding the quality of covert, articulating that it 
would be unacceptable for women to use microbicides without the male partner’s knowledge or 
consent. Some men feel that finding out that their partner is using microbicides without their 
knowledge would destroy trust in their relationship, as they would suspect that the woman has 
other sexual relations outside the relationship. Some think it may even result in abuse, because 
they believe if microbicides were not harmful, then there would not be a need to hide them while 




This was revealed through the comments below, elicited when the researcher questioned male 
participants what their reaction would be if they would find out their partner was using microbicides 
without their knowledge; 
 
“It wouldn’t be okay because, when two people are married, or in a relationship there is a 
principle that we do not keep secrets from each other. Where she will insert these 
products is where I have to get in, so why must she keep it a secret from me?” (Male 
participant, Rural, MP, March 2016) 
 
“I also would not allow her to use it if she does not tell me, especially if I happen to see 
the pills or the gel by accident. I would think that she is busy with other things on the 
side” (Male participant, Rural, MP, March 2016) 
 
“I think it is totally wrong for women to use these products without the men knowing. A 
woman should not put something in her vagina and not tell the man because sex is 
between them. Why do they even suggest that?” (Male participant, Rural, KZN, April 
2016) 
 
“If these products are not harmful then they should not have any difficulties telling us 
men, because when I find out it will raise suspicions as to why she was keeping them a 
secret” (Male participant, Rural, KZN, April 2016) 
 
“She would die if she uses this product without me knowing, especially with those men 
that beat up women” (Male participant, Rural, KZN, April 2016) 
If I found out that my girlfriend was using these products in secret... that could destroy my trust 
because I would think that if anything happens, I t would be because of the products she is 
using. So I think we need more information on these products so I think it would be better if she 
applied or used these products at home (Male participant, Urban, KZN, April 2016) 
 
“I think it shouldn’t be kept a secret. We should discuss it first and be in agreement 
because If she does not tell me I will think there are other things that she is doing that I 




Contrasting the dominant views of KZN rural and MP rural men, a low proportion of men from MP 
rural articulated that women should be allowed to make independent decisions for their protection 
against sexually acquired HIV. 
 
“I think no one is 100 per cent faithful as we all make mistakes, so we should all be free 
to use whatever products work for us to protect ourselves” (Male participant, Rural, MP, 
March 2016) 
 
I believe anyone above 18 years is old enough and they are responsible for their own 
protection. A man does not have the right to dictate a woman’s choice with regard to her 
protection because a male is a male, and a female is a female, and both people face different 
challenges, you see. I think the woman can keep this a secret, and when a man finds out she 
can explain it to him, if the woman is independent then I think it would be better to pack her 
bags and leave (Male participant, Rural, MP, March 2016) 
 
“I think that she has the right to make her own decision, as long as there is transparency 
and communication, that ’baby I have decided to do this’, there is nothing I can do to 
prevent her from doing it” (Male participant, Rural, MP, March 2016) 
 
These responses suggest that in some cases women may be able to adopt the use of FIPM such 
as microbicides. Supporting this finding, Mantell et al (2006) rates that such enabling 
environments are key to ensuring acceptance and effective utilisation of microbicides amongst 
women.  
 
Open use may facilitate acceptance and support amongst men 
Although discreet use of microbicides may be achievable for some women, sustainability may not 
be achievable. Male participants believe that male support can be achieved if women are up-front 
and transparent about using microbicides. Male participants stated that they could assist women 
by reminding them to use the products, and about their clinic dates to collect the products. 
Discreet use on the other hand is perceived as posing challenges for adherence as women may 
not be able to use them in the men’s presence.  
 
“I can remind her to go to the clinic, or tell her to take her pills, or even help her to put 
the gel but if I don’t know… she will be afraid to use the gel, because you see 
139 
 
sometimes we want to have sex, and she does not know, and I don’t want to wait” (Male 
participant, Urban, MP, March 2016) 
 
“Your partner can remind you to go to the clinic and get your supplies, maybe help you 
to insert the gel” (Female participant, Rural, KZN, April 2016) 
 
“I would have to ask her if she has applied the product before we have sex” (Male 
participant, Urban, KZN, April 2016) 
 
“What I think can be the best option, so that there won’t be any secrets in our homes, I 
think it’s best to talk about using the products, at least women can be able to use the 
products freely” (Male participant, Rural, MP, March 2016) 
 
The findings confirm other previous findings (Dayton et al, 2014; Mngadi et al, 2014); that found 
that male involvement impacts positively on acceptance and utilisation of microbicides amongst 
women. The VOICE-C study found consistent use of microbicides to be higher amongst women 
whom their partners have knowledge of their use of the products (Montgomery et al, 2010). The 
CAPRISA 004 trial also noted a relation between explicit use and women’s adherence to the 
tenofovir gel (Mngadi et al, 2014).  
 
Information can encourage acceptance amongst men 
Educational information is considered to be critically important to men’s acceptance of 
microbicides. Both males and females expressed that expressed that they would like for men to 
be provided with sufficient information about microbicides. Women expressed that they think 
microbicides can be easily accepted by men if they are explained to them by health professionals, 
as the message will have more credibility as compared to than when it is introduced by women. 
Women feel educating men could work in their favour by eliminating suspicions of infidelity and 
more particularly in the case of KZN rural, information amongst men can eliminate confusion 
about vaginal enhancement practices in the event that men discover microbicide use as they 
would have knowledge of the products. 
  
“It’s very important that information about these products is also made available to men 
as well, so they know how they must live to remain healthy and HIV negative” (Female 




“What is important is that they should also be educated about these products, so that 
they will know, so they won’t accuse us of cheating. If he doesn’t want to understand, let 
him be and carry on taking your product” (Female participant, Urban, MP, March 2016) 
 
“He won’t understand it. I think if you want your partner to know take him to the people 
who sell it, the clinic or the doctor, maybe he can understand it, because honestly if I 
come and show him that container, he will think that I want to boost my vagina” (Female 
participant, Rural, KZN, April 2016) 
 
“I personally think I need to tell my boyfriend or husband so that even if we experience 
some problems he will know that it is because of this product I am using” (Female 
participant, Rural, KZN, April 2016) 
 
I think information is very important because in a case where he finds out that you are using the 
products, knowing about them can help because at least he will know what they are for, 
because men discuss such things, so he won’t think you are trying or using ‘muti’ to make your 
vagina more nice (Female participant, Rural, KZN, April 2016) 
 
“We must encourage one another, talk about it openly at home. Also when one person 
comes and introduces it at home, the other person can say I have seen this before, so 
there is no need to use it in secret because we will both have some form of knowledge 
about it” (Female participant, Rural, KZN, April 2016) 
 
Men expressed that if they are provided with sufficient information regarding microbicides, they 
also would be able to introduce them to their female partners by reminding them of other possible 
ways of getting infected such as sexual assault. 
 
“I think educating men about the products, raise awareness in both men and women. I 
think that would help because men will not think that women are cheating when they 
suggest to use these product” (Male participant, Rural, KZN, April 2016) 
 
“This is a good initiative however women should tell us about using these products. If its 
gonna take her to take me to the clinic for information and training then she must do it 
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because it is important for them to be open about it however” (Male participant, Rural, 
KZN, April 2016) 
 
“I think information is very important because in a case where I finds out that you are 
using the product, knowing about them can help because at least I will know what they 
are for, because men talk about such things, so at least he won’t think you are cheating” 
(Male participant, Rural, KZN, April 2016) 
  
An interesting view on male support came up in the discussion amongst KZN rural males,  
 
“I can try to introduce it to her, try to explain to her the other possible ways of getting 
infected, things such as rape… Women also cut their hair, or tweeze their eyebrows 
using a razor, sometimes using the same blade” (Male participant, Rural, KZN, April 
2016) 
 
Consistent with previous findings (Dayton et al, 2014), participants expressed the need for men 
need to be taught about microbicides, as they believe it could minimize suspicion of infidelity and 
other problems where men mistake microbicides for products such as snuff, which women often 
use to enhance their vaginas for the men’s pleasure. Furthermore, studies show that male 
involvement can increase community acceptance and reduce stigma around the product, improve 
communication about sexual matters and increase shared responsibility for protection (Woodsong 
2006; Montgomery 2011; Schuler et al, 2013; Montgomery et al, 2010). A study by Zulu and 
Chepngeno (2003) found that couples who had access to HIV and AIDS information were more 
likely to have discussions on sexual risk and protection, The study also confirms a study on 
contraception, Sharon Edwards (1994) noted that the participants believed that men will only take 
responsibility for family planning methods if they are considered as having as much responsibility 
as women for reproductive health care.  
 
Male-Supported or Female-Initiated prevention methods? 
Much controversy has come forth regarding the issue of male involvement in microbicide use. 
The argument is whether involving men would be favourable or further disempowering to women’s 
agency for their protection against HIV. The decision to involve men in this study was encouraged 
by the need to examine the impact of male involvement in acceptance and promote utilisation and 
adherence amongst females. As argued in Chapter Two, intimate partners have great influence 
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on behaviour change (Mathew, 2012). The influence of partners in adopting microbicides was 
also discussed in this current study during discussions on the issue of covert use. Female 
participants stated;  
“But let’s be honest, some men will not allow their women to use these products” 
(Female participant, Rural, MP, March 2016) 
“And once you tell him that you are using these products they might ask what it’s for, and 
you’ll have to tell them that they are for HIV prevention… then they will say no” (Female 
participant, Rural, MP, March 2016) 
“What can I say… he won’t be happy about it, but he would also not allow me to use the 
products if I told him so, I would not tell him” (Female participant, Rural, MP, March 
2016) 
“Why would you even tell him? Some women do not think carefully about things, you 
can’t tell your partner that you are on contraceptives because he won’t allow you. It’s 
going to be the same with these things” (Female participant, Rural, MP, March 2016) 
“I would not tell him because men have a lot of questions, and even when they know 
about something, they do not allow us to do it” (Female participant, Urban, MP, March 
2016) 
 “I would not tell him because men have a lot of questions, and even when they know 
about something, they do not allow us to do it” (Female participant, Urban, KZN, April 
2016) 
 “Our partners don’t even want to see the family planning card, so how much more with 
microbicides?” (Female participant, Rural, MP, March 2016) 
Some women were afraid disclosing microbicide use would result in men making excuses to use 
against utilisation. This was captured from the following responses: 
“That’s where the problem is… that when you tell them, for instance with the 
contraceptive injection, they say things like your vagina is not tight enough, but when 




“I think hiding the products is good because, once you tell him, he will start noticing even 
the smallest things when you are having sex. He will complain about side effects” 
(Female participant, Rural, MP, March 2016) 
Female’s views on the issue of disclosing microbicides includes the fear that men would object to 
using them. Drawing from their experiences with female-centred programmes such as family 
planning, women demonstrated certainty that men would be against microbicides use. This 
observation is supported by other studies (Mantell et al, 2005; Nota, 2016), that offering women 
uncontested protection may be perceived as posing a threat to men’s dominant positions in 
relationships and in sexual decision-making. Other studies (Lanham et al; 2014, Moodley, 2007) 
caution against the possibility of diminishing women’s autonomy to decide whether or not to adopt 
the use of microbicides. This finding therefore sustains the recommendation to promote “Male-
Supported Female- Initiated” (MSFI) methods (Govender and Nota’s, Forth coming), rather than 
the previously proposed female-initiated prevention methods (FIPM) methods.  
 
Summary of findings 
The findings revealed; 
- Varying product acceptability amongst men and women- based on product characteristics, 
the dosing regimen, and the application process. 
- Long-term, less user-reliant products and non-interference with male sexual pleasure are 
key to the success of PrEP products. 
- Male sexual pleasure precedes the need to protect against infection 
-  The study also found that partial efficacy is deemed futile. 
- Women are not empowered to make independent sexual decisions 
- Covert use of microbicides is not the most appealing quality, perceived as impractical and 
culturally inappropriate, and potentially harmful for women. 
- While male involvement has the potential to promote acceptability and uptake in other 
contexts, it can be detrimental in other contexts- taking away from the initial goal of 
microbicides to empower agency and autonomous decisions for sexual protection 
amongst women. 





CHAPTER SIX: DISCUSSION 
 
Introduction 
This study explored the perceptions of men and women across urban and rural settings in Durban 
and Nelspruit towards microbicides as female-initiated HIV prevention methods for women. A 
major part of this research sought to build on a paucity of studies assessing the impact of male 
involvement in female-initiated prevention methods (FIPM), as well identifying if doing so can help 
in promoting and acceptance and uptake of microbicides amongst women. 
 
The study was located within the Social Ecological Model of Communication Health Behaviour 
(SEMCHB) and the Culture-Centered Approach (CCA), examining women’s acceptability and use 
of microbicides amongst the greater structures of social networks and the community, while also 
examining microbicides viability within the various cultural contexts. The SEMCHB and CCA 
proved to be appropriate frameworks to examine the perceptions of males and females towards 
microbicides. At the core of the SEMCHB is the importance of understanding the impact of various 
structures of social networks, the community and society on individual behaviour change. While 
environmental factors such as socio-cultural, structural and economic factors also have the 
greatest influence on health behaviour. Central to the CCA is the notions that the best approaches 
to HIV prevention should create platform for the people whom the intervention programme is 
designed. This approach leads to the understanding that these biomedical tools must be culture-
sensitive in order to be relevant and effective for women in diverse contexts. These theories 
therefore assisted in examining the perceptions of microbicides through various structures of 
influence.  
 
The data was gathered through the CCA, which encouraged dialogue and critical thinking 
amongst the male and female participants on the subject of microbicides as FIPM. The data was 
analysed through thematic analysis, which involved re-reading the data and searching for 
recurrent themes and thereafter discussing the data under the identified themes. This chapter 
thus provides a discussion of the study findings captured through the following themes:  
  
1, Perception of microbicides; 2, Microbicide: Varying product acceptability between males and 





In the next section of this chapter, the discussion will be systematically presented under each of 
the study’s objectives below:  
 
To investigate men and women’s perceptions of microbicides as a female-initiated HIV 
prevention method. 
In investigating the perceptions of microbicides, the study found generally positive views and 
attitudes towards microbicides as a possible prevention method against HIV. A large proportion 
of male and female participants from all study settings were aware of the risk of HIV infection 
amongst women. It is encouraging therefore to note that participants comprehend the need for 
additional prevention methods for protection against HIV acquisition, especially in the absence of 
an effective HIV and AIDS vaccine.  
The possibility of options to be provided by microbicides in the near future was perceived 
positively women across all settings, as they expressed a need for prevention methods that offer 
them heightened control of their protection against HIV. Reasons provided in support of 
microbicides included the inability to initiate condom use due to the fear of physical or financial 
abuse, alcohol use- often resulting in non-use of the condom, and challenges with using the 
female condom covertly. Other reasons were due to the desire to have the option to choose a 
product that aligns with one’s lifestyle. Confirming the widely acknowledged need for multiple 
prevention methods so as to widen prevention options for women, thus increasing their ability to 
protect themselves against HIV (Peters et al, 2010).  
Further evaluation of participant’s perceptions towards microbicides yielded negative views 
amongst men. Despite knowledge of high risk of infection, a large proportion of men reported that 
PrEP products should be used only by younger women, uncommitted women and promiscuous 
women. These findings are disturbing, as a high proportion of men admitted to engaging in 
multiple and concurrent sexual relations. Some male participants stated that protection is not used 
for all sexual acts, but only with women they believed to be promiscuous therefore this entails a 
high risk of infection. For married and cohabiting women, this may present an even greater risk 
as the norm across all settings remains that barrier methods are not to be used in such 
relationships. The results are consistent with those of other studies (Woodsong, 2004; Greene et 
al, 2010), in which barrier methods were viewed as inappropriate for use by married couples or 
people in long-term relationships.  
The study also found that the production of products that offer partial efficacy is a futile attempt 
towards HIV prevention. A fatal attitude was noted amongst men who perceived microbicide’s 
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partial efficacy as providing false hope for protection. The requirement to be used in conjunction 
with the condom was perceived negatively. Male participants demonstrated possible risk 
compensation due to the preference for unprotected sex. The results demonstrate a high 
probability of condoms being substituted for PrEP products. The results therefore suggest that 
men’s acceptance of microbicides would be encouraged by perceived ability to engage in 
condom-less sex. While this may encourage the use of microbicides, it can also be detrimental 
as women would still be partially exposed to HIV. This affirms a study by Woodsong (2004), that 
male involvement may impact negatively on women’s autonomy for protection; as they may be 
forced into using microbicides unwillingly by men who prefer microbicides over condoms 
(Woodsong, 2004).  
 
Long-term protection and non-interference with sexual pleasure appears to be key to the success 
of PrEP products. Varying product acceptability, based on the product characteristics, dosing 
regimen, and the application process. Both male and female participants in all study settings 
demonstrated a substantially high acceptance for the injectable PrEP.  Four main reasons largely 
accounted for the preference to use the injectable: the familiar dosing strategy, its feasibility due 
to long-term protection, accommodative of spontaneous sex and non-interference with male 
sexual pleasure.  
The study found that microbicide use may be challenging for married and cohabitating couples. 
Daily oral truvada was considered safe and familiar however, daily intake is not the most 
appealing quality. The findings suggest that oral truvada may not be easy to adhere to, mainly 
due to the possibility of failing to adhere to routine. The tenofovir gel’s dosing regimen is found 
unappealing and impractical. Concerns included the likelihood of not being able to use the gel for 
every sexual encounter, as sex is mainly unanticipated. The lubricative properties were of greatest 
concern. For female participants, excessive wetness of the vagina could result in of 
unfaithfulness, while male participants were more concerned about how it could affect their sexual 
pleasure, due to the dominant preference of dry sex. The dapivirine ring was found to be a 
considerable option, after the injectable, mainly due to the long-term protection offered however, 
the product characteristic and its application process was found undesirable by a high proportion 
of men and women. Women are worried that the ring may be uncomfortable, that it may fall out 
or that the male may feel it during sex. Men on the other hand disapprove of a product that is 
applied through the vagina, this includes the tenofovir gel. In the case of KZN rural men, the dislike 
of vaginal application is informed by the trend of vaginal practices for vaginal enhancement 
amongst women in the community. Products such as tenofovir gel and the dapivirine ring 
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therefore are most likely to be rejected in such contexts. The most preferable product was the 
injectable, due to the long-term protection which is perceived as addressing issues of 
spontaneous sex, frequent clinic visits or the possibility of being discovered by the male partner. 
The findings are consistent with those from another microbicide acceptability study (Ramjee et al, 
2001), which found that men were against prevention methods that interfere with sexual pleasure. 
The findings suggest that the proposed microbicide products may still not be sufficient for effective 
prevention of HIV amongst women. Women desire a long-term, less user-reliant prevention 
method, with a desirable application regimen that does not include vaginal insertion or application, 
or affect sexual pleasure. 
Identify the underlying socio-cultural, economic and structural factors that may 
impede acceptance and utilisation of microbicides as an HIV prevention method. 
Given the patriarchal and cultural context of South Africa, perceptions of covert use of 
microbicides as an unappealing quality were common amongst male participants. The greatest 
factor influencing men’s decision against microbicides is the perceived threat it hovers over men’s 
dominant positions in sexual relationships. The main reason informing this view is the control of 
discreet use that microbicides offers women, perceived as having the likelihood to encourage 
unfaithfulness amongst women due to uncontested protection. Men’s concerns about the potential 
of infidelity amongst women overshadows the acknowledged need for women’s protection. 
Overall, men demonstrated a sense of entitlement to being informed and involved in the decision 
to use, and about which product to use, if at all utilisation is allowed. 
The findings are consistent with Nota’s (2016) study that men are likely to be against microbicides 
due to the perceived threat over men’s dominant position in sexual decision-making. Therefore it 
is evident that women’s decisions to use protection is influenced by various notions nested within 
gender inequality (Beksinska et al, 2012). 
For women, the utmost pronounced difference was on views regarding covert use. Although 
women demonstrated a clear understanding of the option of discreet use. A high proportion of 
women were against discreet use of microbicides due to issues of communication, trust and 
commitment, particularly in long-term relationships. Older women in particular demonstrated an 
obligation to disclose microbicide use, while younger women demonstrated more empowerment, 
expressing that they do not require the male partner’s permission for use. The findings show that 
women in these settings are not empowered to make independent decisions on sexual protection. 
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Cultural and socio-economic imbalances between men and women were identified as key barriers 
to acceptance of microbicides, the cultural aspect applying mostly in KZN rural.  
Moreover, high proportions of women across all settings in this study expressed concerns on 
adherence when microbicides are used covertly. Concerns included not being able to use 
microbicides in the men’s presence which could hinder adherence, the inability to store the 
products at home, and the constant worrying about being discovered by the male partner, which 
could result problems in relationships- IPV, financial abuse, etc.  
Explore the impact of male involvement in acceptance and use of microbicides. 
The study found that male involvement in the use of microbicides has complexities. The results 
indicate that including men could encourage acceptance and uptake however, there is likelihood 
that doing so could be detrimental; as it could take away from the initial goal of empowering 
women to make independent decisions for their sexual health. Although male involvement has 
been found to be successful, and is increasingly encouraged in promoting acceptance and use of 
microbicides (Lanham et al, 2014; Kelly et al, Mngadi et al, 2014), the findings indicate that it 
needs to be explored further because, as with covert use, this recommendation may not be 














CHAPTER SEVEN: CONCLUSIONS AND RECOMMENDATIONS  
 
Introduction 
The first chapter sought to highlight the statistics relating to HIV and AIDS prevalence globally 
and more particularly in South Africa. The second chapter reviewed literature on HIV amongst 
women, the underlying factors that perpetuate women’s susceptibility to HIV infection, the history 
of prevention strategies and methods for women to date, microbicides as possible female-initiated 
prevention methods (FIPM) and the issue of male involvement in microbicide use. In Chapter 
Three, the study is placed within an ecological perspective, whereby Kincaid et al’s (2007) Social 
Ecology Model of Communication and Health Behaviour (SEMCHB) was employed and within the 
Culture-Centered Approach (CCA). The perceptions on microbicides were thus examined within 
the greater structures of social networks and the community and the various cultural contexts. 
Chapter four discussed the research methods and data collection procedures employed in the 
study. The research methods included a case study as a research design under the qualitative 
approach, using focus group discussions (FGD) for data collection and thematic analysis for 
analysing the data. Chapter five provides an analysis of the data under the study objectives to 
show the success of the study in in relation to its objectives. In chapter five, a discussion of the 
findings is presented. In the final chapter (Chapter Seven), an overall conclusion for the study is 
provided, as well as recommendations for future research.  
Conclusion 
While the development of microbicides has brought hope that the HIV crisis amongst women can 
be controlled, the effectiveness of these new prevention technologies can only be realised when 
there is acceptance as well as correct and consistent use amongst women. In addressing the 
issue of decision-making for protection, efforts should be extended to understanding relationship 
power dynamics in heterosexual relationships and how these can impact on women’s acceptance 
and up-take of microbicides as prevention methods for HIV. 
 
While there is an acknowledged need for male involvement, it is critically important that the goal 
to empower women is not neglected. Greater emphasis should still be placed on empowering 
women to make independent sexual health decisions in cases where involving men could be 
detrimental. Overall the findings argue that while male involvement may yield positive outcomes 
such as adherence and partner support in some settings, this may not be achievable in some 
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In view of the above-mentioned findings, the following recommendations are made: 
1. Focus on empowering independent decision-making amongst women 
Firstly, the recommendation to promote partner support needs to be explored further because it 
may not be feasible for all women. Presenting and promoting microbicides as requiring male 
support may be misleading, resulting in misinterpretations where male partner involvement is 
understood as a requirement and therefore resulting in challenges for women who choose not to 
disclose. As a result, the decision on how to use microbicides should be left at the hands of 
women, as an option (Nota, 2016). Much emphasis however must be placed on empowering 
women to make independent sexual decisions without involving the male partner. 
2. Further exploration of the impact of male involvement in microbicide use 
Inconsistencies regarding the quality of covert use amongst women call for further assessment of 
what works for women. While covert use is desired for ensuring adherence, this however may not 
be achievable when microbicides are used covertly. On the other hand, disclosing microbicide 
use may further disempower women, as it could take away from the initial goal of empowering 
women to make independent decisions regarding their protection against sexually acquired HIV. 
Development and policy makers have a task to explore the issue of male involvement, in 
identifying effective solutions for cases where the attempt to involve men harvests unfavourable 
results.  
3. Focus on possible risk compensation 
It is critically important to understand that demonstrated acceptance of microbicides amongst 
women may not translate into adoption or use, while use may not necessarily entail protection. In 
a context where the use of condoms is at a decline, due to preferences for unprotected sex, the 
use of microbicides may be as detrimental as non-use of condoms, if not worse. It is apparent 
that microbicide use may substitute the use of condoms as prevention methods against HIV 
infection. Development planners need to specifically and specially target marital and cohabitating 
couples, offer partner-tailored informational and educational programmes to create and increase 
understanding of microbicides on both partners, so as to eliminate non-use of condoms once 











Appendix 2: Focus group guiding questions 
 
The study will consist of twelve focus groups that will each be an hour and a half long. Each focus 
group will comprise of eight to ten participants, four of which will be males only, another four being 
females only, as well as four mixed groups with an equal number of males and females. The 
researcher will start by providing background information on microbicides in order to ensure that 
the participants understand the subject of the study they are being questioned about. The 
researcher will make it clear that no product will be administered or promoted, this is simply 
research on the people’s perceptions on microbicides. Participants will be told upfront that these 
products are undergoing clinical trial and are no available and may not be available in the future, 
we just want to gain insight into what they think about the product if it was to be available. The 
researcher will start by asking more general questions such as the participant’s knowledge about 
HIV, other female prevention methods and then move onto microbicide studies. 
 
 
Questions for female participants 
 
 
1. What knowledge do you have of the HIV pandemic amongst women? 
 
- Do you know of any female-centred HIV prevention methods? 
- Do you think those methods are enough, considering the high rate of HIV infections 
amongst women? 
- Do you think those methods have been successful in preventing new HIV infections 
among women? 
- Do you think there is a need for more HIV prevention methods women can use? 
 
2. What are your views and opinions about microbicides as a future prevention method for 
HIV amongst women? 
- Who do you think should use microbicides? 
-  
- What are your views about the ability for microbicides to be used by females without 
the male partner’s knowledge? 
- Do you think microbicides are practical for women all women, or is there still a need 
for more context- specific prevention methods? 
 
3. What are the factors that you believe may prevent women from using microbicides? 
- How do you think these factors can be addressed to ensure effective use of 
microbicides? 
 
4. What would your male partner’s reaction be if he were to discover that you are using 
microbicides? 






Questions for male participants 
 
1. What do you know about HIV? 
 
2. What are your views on available prevention methods for HIV? 
- Do you think those methods have been effective in preventing new HIV infections to 
date?  
- Do you think there is a need for diverse HIV prevention methods, including ones that 
women can use? 
3. How different do you think PrEP products are from available prevention methods such as 
male and female condoms? 
- Which microbicide product would you prefer your female partner to use? 
- What motivates your choice? 
- What do you think of the other products in relation to your sex life- (convenience, 
comfort, etc)? 
 
4. What are your views about the ability of microbicide to be used without the male partner’s 
knowledge?  
- Do you think females should consult their male sexual partners about utilizing 
microbicides? 
- What would your reaction be if you were to find out your female partner was using 
microbicide without your knowledge? 
 
5. Would you support your female partner in using microbicides? 
- Do you think you can influence your partner’s decision to use microbicide? 
- What role do you think you can play in encouraging your female partner to acceptance 


















My name is Londeka Mbewe, I am writing to request your participation in a research project 
titled Microbicide acceptability and utility study: Investigating perceptions of men and women 
across urban and rural settings in Durban and Nelspruit. 
 
The study is conducted under the supervision of University of KwaZulu-Natal Centre for Culture 
and Media in society (CCMS), under the supervision of Dr Eliza Govender. The study sets out to 
identify the feasibility of microbicides in HIV prevention amongst women in urban and rural 
settings.  
 
You are therefore requested to participate in a focus group discussion that will take place at 
………………………. On … The day of ………………..…2016.  
The duration of the focus group will be an hour and a half long, commencing at 13h00pm to 
14h30pm. I am requesting your permission to record the focus group proceedings for the 
purpose of this research.  
 
The data obtained through the focus group will be kept securely for a period five years for 
purposes of verification by the supervisor, Dr Eliza Govender, at the University Of KwaZulu-
Natal. Should the participants’ request it, an electronic copy of the final thesis will be sent to 
them on completion. 
 
Participation in this study is voluntary. Participants will not be paid for in money, however, they 
will be provided with refreshments. Participants may withdraw from the research at any time 
without any negative consequences. In general, responses will be treated in a confidential 
manner however, participants are urged not to disclose any personally sensitive information 
during the research proceedings. I will not use confidential information without the participant’s 
permission. Participants will be treated with respect and dignity, and they will not be deceived or 
tricked into reality information unwillingly. I will provide a consent form that includes approval for 
publishing names, in a case where the respondents have asked for anonymity, they will be 
referred to by a coded number system or pseudonyms.  
 
Please note that this HIV prevention method that is still undergoing various clinical trials, 
therefore there are no licensed microbicides available in the public health service at the 
moment. The importance of the study lies in uncovering the underlying factors that may impede 
or facilitate the use of microbicides. The purpose is to identify ways in which to promote 
acceptability and ensure effective utility and up-take in each context. 
 


















Igama lami ngu Londeka Mbewe, Ngibhalela ukucela ukuthi sizohlanganyela ucwaningo 
engizobe ngilenza. Isihloko salolu cwaningo sithi: Ukwamukelwa noku setshenziswa kwe 
microbicide: Ucwaningo lwemibono yabantu besilisa nabe sifazane ezindaweni zase 
madolobheni nase makhaya eThekwini nase Naspoti.  
 
Lolucwaningo lwenzelwa ngaphantsi kwemigomo ye Nyuvesi ya KwaZulu-Natal, Centre for 
Communication, Media and Society (CCMS), ngaphansi komhloli u-Dokotela Eliza Govender. 
Lolu cwaningo luphenya ukuthi ukusetshenziswa kwale microbicide ingabe buhambiselana 
nabuphi ubunzima ekusetshenzisweni kwayo njenge ndlela eyokuvikela igciwane le sandulela 
ngculaza ezindzaweni zase dolobheni nase makhaya. 
 
Ingqikithi yalolu cwaningo lilele ekutheni kutholakale izimo ezinga vimbela noma ezinga 
thuthukisa ukuthi abantu besi mame bakwazi ukusebenzisa ama microbocides. Iphinde ibheke 
ukuthi lezo zimo zingalungiswa kanjani, nanokuthi abantu besilisa bangasetshenziswa kanjani 
ekutheni bakhuthaze omama ukuthi bamukele, basebenzise, baphinde baqhubeke 
nokusebenzisa lama microbicide ukuze bazivikile ekutholeni isandulela ngculaza. 
 
Uyacelwa ukuthi uzohlanganyela kule ngqoxo ezoba khona e………………………. 
ngomhlaka…… enyangeni ya ………..2016. Lengxoxo izothatha isikhathi esi ngange hora nemi 
zuzu engamashumi amathathu. Izoqala nge hora lokuqala (13h00) kuye ku hora lesibili 
namashumi ama thathu (14h30) emini. Ngicela imvumo yakho ukuthi ngisebenzise i-tape 
recorder uma ngenza lolu cwaningo khona ngizokwazi ukulalela uma sengi hlaziya imiphumela.  
 
Lemininingwane ezotholwa kulolu qwaningo izo bekwa ehhovisi lika Dokotela Eliza Govender, 
eNyuvesi ya KwaZulu-Natal iminyaka emi hlanu. Lokhu kwenzelwa ukuthi kuzobuyela kuyo uma 
kudingeka isiqiniseko esithize mayelana nalolu cwaningo. Uma labantu abazoba ingxenye 
yalolu cwaningo bazocela ukubona lomsebenzi, bazo thunyelelwa imiphumela yalomsebenzi 
uma umcwaningi ese qedile. 
 
Abazobamba iqhaza kulolu cwaningo bazobe bayi ngxenye yalo ngokuzi nikezela. Abantu 
ngeke bakhokhelwe ngemali, kodwa bazophiwa okuncane okuya ethunjeni. Abantu banga yeka 
noma inini ukuba ingxenye yalolu cwaningo ngaphandle kokuthi kube khona okubi 
okubehlelayo. Izmpendulo zabantu zizofihlwa, ziphathwe ngentlonipho kodwa abantu baya 
nxuswa ukuthi bangakhulumi ngezinto noma izindzaba zabo abangeke bafune ukuzi dalula 
kalula. 
 
Umcwaningi ngeke asebenzise ulwazi azoluthola kulolu qwaningo ngaphandle kwemvumo 
yabantu ababe yingxenye yalo lolu cwaningo. Abantu bazophathwa ngentlonipho enkulu, ngeke 
futhi bakhohliswe ngokuthi bakhulume ngezinto ezihambisana ngqo nezimpilo zabo nolwazi 
abangeke bathande ludalulwe ngaphandle kwemvumo yabo. Umcwaningi uzo nikeza abantu 
ifomu abazoli sayina, elizobe lichaza ukuthi abantu bayamuvumela ukuthi asebenzise amagama 
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abo eqiniso noma okuzalwa, noma aqambe amagama amanga uma bangathandi ukuthi 
kubhalwe amagama abo. 
 
Ngicela ukuthi wazi ukuthi i-microbicide isa cwaningwa, yikho akukho lapho itholakala khona. 
Okubalulekile ngalolu cwaningo ukuthi kutholakale lezinto ezingavimbela abantu besi fazane 
ukuthi basebenzise ama microbicide njengendlela yokuzivikela ukuthi bathole isifo se sandulela 
ngculaza. Lokhu kuzo siza ekutheni abantu abenza le microbicide yokuvikela isandulela 
ngculaza bakwazi ukwenzela bonke abantu besi fazane kuzo zonke izindawo, nanokuthi 
kutholakale izindlela ezingasiza ekutheni bonke abantu besi fazane bayamukele, baphinde 
baqhubeke noku sebenzisa ama microbicide. 
 












Ligama lami ngingu Londeka Mbewe, Ngibhalela kucela kutsi utohlanganyela kuleli cwaningo 
lengitobe ngilenta lesihloko lesitsi: Kwamukelwa neku setjentiswa kwe microbicide: Licwaningo 
lwemibono yabo babe nabo make etindzaweni tase madolobheni nase makhaya eThekwini 
nase Naspoti.  
 
Leli cwaningo lwentelwa ngaphansi kwemigomo ye Nyuvesi ya KwaZulu-Natal, e-Centre for 
Communication, Media and Society (CCMS), ngaphansi kwe mhloli Dokodela Eliza Govender. 
Lelicwaningo liphenya kwekutsi ngabe imicrobicide inga sebentiseka lula njenge ndlela 
yokuvikela ligciwane le HIV kubo make etindzaweni tase madolobheni nase makhaya.  
 
Ingcikitsi yaleli cwaningo incike ekutseni kutfolakale letintfo letinga vimbela noma letinga 
tfutfukisa kutsi bantfu bomake bakhone kusebentisa i-microbocide. Iphindze ibuke kutsi leto 
tintfo tinga lungiswa njani, nanokutsi bantfu besilisa bangasetjentiswa ngayiphi indlela ekutseni 
bakhutsate bomake kutsi bamukele, basebentise, baphindze bachubeke nekusebentisa i-
microbicide. 
 
Uyacelwa kutsi utohlanganyela kuleti ngcogco letotoba khona e………………………. 
mhlaka…… enyangeni ya ………..2016. Letingcogco titawu tsatsa sikhatsi lesi ngange lihora 
nema minitsi lalishumi lamatsatfu. Itawucala ngensimbi yekucala (13h00) kuye ku yesibili 
nemashumi lamatsatfu (14h30) emini. Ngicela imvumo yakho kutsi ngisebentise i-tape recorder 
uma ngenta leli cwaningo ngitokwati kulalela uma sengihlatiya miphumela. 
 
Lemininingwane letawu tfolwa kuleli cwaningo itawu bekwa ehhovisini la Dokodela Eliza 
Govender, eNyuvesi ya KwaZulu-Natal minyaka lesihlanu, kwentele kutsi kutawubuyela kuyo 
uma kudzingeka siciniseko lesitsite mayelana naleli cwaningo. Uma labantfu labatawu tsatsa 





Labatotsatsa incenye kuleli cwaningo benta njalo ngeku nikelela. Bantfu ngeke babhadalwe 
ngemali, kepha batophiwa lokuncane lokuya ethunjwini. Bantfu banga yekela noma ngabe 
ngunini kuba incenye yaleli cwaningo ngaphandle kwekutsi kube khona lokubi lokunga behlela. 
Timphendvulo tebantfu titawu fihlwa, tiphatswe ngenhlonipho kepha bantfu baya ncuswa 
kwekutsi bangakhulumi ngetintfo noma tindzaba tabo lebangeke batsandze kutsi tatiwe 
ngulabanye bantfu.  
 
Mcwaningi ngeke asebentise lelwati latalutfola kuleli cwaningo ngaphandle kwemvumo yebantfu 
lebabe yincenye yaleli cwaningo. Bantfu batophatswa ngalenkhulu inhlonipho, ngeke futsi 
bakhohliswe ngekutsi bakhulume ngetintfo letihambisana ngco netimphilo tabo noma lebangeke 
batsandze kutsi tatiwe ngulabanye bantfu ngaphandle kwemvumo yabo. Mcwaningi utawu nika 
bantfu lifomu lebatawuli sayinda, lelitobe lichaza kutsi bantfu bayamuvumela kwekutsi 
asebentise magama abo eliciniso noma ekutalwa, noma acambe emagama emanga uma 
bangatsandzi kwekutsi kubhalwe emagama abo. 
 
Ngicela kutsi wati kwekutsi ma microbicides asa cwaningwa, kungako akukho lapho itfolakala 
khona. Lokubalulekile ngaleli cwaningo kuseku tseni kutfolakale letintfo letingavimbela bafati 
ekutseni basebentise imicrobicide njengendlela yekutivikela kutsi bangatfoli i-HIV. Loku kutosita 
ekutseni bantfu labenta letinsita bakwati kwentela bonkhe bafati kuto tonkhe tindzawo, nekutsi 
kutfolakale tindlela letingasita ekutseni bonkhe bafati bamukele, baphindze bachubeke neku 
sebentisa lendlela yekuvikela i-HIV. 
 
Nginga bonga kakhulu uma ungavuma kuba incenye yaleli cwaningo. 
 
 
Details of the researcher and institution of research: 
 
















    



























































Please do not hesitate to contact any of the above persons, should you want 
further information on this research, or should you want to discuss any aspect of 




Signed consent  
 I understand that the purpose of this interview is for solely 
academic purpose. The findings will be published as a thesis, 
and may be published in academic journals. 
       
Yes             No 
 I understand I may choose to remain anonymous. (Please 
choose whether or not you would like to remain anonymous.) 
Yes             No 
 I understand that I many choose whether or not my name will 
be quoted in remarks and or information attributed to yourself 
in the final research documents.  
Yes             No 
 







 I choose to use a pseudonym, not my real name. 
 I understand that I will not be paid for participating but a 
small, non-monetary souvenir will be given. 
Yes             No                       
 I understand that I reserve the right to discontinue and 
withdraw my participation any time. 
Yes             No 
 I consent to be frank to give the information.  Yes             No 
 I understand I will not be coerced into commenting on issues 
against my will, and that I may decline to answer specific 
questions. 
Yes             No 
 I understand I reserve the right to schedule the time and 
location of the interview. 
Yes             No 
 I understand that an audio recorder will be used during the 
research proceedings. 
Yes             No 
 
* By signing this form, I consent that I have duly read and understood its content. 
 
 
 Name of Participant              Signature         Date 
 































Focus Group Discussion 1, MP rural females. Moderated by Londeka Mbewe, in Matsafeni- 
Nelspruit, South Africa, March 2016. 
  
Focus Group Discussion 2, MP rural males. Moderated by Londeka Mbewe, in Matsafeni- 
Nelspruit, March 2016. 
 
Focus Group Discussion 3, MP urban females. Moderated by Londeka Mbewe, in Tekwane 
South- Nelspruit, March 2016. 
 
Focus Group Discussion 4, MP rural females. Moderated by Londeka Mbewe, in Tekwane South- 
Nelspruit, March 2016. 
 
Focus Group Discussion 5, MP rural females. Moderated by Londeka Mbewe, in Umlazi-Durban, 
KwaZulu-Natal, April 2016. 
 
Focus Group Discussion 6, MP rural females. Moderated by Londeka Mbewe, in Umlazi-Durban, 
KwaZulu-Natal, April 2016. 
 
Focus Group Discussion 7, MP rural females. Moderated by Londeka Mbewe, in Umnini-Durban, 
KwaZulu-Natal, April 2016. 
 
Focus Group Discussion 8, MP rural females. Moderated by Londeka Mbewe, in Umnini-Durban, 
KwaZulu-Natal, April 2016. 
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